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General introduction 
 
 
1. EU FOOD SAFETY GENERAL LEGAL 
FRAMEWORK 
 
Food safety can be defined as the 
condition which ensures that food will not 
cause harm to the consumer when it is 
prepared and/or eaten according to its intended 
use [1]. Following a series of headline-hitting 
food safety crises in the late 1990s, it became 
apparent that national regulations on their own 
were no longer able to provide sufficient 
consumer protection in a globalized world. At 
the European level, legislation has therefore 
been enacted, transposed into national 
provisions and supplemented as needed. The 
European Commission’s White Paper on food 
safety in 2000 was the driver towards a new 
structure for food safety in the European Union 
(EU). It presented a new concept for Europe’s 
consumer protection based on the safety of all 
relevant stages of the food supply chain, i.e. 
the somewhat commonplace used concept 
“from farm to fork”. 
Regulation (EC) No. 178/2002 and 
Regulation (EC) No. 882/2004 are the legal 
foundations for food legislation in the EU and 
apply directly in all EU Member States (MSs) 
without having to enact national laws, 
providing European consumers with an 
uniform level of food safety. Specifically, 
Regulation (EC) No. 178/2002 lays down the 
general principles and requirements of food 
law in the EU as based on the farm-to-fork 
concept. Moreover, it establishes the remits of 
the European Food Safety Authority (EFSA) 
and has created the Rapid Alert System for 
Food and Feed (RASFF) network. Regulation 
(EC) No. 882/2004 lays down the general 
principles of official controls to be performed 
to ensure compliance with food and feed law in 
the EU [1]. 
 
 
2. FOOD-BORNE DISEASES 
 
2.1. Public health impact 
 
Consumers are threatened by more 
than 200 known pathogenic agents 
transmissible through food [2], including, 
among others, a wide range of viruses, 
bacteria, parasites and prions with known 
zoonotic potential, that is, transmissible 
between animals and humans. Most of these 
food-borne zoonotic pathogens are commonly 
found in the intestines of healthy food-
producing animals and typically present in 
humans with acute gastroenteritis [2]. 
Gastrointestinal symptoms due to food-borne 
disease are generally mild to moderate in 
severity and self-limiting in persistence, lasting 
only a few days. This lends food-borne 
diseases to be sometimes regarded as comedy 
diseases, not pleasant to have or to talk about, 
but something more than a mere inconvenience 
[3]. Yet trivializing food-borne diseases 
ignores their magnitude and potential life-
threatening complications or long-term 
sequelae. Annual estimates of food-borne 
diseases vary from 76 million cases in the 
United States of America (USA) [4] to 5.4 
million in Australia [5], 1.3 million in England 
and Wales [6] and 680 thousand in The 
Netherlands [7]. Complications of food-borne 
diseases may involve severe dehydration, 
gastrointestinal perforation, septicaemia, renal 
failure, hepatitis and neurological syndromes 
[2,4,8]. In addition, several food-borne 
diseases have been associated with chronic 
sequelae such as irritable bowel syndrome 
(IBS) [8–11], inflammatory bowel disease 
(IBD) [11,12], reactive arthritis [8,11,13] and 
Guillain-Barré syndrome [8,14].  
Although the global burden of food-
borne diseases is currently unknown, the 
World Health Organization (WHO) has 
estimated that diarrhoeal diseases alone (a 
considerable proportion of which is food-
borne) account for 73 million of disability-
adjusted life years (DALYs), a measure of 
disease burden expressed as the number of 
years lost by the global population due to 
illness, disability or early death imputable to 
the disease in question [15]. Moreover, 
economic losses due to the direct and indirect 
costs of food-borne diseases, including medical 
care, patients’ absence from work or school, 
disposal of contaminated food and food sales 
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drop due to consumer reaction to food safety 
crises, may be considerable as well. For 
instance, it has been estimated that, 
collectively, the human disease costs for seven 
common food-borne pathogens 
(Campylobacter jejuni, Clostridium 
perfringens, Escherichia coli O157:H7. 
Listeria monocytogenes, Salmonella spp., 
Staphylococcus aureus and Toxoplasma 
gondii) in the USA account for 6.5–34.9 
billion of 1995 USA dollars annually [16]. 
These are some of the reasons as to why, over 
the last decades, food-borne diseases have 
significantly moved up the political agenda of 
the industrialized world and generated, on 
occasions, substantial scientific and media 
attention [17]. 
Food-borne diseases have a complex, 
dynamic nature. Not only because of the many 
pathogens and related clinical outcomes, but 
also because of the wide range of foods serving 
as sources of human infection and animals 
acting as reservoirs for food-borne pathogens, 
as well as the numerous factors that may affect 
contamination, growth, persistence, and 
inactivation of pathogens themselves 
throughout the farm-to-fork continuum [18]. 
Despite considerable research efforts leading 
to a generation of new or improved methods 
for detecting and characterizing food-borne 
pathogens, supporting public health risk 
assessments and policy development as well as 
implementing effective intervention strategies 
such as vaccination for food-producing 
animals or post-harvest treatments [17], safe 
food can never be taken for granted. It is 
simply impossible to test every single food 
item for every imaginable pathogen, not to 
mention that this would make our food 
prohibitively expensive. Moreover, the 
epidemiology of food-borne pathogens 
changes continuously: known pathogens may 
be transmitted by hitherto unknown vehicles 
while new pathogens continue to emerge. 
Population growth and demographic shift 
towards an ageing and more susceptible 
population, globalization of the food supply, 
changing eating habits, farming practices and 
food technologies, and even climate change, 
have been proposed as factors driving the ever-
changing epidemiology of food-borne 
pathogens [17,19,20]. It is therefore extremely 
important to strengthen research and improve 
public health surveillance of food-borne 
pathogens in order to monitor what is going on 
in the population and to empower decision 
makers to guide and manage more effectively 
by providing timely, useful evidence. 
 
2.2. Surveillance in humans 
 
Public health surveillance is defined as 
the ongoing systematic collection, analysis, 
and interpretation of data, with their timely 
dissemination to those responsible for 
preventing and controlling the disease in 
question [21]. Recent developments in the field 
of food-borne disease epidemiology are also 
the result of improvements in surveillance 
systems. The most widely used measure of the 
magnitude of food-borne diseases in a 
population is the estimation of the incidence of 
cases infected with specific pathogens. Most 
frequently used as a basis for such estimates is 
the incidence of laboratory-confirmed cases of 
specific pathogens usually captured by passive 
surveillance of notifiable diseases. This type of 
surveillance typically collects aetiological 
information on food-borne pathogens affecting 
only a small proportion of patients with 
(severe) gastrointestinal symptoms that seek 
for medical care, with subsequent laboratory 
testing for selected ranges of gastrointestinal 
pathogens. However, it has been shown that 
the laboratory tests requested by physicians do 
not always comply with existing knowledge of 
the aetiology of acute gastroenteritis [22]. 
Furthermore, laboratory capacity may not be 
standardized over the different diagnosing 
laboratories, as may be also the case for the 
reporting of cases to the surveillance systems 
[18]. As a consequence, the magnitude of 
food-borne diseases, as observed by passive 
surveillance, represents only the tip of the 
iceberg of the actual magnitude of such 
diseases in the population. For instance, in the 
EU, over 320,000 human cases of zoonotic 
food-borne diseases are reported each year by 
the EU MSs to the European Surveillance 
System (TESSy), but the real number is likely 
to be ~100 times higher [7].  
Approaches to estimate the degree of 
under-ascertainment, or under-reporting, of 
pathogen-specific gastroenteritis cases in the 
population have been developed, allowing for 
the reconstruction of the so-called surveillance 
pyramid (Figure 1) and the estimation of the 
real community incidence of the major food-
borne diseases in the EU [7,23,24]. Other 
surveillance systems may, instead, primarily 
target syndromes related to food-borne 
diseases (i.e. acute gastroenteritis) or over-the-
counter medication sales (i.e. antidiarrhoeals 
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and antiemetics), two useful systems for early 
warning of community outbreaks, e.g. [25–27], 
especially in emergency situations, such as 
natural disasters [28] or unusual mass 
gatherings [29]. Finally, active surveillance of 
selected pathogens of greatest interest in given 
populations may be implemented to fill 
specific gaps in knowledge, e.g. severe 
rotavirus gastroenteritis in children [30]. 
Indeed, quantifying the impact of food-borne 
diseases on a given population is complicated, 
perhaps increasingly so, by a number of factors 
such as different susceptibility to 
(symptomatic) infection of existing 
(sub)populations (i.e. children, elderly, 
immunocompromised people, pregnant 
women, etc.) or different genetic traits (e.g. set 
of virulence and antimicrobial resistance 
genes) within the same pathogen species or 
types, which may significantly affect the 
severity of clinical symptoms and the 
effectiveness of medical treatment, not to 
mention the changes in consumers' behaviours 
regarding exposure to pathogens [18]. In such 
situations, extrapolations from a surveillance 
system to the whole population may therefore 
require further adjustments and special 
consideration. 
  
 
Figure 1. Surveillance pyramid of food-borne diseases. 
 
2.2. Human illness source attribution 
 
Source attribution is defined as the 
estimation of the relative contributions 
(partitioning) of different sources of human 
infection to the human disease burden [31]. 
Source attribution is a growing area of research 
that incorporates an increasing number of 
methodological approaches and data sources. 
A detailed discussion of source attribution 
applications, including their advantages and 
limitations, may be found elsewhere [31,32]. 
The term source is often used as a collective 
term to cover any point along the transmission 
chain, such as the animal reservoir or 
amplifying host (e.g. chicken, cattle, etc.), the 
vehicle (e.g. food, water, direct contact, etc.) 
and even specific food items (e.g. meat, milk, 
eggs, etc.). However, for the purposes of 
source attribution, a specific terminology is 
generally used. 
 Reservoirs or amplifying hosts: these are 
animals or non-animal sources upon which 
the pathogen depends for its survival that can 
be grouped or subdivided into 
epidemiologically meaningful categories 
depending on the question being addressed. 
For instance, cattle, sheep and goat may be 
grouped together as ruminants if it is not 
relevant or possible to determine their 
independent contributions. Alternatively, 
poultry may be subdivided according to the 
supplier. Source attribution at the reservoir 
level provides estimates of the relative 
contributions of the amplifying hosts to the 
human disease burden for the purposes of 
targeting interventions at the top of the 
transmission route. In such attribution 
models, it may also be appropriate to use 
non-animal sources, such as the environment 
(e.g. water samples) to capture also the 
contribution from unmeasured hosts or group 
of hosts, such as wildlife. 
 Routes or pathways (of transmission): these 
may be considered the primary ways by 
which pathogens shed by the reservoirs reach 
and infect humans. Again these can either be 
grouped or subdivided according to the 
question being addressed. Meaningful 
categories for informing policy are food, 
environment, water (which may be 
considered part of the environmental 
pathway) and direct contact. A number of 
approaches have been used to estimate the 
contribution of different pathways. Top-
down approaches, which subdivide the 
contribution of amplifying hosts into food 
and environmental pathways; or bottom-up 
approaches, which combine the contributions 
from different exposures and risk factors.  
 Exposures: primary pathways can be 
subdivided into a number of secondary 
exposures. For instance, the food pathways 
can be divided into meat and milk, while 
environmental contamination of surface 
water may affect drinking-water and 
recreational water.  
 Risk factors: these are characteristics, 
conditions or behaviours that increase the 
probability of disease. For instance, in case-
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control studies, variables are measured that 
describe specific determinants of risk (such 
as the consumption of a specific food item). 
The magnitude of such risk associated with 
these factors is estimated and the statistical 
significance of association is tested. These 
are represented as a further subdivision of 
pathways and exposures. For example, cattle 
(reservoir) may contaminate the food chain 
(pathway) resulting in hazard in the milk 
supply (exposure), which manifests itself as 
an increased risk associated with the 
consumption of unpasteurized milk (risk 
factor).  
Attributing human infections to 
specific sources is crucial to inform policies 
for food-borne disease prevention and control. 
Specifically, source attribution is used to 
prioritize and measure the impact of targeted 
interventions for food-borne diseases, as well 
as to identify the most promising points of the 
transmission chain where such interventions 
should be targeted [31,32]. A number of 
approaches (reviewed by Pires et al. [31]) can 
be used for source attribution, including 
microbial subtyping, outbreak summary data, 
epidemiological studies, comparative exposure 
assessment, and structured expert opinion. 
These approaches can be broadly divided into 
epidemiological and microbiological 
approaches, and their utility varies according 
to data availability and research question being 
addressed [32].  
For most source attribution studies on 
human salmonellosis and campylobacteriosis 
(the two food-borne diseases on which this 
thesis is focused), the microbial subtyping 
approach is the method of choice. This 
approach compares the distributions of 
microbial subtypes in human cases with those 
isolated from a range of animal, food and 
environmental sources to estimate the 
contribution of each source to the human 
disease burden. Data generated by either 
phenotypic or genotypic typing methods are of 
considerable value for understanding the 
epidemiology of food-borne diseases by 
refining knowledge on the relative 
contributions of reservoirs, pathways, 
exposures and risk factors in source attribution 
models. In particular, they provide a means of 
monitoring changes in reservoir attribution and 
epidemiology over space and time, which is of 
particular value for assessing the impact of 
different public health interventions. However, 
the disadvantages include the costs of 
sampling, isolation and genotyping of isolates 
which, if not already integrated in existing 
surveillance programmes, may be prohibitive 
in most cases. 
A number of modelling tools are 
nowadays available for source attribution using 
the microbial subtyping approach. These 
models will be presented in detail throughout 
this thesis and are briefly introduced here as 
follows: 
 Proportional Similarity Index (PSI) or 
Czekanowski index: this is an objective and 
simple estimate of the area of intersection 
between two frequency distributions of 
microbial subtypes [33,34]; thus, it can be 
used to assess the (dis)similarity of such 
frequency distributions between reservoirs 
and human cases. The PSI ranges from 0 (no 
common subtypes) to 1 (identical 
distribution). Confidence intervals can be 
approximated by bootstrapping. 
 Dutch model: this method compares the 
number of reported human cases caused by a 
particular subtype with the relative 
occurrence of that subtype in each reservoir 
[35]. This model assumes an equal impact of 
the different subtypes and sources on human 
cases. It is easy to apply and the method of 
Garret et al. [36] can be extended to provide 
bootstrap confidence intervals. 
 Hald model and modified Hald model: the 
Hald model is a Bayesian risk assessment 
model, originally developed to quantify the 
contribution of different food sources to 
human salmonellosis cases in Denmark [37]. 
Afterwards, this model has been modified 
and adapted to data of different origin and 
diseases other than salmonellosis, such as 
campylobacteriosis [34]. The original model 
compares the number of human cases caused 
by different types with their prevalence in 
different food sources, weighted by the 
amount of food consumed, accounting for 
differences in subtypes and sources to cause 
diseases in humans. This is a Bayesian 
development of the earlier Dutch model and 
requires a heterogeneous distribution of 
some of the frequently occurring  types 
among the sources. By using a Bayesian 
approach, the Hald model can explicitly 
include and quantify the uncertainty around 
each of the parameters. The modified Hald 
model overcomes some of the problems of 
the original model associated with over-
parameterization and incorporates 
uncertainty in the prevalence matrix [34]. 
Other modifications of this model have been 
developed and successfully applied to 
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salmonellosis in Sweden [38], France [39] 
and the USA [40], and to listeriosis in 
England and Wales [41]. 
 Asymmetric Island (AI) model: this is a 
population genetics approach and is 
fundamentally different from the Dutch and 
Hald models. It is a model of gene flow 
derived from population genetics that 
reconstructs the genealogical history of the 
isolates, based on their allelic profiles, and 
estimates mutation and recombination rates, 
as well as the migration rates from each 
reservoir into the human “islad” [42]. These 
migration rates are then used to estimate the 
relative contribution from each of the 
reservoirs. This technique has one major 
advantage over the other methods as it can 
assign human cases infected with subtypes 
that have no identified animal or 
environmental reservoirs. 
 Dynamic attribution model: this model 
describes how reservoir attribution changes 
over time, and can be used for ongoing 
surveillance and for assessing the impact of 
interventions [43,44]. The Hald model forms 
the basis of current dynamic attribution 
models, and various ways by which the 
classical output of the Hald models may be 
improved have been developed, e.g. [45]. 
A critical issue of source attribution 
modelling is the point of attribution, that is, the 
location along the farm-to-fork continuum that 
is addressed by a given attribution approach. 
For instance, attribution focused at the point of 
production would identify the food-producing 
animal reservoirs of on-farm microbiological 
contamination prior or during harvesting, 
whereas attribution at the point of consumption 
or exposure would identify foods as they are 
prepared and eaten. Different types of data and 
different analyses may point to different points 
of attribution, and even the same type of data 
may point to multiple points of attribution. 
Because pathogens that cause food-borne 
diseases may enter the food chain at different 
points, the burden of disease attributed to 
specific sources may vary from one point to 
another. For example, attribution of human 
Campylobacter infections may partition more 
illness to the chicken reservoir than to broiler 
meat at the point of consumption since other 
foods, e.g. raw vegetables, may become cross-
contaminated during food preparation. The 
point of attribution essentially depends on the 
method chosen and the data used. Figure 2 
presents the major transmission routes for 
food-borne infections and indicates at which 
point in the transmission chain the different 
approaches can attribute human illness.  
 
 
Figure 2. Routes of transmission of zoonotic pathogens and points of human illness attribution as proposed by Pires et al. [31]. 
 
The food system is dynamic in nature, 
meaning that attribution estimates rapidly 
become out of date. It is largely unclear how to 
interpret apparent trends moving forward or 
how to aggregate data over time. Changes in 
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the durable immunity of the population or of 
the antimicrobial resistance of pathogens can, 
to some extent, reasonably affect attribution 
estimates, as do changes in consumption 
patterns and changes in contamination due to 
regulatory changes or implementation of 
intervention strategies [31]. 
 
3. HUMAN SALMONELLOSIS AND 
CAMPYLOBACTERIOSIS 
 
Throughout the 1990s until today, the 
two most reported zoonotic food-borne 
bacteria in the industrialized world, Salmonella 
spp. and Campylobacter spp., have dominated 
the most research and surveillance attention 
from government agencies and, to a large 
extent, the most awareness from the food 
industry. These pathogens contribute to the 
greatest burden of food-borne diseases for 
which aetiology is known [7,23] and provide 
an example of the persistence of food-borne 
pathogens despite considerable efforts aimed at 
their prevention and control in the food chain. 
Not surprisingly, therefore, that human 
salmonellosis and campylobacteriosis 
nowadays command the majority of public 
health interest.  
 
3.1. Salmonella 
 
Salmonella is a genus of Gram-
negative, facultative anaerobic, rod-shaped, 
non-spore forming and predominantly motile 
bacteria (diameter 0.7–1.5 µm, length 2–5 µm) 
belonging to the Enterobacteriaceae family. 
Salmonella was first reported in 1885 by (and 
named after) Dr. Daniel Elmer Salmon (1850–
1919), an American veterinary pathologist. 
The genus Salmonella is divided into two 
species, S. enterica and S. bongori, with the 
species S. enterica being further divided into 
six subspecies (S. enterica subspp. enterica, 
salamae, arizonae, diarizonae, houtenae and 
indica).  
Serotyping is used to differentiate 
Salmonella isolates beyond the subspecies 
level. Serotypes (or serovars) are designated 
based on the immunoreactivity of the O and H 
antigens. A considerable amount of diversity 
exists in these two antigens, resulting in the 
designation of more than 2500 known 
Salmonella serotypes and the regular 
recognition of new serotypes. The simplified 
antigenic formulae of these serotypes are listed 
in a document called the Kauffmann-White 
scheme [46], and the WHO Collaborating 
Centre for Reference and Research on 
Salmonella, at the Institut Pasteur in Paris, 
France, is in charge of updating this scheme 
[47]. Salmonellas most frequently transmitted 
through food are often referred to as non-
typhoid to differentiate them from S. Typhi and 
S. Paratyphi, the causative agents of the 
Typhoid Fever, which is restricted to human-
to-human transmission. Two particular non-
typhoid Salmonella serotypes, S. Enteritidis 
and S. Typhimurium, have become major 
causes of food-borne disease in the 1980s and 
1990s in the industrialized world.  
S. Enteritidis and S. Typhimurium (and 
a few others) can further be divided in a 
number of phage types, which indicate subsets 
on one serotype that are susceptible to the 
same lytic bacteriophages [48]. Antimicrobial 
susceptibility testing is often used in 
combination with other subtyping methods. 
However, antimicrobial resistance is a 
relatively unstable characteristic as it is often 
carried by horizontally transferrable genetic 
material (transformation, conjugation and 
transduction). Common methods for 
Salmonella genotyping include, but are not 
limited to, Pulsed-Field Gel Electrophoresis 
(PFGE, often considered as the gold standard 
in epidemiological studies), Multilocus 
Variable Number Tandem Repeat Analysis 
(MLVA), Multilocus Sequence Typing 
(MLST) and (multiplex-) PCR-based methods. 
The combined use of phenotypic and genotypic 
typing methods, such as serotyping, phage 
typing, antimicrobial resistance testing, PFGE 
and MLVA, allows for a very detailed 
comparison of Salmonella strains. 
Nevertheless, in most cases, the use of 
serotyping only is regarded as sufficiently 
discriminatory, but for frequently occurring 
serotypes and in outbreak investigations, the 
use of serotyping only is often insufficiently 
informative.   
Salmonella spp. are capable of 
colonizing, usually asymptomatically, the 
intestines of a wide range of warm and cold 
blooded hosts, including virtually all the major 
food-producing animals (e.g. poultry, cattle, 
pigs, etc.), pets, wildlife, reptiles and 
amphibians. Salmonellas are excreted from 
infected animals to the environment, where 
they can survive for extended periods, e.g. up 
to 60 days in faecally contaminated water or 
soil [49,50]. Transmission to humans occurs 
mainly through consumption of food of animal 
origin that has been faecally contaminated 
during slaughtering or processing, as well as 
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through consumption of any edible product 
that has been cross-contaminated during food 
preparation. Human Salmonella infection is 
frequently acquired because of mishandling or 
undercooking of food, especially poultry, eggs, 
seafood and raw milk. Up to 95% of human 
Salmonella infections are indeed estimated to 
be food-borne [51]. Nevertheless, salmonellas 
can also be transferred through direct or 
indirect contact with animals, their waste 
products or anything contaminated in their 
environments.  
A recently identified trend in human 
Salmonella infections has been an increased 
association of outbreaks with unusual vehicles, 
such as fresh produce, given that manure is 
frequently used as a fertiliser. Studies have 
also suggested that some Salmonella spp. have 
now evolved to colonize vegetables [52–54] or 
the environment [55]. Furthermore, food 
handlers infected with salmonellas can 
transmit them if they, for instance, do not 
thoroughly wash their hands after toilet visit. 
This is the special case of the aforementioned 
host-adapted serovars S. Typhi and S. 
Paratyphi, which indeed spread from person to 
person, especially in countries with deficient 
wastewater systems. 
Human salmonellosis targets 
predominantly the gastrointestinal tract, 
causing acute gastroenteritis, with diarrhoea, 
abdominal pain, fever and sometime vomiting. 
It takes a very small amount of salmonellas to 
sicken a person, possibly as little as 20−200 
bacterial cells, and the first signs of illness can 
occur within 6–72 hours (incubation period), 
depending on the host health status, the 
serotype, the inoculum and the composition of 
contaminated food. Antibiotic treatment is not 
usually required as the disease is frequently 
self-limiting, lasting 4–7 days. However, in 
high risk groups (e.g. infants and young 
children, elderly, transplant recipients, 
pregnant women and people with a weakened 
immune system), symptoms may be so severe 
to require hospitalization. Development of 
complications, such as severe dehydration, 
septicaemia and extra-intestinal infections (e.g. 
meningitis, endocarditis or osteomyelitis), can 
be life-threatening. Possible documented long-
term sequelae are reactive arthritis and 
functional gastrointestinal disorders, such as 
IBS and IBD [8]. 
Non-typhoid Salmonella species were 
estimated to cause ~93.8 million human cases 
of gastroenteritis globally each year, with 
~155,000 deaths [56]. Approximately 6.2 
million cases/year have been estimated to 
occur in the EU [23] and over 1.4 million in 
the USA [51]. Furthermore, the Sensor study 
in The Netherlands [57] has been used as a 
basis for the calculation of the burden of 
salmonellosis in terms of DALYs (7 DALYs 
per 100,000 population/year) [7].  
In 2010 in the EU, the incidence of 
reported laboratory-confirmed human 
salmonellosis cases was 21.5 cases per 100,000 
population, with a statistically significant 
decreasing trend since 2005 (38.2 cases per 
100,000 population), a possible reflection of 
successful Salmonella control programmes in 
poultry [58]. Indeed, most EU MSs met their 
Salmonella reduction targets for poultry in 
2010, and Salmonella is declining in these 
animal populations. S. Enteritidis and S. 
Typhimurium are the most frequently isolated 
serotypes from human cases, accounting for 
~45% and ~22%, respectively, of all known 
serotypes in humans. Notification rate is 
usually highest in small children (<5 years of 
age), with <1% of fatal cases. A peak in the 
number of reported human Salmonella 
infections normally occurs in August–
September, with a rapid decline in winter 
months. This pattern is prominent for all age 
groups, supporting the influence of outside 
weather conditions (i.e. warmer temperatures) 
on bacterial multiplication. The proportion of 
cases that are acquired domestically, upon 
traveling and with unknown origin is ~63%, 
~11% and ~26%, respectively. Nordic 
countries such as Finland, Sweden and Norway 
usually have the highest proportions of 
imported cases of human salmonellosis, 
whereas infections seem to be mainly 
domestically acquired in the majority of other 
EU countries [58].  
Food-borne outbreaks of human 
salmonellosis are frequently reported. This is a 
reflection of a low infectious dose, especially 
when delivered in particular low-moisture 
foodstuffs, such as peanut butter, infant 
formula, chocolate, cereal products and dried 
milk [59], but also an ability to grow in food 
and in the environment, allowing amplification 
and long-term survival. Such diverse habitats 
also provide opportunities for adaptation and 
evolution. This is demonstrated by the 
changing trends in human salmonellosis 
observed in recent years. For instance, during 
the 1980s, a peak in human salmonellosis was 
observed throughout the developed world. This 
increase was mainly due to S. Enteritidis phage 
type (PT) 4, which was epidemiologically and 
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microbiologically linked to eggs and poultry 
(layer hens). These salmonellas have indeed 
adapted to preferentially colonize the avian 
reproductive tract, persist in the ovary and 
oviduct and survive in layer henʼs eggs [60]. 
Intervention measures against S. Enteritidis 
PT4, including vaccination, first of breeder 
flocks and then of layers, has significantly 
reduced egg-associated infections during the 
late 1990s in several European countries, but 
from 2000 there has been further increase in 
human salmonellosis, this time with non-PT4 
strains, such as PT1, PT14B and PT21. 
Outbreak data, coupled with intensive 
laboratory investigations, has suggested that at 
least some of these strains are, once again, 
associated with eggs; thus, as one Salmonella 
type is controlled, others appear to evolve to 
fill the vacant niche. It follows, therefore, that 
Salmonella spp. are remarkably adaptable and 
able to evolve to respond to environmental 
challenges. 
 
3.2. Campylobacter 
 
Campylobacter is a genus of Gram-
negative, mostly sender, motile, non-spore 
forming, spirally curved rods (diameter 0.2–0.5 
µm, length 0.5–8 µm) belonging to the 
Campylobacteraceae family. Campylobacter 
was first described in 1886 by Dr. Theodor 
Escherish (1857–1911), who observed this 
bacterium in infants died because of a disease 
he named "cholera infantum", as reported by 
Samie et al. [61]. However, owing to 
difficulties in culturing these bacteria, they 
have been neglected until the first isolation 
from human faeces in 1972 [62]. 
Campylobacters have been referred to as 
"Vibrio like organisms" until 1963 when 
Sebald and Veron [63] gave the actual name of 
Campylobacter to the genus based on their 
shape, low DNA base composition, their 
micro-aerophilic growth requirement, and their 
non-fermentive metabolism [64]. The genus 
Campylobacter contains 16 species and six 
subspecies. The species C. jejuni and C. coli 
are those most commonly isolated from human 
cases, accounting for ~93% of confirmed 
human Campylobacter cases characterized at 
the species level in the EU [58]. Both C. jejuni 
and C. coli are thermophilic, oxidase, catalase 
and nitrate positive, sensitive to nalidix acid 
and resistant to cephalothin [65].  
A variety of Campylobacter typing 
approaches have been developed. Originally, 
typing methods were based on phenotypic 
characteristics, such as serotyping and phage 
typing. These methods are still in use but have 
proved to have a poor discriminatory power 
and limited value in epidemiological and 
source attribution studies. Molecular 
techniques such as fla-typing, ribotyping, 
PFGE, Amplified Fragment Length 
Polymorphism (AFLP) and Random Amplified 
Polymorphic DNA, (RAPD) are frequently 
used to complement phenotypic methods. 
MLST has been increasingly used for 
Campylobacter genotyping. MLST involves 
sequencing the forward and reverse strands of 
seven target gene fragments (Figure 3) [66]. 
The genes targeted code for essential metabolic 
functions (i.e. housekeeping genes) and 
therefore they are expected to be present in all 
isolates. These genes are under stabilizing 
selection, which limits the diversity available 
from each gene fragment. The use of seven 
genes provides sufficient information to allow 
isolates to be genealogically grouped. Indeed, 
by indexing the variation present in these 
seven housekeeping genes, MLST allows for 
the identification of genetic lineages in 
Campylobacter populations. A unique 
sequence pattern is assigned to a sequence type 
(ST), while closely related STs sharing the 
same alleles at different loci are considered as 
belonging to the same clonal complex (CC), 
the members of which possess a common 
ancestor [66].  
 
 
Figure 3. Chromosomal locations of the seven loci used in C. jejuni 
MLST [66]. 
 
The weakly clonal nature of 
campylobacters makes the use of most 
subtyping methods a difficult approach for 
tracking sources of human campylobacteriosis. 
In this regard, MLST has proved successful in 
source attribution of sporadic cases, e.g. 
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[34,42,67–71], as will also be shown in more 
detail later in this thesis.  
Campylobacters are widespread in 
nature. They are intestinal commensal bacteria 
of wild and domesticated animals, especially 
avian species (preferential hosts), resulting in 
contamination of the environment, including 
water sources. Although Campylobacter spp. 
are mostly perceived as food-borne pathogens, 
there is evidence for other transmission 
pathways, including direct and indirect contact 
with infectious animals, people and 
environments [72–75]. Campylobacters are 
prevalent in food-producing animals, such as 
poultry, cattle, pigs and sheep, as well as in 
pets, including cats and dogs, in wild birds and 
in water sources. Animals, however, rarely 
succumb to symptomatic infection. The 
bacteria can contaminate various foodstuffs, 
including meat, raw milk and dairy products 
and less frequently fish and fishery products, 
mussels and fresh produce.  
Case-control studies of sporadic 
human cases have evidenced that consumption 
of chicken is the most important risk factor for 
human campylobacteriosis [72–76]. However, 
as Campylobacter strains of chicken origin 
may reach humans through pathways other 
than food [77], the consumption and handling 
of chicken may account for up to 40% of 
human infections, while up to 80% may be 
attributed to the chicken reservoir as a whole 
[58]. Other frequently reported risk factors are 
consumption of unpasteurized milk [73, 
75,78], eating in restaurants [78–81], contact 
with pets, especially puppies [76,78,80,82–84], 
contact with farm animals [73,76,78–80,84,85] 
and foreign travel [75,76,78,80–82]. Cross-
contamination during food-preparation in the 
home has also been described as an important 
transmission route [86].  
As Campylobacter is not able to 
multiply in foods and has a relatively long 
incubation period (2–5 days), contamination 
would less often lead to outbreaks and most 
cases are indeed sporadic. Large outbreaks 
have often been caused by consumption of 
unpasteurized milk and contaminated drinking 
water. Survival of Campylobacter outside the 
amplifying host is poor, particularly under dry, 
relatively warm and anaerobic conditions. 
However, the infective dose of these bacteria is 
generally low, and ~500 bacterial cells are 
sufficient to cause disease in humans. Patients 
can experience mild to severe gastrointestinal 
symptoms, with watery, sometimes bloody, 
diarrhoea, abdominal pain, fever, headache and 
nausea. Infections are usually self-limiting and 
last only a few days. Besides extra-intestinal 
infections, an acute Campylobacter infection 
can have serious long-term consequences, 
including the peripheral neuropathies Guillain-
Barré syndrome and Miller-Fisher syndrome, 
reactive arthritis and functional gastrointestinal 
disorders [8,11]. 
Campylobacter spp. are considered to 
be the most common bacterial cause of human 
gastroenteritis in the western world. In 
developed countries, the organism is isolated 
3–4 times more frequently from patients with 
gastroenteritis than Salmonella spp. or E. coli. 
Although scarce, data from developing 
countries suggest that the burden of human 
campylobacteriosis is considerable. 
Approximately 9.2 million human 
campylobacteriosis cases/year have been 
estimated to occur in the EU [23] and over 2.5 
million in the USA [51]. The Sensor study in 
The Netherlands [57] provided a basis for 
estimating the burden of human 
campylobacteriosis in terms of DALYs (18 
DALYs per 100,000 population/year) [7]. The 
incidence of human campylobacteriosis was 
estimated to be ~9 per 1000 population/year in 
the United Kingdom (UK) (for 2008–2009) 
[87] and ~6 per 1000 population/year in The 
Netherlands (for 2009) [7], leading to only one 
out of every ~9 cases in the UK and one out of 
12 in The Netherlands to be reported to 
national surveillance systems. In the USA, it is 
estimated that one out of ~30 cases is reported 
by FoodNet sites, and that national incidence 
was 1.3 million cases in 2006 [88]. These 
studies also indicate that one out of seven 
patients with campylobacteriosis in the UK, 
and one out of four in The Netherlands, 
consulted their general practitioner, a reflection 
of the generally severe nature of human 
campylobacteriosis.  
Relative risks to travellers have been 
used to approximate the relative incidence in 
local residents, as recently published for 
Salmonella spp. and Campylobacter spp. in the 
EU [23]. These studies may provide a 
comparable estimate of the force of infection 
in different countries, although there are many 
caveats when interpreting such data. These 
include under-diagnosis or misdiagnosis of 
travel-related cases, late appearance of 
symptoms, absence of information on the 
nature and duration of travel and traveller's 
immunity (in particular against local endemic 
strains), especially as compared to the resident 
population.  
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In 2010 in the EU, the incidence of 
laboratory-confirmed human Campylobacter 
infections was 48.6 per 100,000 population. 
Children under five years of age had the 
highest notification rate (126.8 cases per 
100,000 population). The case fatality rate was 
<1%.  Such incidence figures lend human 
campylobacteriosis to be the most commonly 
reported gastrointestinal bacterial disease in 
the EU with a statistically significant 
increasing trend as from 2005 [58]. 
Campylobacter prevalence is usually highest in 
broiler meat. The proportions of cases 
imported from abroad, acquired domestically 
and with unknown origin were 6.3%, 57.2% 
and 36.5%, respectively. The highest number 
of cases is usually reported during the summer 
months (June–August) gradually decreasing 
from September to December [58]. 
Given the sporadic nature of human 
campylobacteriosis and the important role 
played by cross-contamination, it is very 
difficult to trace the sources of human 
Campylobacter infection to the original 
reservoirs. However, recent insights in source 
attribution modelling and recognition of the 
role of immunity in protecting against 
Campylobacter infection, together with risk 
assessment studies, have helped to guide risk 
management along the farm-to-table 
continuum. Some countries have indeed 
invested heavily in reducing human 
campylobacteriosis transmitted via specific 
food chains. Yet, from a global perspective, 
human campylobacteriosis remains difficult to 
prevent and there is an urgent need of 
developing alternative tools for informing 
public health interventions more effectively.  
 
 
4. OBJECTIVES AND OUTLINE OF THE 
THESIS 
 
4.1. Objectives 
 
This thesis is focused on the 
epidemiology of human salmonellosis (in 
Italy) and human campylobacteriosis (in The 
Netherlands), and deals with multiple specific 
objectives therein. As Italyʼs current 
surveillance systems do not provide detailed 
epidemiological data for zoonotic enteric 
pathogens other than Salmonella spp., Dutch 
data on Campylobacter spp. were used to 
address the specific objectives for this 
pathogen. This was made possible through an 
ongoing collaboration between the Italian 
Istituto Superiore di Sanità (funding body of 
the present PhD position) and the National 
Institute for Public Health and the 
Environment (RIVM) in The Netherlands.  
This thesis had the following four 
objectives: 
1. To overview the epidemiological trends of 
human salmonellosis in Italy, particularly of 
S. enterica subsp. enterica serotypes, and to 
identify the most promising targets for 
improving the sensitivity towards pathogens 
causing human gastroenteritis of Italyʼs 
current surveillance systems. 
2. To develop source attribution models based 
on the microbial subtyping approach to 
estimate the relative contributions of 
different animal and food sources to human 
Salmonella infections in Italy and to 
investigate possible changes in attribution 
estimates over different models, time 
periods and attribution points along the 
farm-to-fork continuum. 
3. To develop a combined analysis of source 
attribution and epidemiological (case-
control) data to investigate reservoir-specific 
risk factors for human campylobacteriosis 
while accounting for sampling issues and 
potential biases arising from source 
attribution in space and time. 
4. To extend the combined source attribution 
and case-control analysis to include also 
factors that are not usually considered when 
examining likely sources of human 
campylobacteriosis, such as the potentially 
complex transmission cycles involving pets 
and returning travellers. 
The specific objectives of this thesis do 
outline its structure. Indeed, this thesis is 
divided in two large parts according to the 
main pathogen in question (Salmonella or 
Campylobacter) and then it is further divided 
in seven, separate (but strictly interconnected) 
chapters, each of which is an article that has 
been published or submitted for publication in 
peer reviewed international journals. 
 
4.2. Outline of part I of the thesis – Human 
salmonellosis (in Italy) 
 
This part of the thesis is divided in 
three chapters dealing with objective No. 1 
(Chapters 2 and 3) and objective No. 2 
(Chapter 4). 
 
4.2.1. Chapter 2 (or Manuscript/Article I)  
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In Chapter 1, trends in physician-
reported gastroenteritis cases (divided in non-
typhoid salmonellosis and infectious diarrhoea 
other than non-typhoid salmonellosis) and 
food-borne disease outbreaks in Italy are 
described using official notification data from 
the current national (passive) surveillance 
system. To identify the most promising 
changes to be made for improving the 
sensitivity towards pathogens causing 
gastroenteritis of Italyʼs current surveillance 
systems, a quantitative evaluation of the 
impact of the two recently implemented 
regional surveillance systems of Lombardy and 
Piedmont regions (in northern Italy) on the 
notification rates of gastroenteritis cases and 
food-borne disease outbreaks is also presented.  
 
4.2.2. Chapter 3 (or Manuscript/Article II)  
 
In Chapter 3, a detailed analysis of the 
trends of S. enterica subsp. enterica serovars 
isolated from human cases in Italy during the 
last 30 years is presented using data from the 
Italian national laboratory-based surveillance 
system(s) in order to identify the (re)emerging 
serovars and the possible causes driving the 
epidemiological patterns of human 
salmonellosis in Italy. 
 
4.2.3. Chapter 4 (or Manuscript/Article III)  
 
In Chapter 4, a modified version of the 
Dutch model and the modified Hald model for 
source attribution were adapted to Italian 
Salmonella data to estimate the proportions of 
domestic, sporadic human Salmonella 
infections in Italy attributable to four putative 
sources of infection (Gallus gallus, turkeys, 
pigs and ruminants) from 2002 to 2010, both at 
farm and food levels. A comparison of 
attribution estimates over different models, 
time periods and points of attribution was also 
performed. 
 
4.3. Outline of part II of the thesis – Human 
campylobacteriosis (in The Netherlands) 
 
This part of the thesis is divided in four 
chapters dealing with objective No. 3 
(Chapters 5 and 6) and objective No. 4 
(Chapters 7 and 8). 
 
4.3.1. Chapter 5 (or Manuscript/Article IV)  
 
In Chapter 5, several analyses based on 
MLST data from human and animal C. jejuni 
and C. coli isolates collected over 12 years in 
The Netherlands, together with MLST data 
from other countries, are performed to 
determine the extents of geographical and 
temporal biases on attribution estimates, as 
well as the possible methods to be used for 
minimizing such biases, when using non-local 
or non-recent MLST data for source attribution 
in space and time of human campylobacteriosis 
based on the AI model. A power-analysis is 
also presented to provide the minimum number 
of source isolates needed to perform source 
attribution using the AI model. 
 
4.3.2. Chapter 6 (or Manuscript/Article V)  
 
In Chapter 6, MLST-based source 
attribution of human campylobacteriosis using 
the AI model, and a case-control study of 
chicken-, ruminant- and environment-specific 
risk factors for human campylobacteriosis in 
The Netherlands derived from a newly 
developed analysis combining source 
attribution and epidemiological data, are 
presented.  
 
4.3.3. Chapter 7 (or Manuscript/Article VI)  
 
In Chapter 7, a study aimed at 
clarifying the role of pets (dogs and cats) in 
Campylobacter zoonotic transmission is 
presented. MLST-typed C. jejuni and C. coli 
isolates from pets and their owners are 
compared in a one-to-one relationship and risk 
factors for pet-associated human 
campylobacteriosis are investigated using the 
combined source attribution and case-control 
analysis developed in Chapter 6. 
 
4.3.4. Chapter 8 (or Manuscript/Article VII)  
 
In Chapter 8, MLST profiles of C. 
jejuni and C. coli strains isolated from 
travellers returning to The Netherlands, the 
risk factors potentially responsible for the 
acquisition of such strains upon traveling, and 
those potentially responsible for their 
secondary spread to domestic populations, are 
investigated by performing a case-control 
study on risk factors for travel-related 
campylobacteriosis and a combined case-
control and source attribution analysis to 
investigate risk factors for domestically 
acquired campylobacteriosis caused by STs of 
probable exotic origin.  
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Surveillance of acute infectious gastroenteritis 
(1992–2009) and food-borne disease outbreaks 
(1996–2009) in Italy, with a focus on the 
Piedmont and Lombardy regions 
 
 
ABSTRACT 
 
We describe trends in the occurrence of acute infectious gastroenteritis (1992 to 2009) and food-borne 
disease outbreaks (1996 to 2009) in Italy. In 2002, the Piedmont region implemented a surveillance 
system for early detection and control of food-borne disease outbreaks; in 2004, the Lombardy region 
implemented a system for surveillance of all notifiable human infectious diseases. Both systems are 
internet based. We compared the regional figures with the national mean using official notification 
data provided by the National Infectious Diseases Notification System (SIMI) and the National 
Institute of Statistics (ISTAT), in order to provide additional information about the epidemiology of 
these diseases in Italy. When compared with the national mean, data from the two regional systems 
showed a significant increase in notification rates of non-typhoid salmonellosis and infectious 
diarrhoea other than non-typhoid salmonellosis, but for food-borne disease outbreaks, the increase was 
not statistically significant. Although the two regional systems have different objectives and structures, 
they showed improved sensitivity regarding notification of cases of acute infectious gastroenteritis 
and, to a lesser extent, food-borne disease outbreaks, and thus provide a more complete picture of the 
epidemiology of these diseases in Italy. 
 
 
1. INTRODUCTION 
 
Acute gastroenteritis of infectious 
aetiology is a public health problem worldwide 
[1]. Although cases in industrialised countries 
are usually characterised by low mortality, the 
economic impact on health services (direct 
costs) and on the general public (indirect costs) 
can be considerable [2]. Any initiative aimed at 
controlling acute infectious gastroenteritis in a 
population should be based on the extent of the 
problem. However, the true incidence of the 
disease in the population, based on data from 
national surveillance systems, is usually 
underestimated, e.g. [3]. In Italy and other 
countries, this problem can be attributed to 
several factors: (i) most cases have mild, self-
limiting symptoms, which do not motivate 
patients to seek medical attention; (ii) stool 
examination is not always recommended by 
the attending physician and an aetiological 
diagnosis is rarely made; (iii) diagnostic 
capabilities and protocols differ greatly among 
laboratories; and (iv) under-reporting, as it is 
known that physicians rarely report cases.  
In Italy, surveillance of acute 
infectious gastroenteritis and food-borne 
disease outbreaks is part of the activities of the 
Italian National Surveillance System of 
Infectious Diseases (SIMI), which has been in 
place since 1990 [4]. Notification data of cases 
of acute infectious gastroenteritis and food-
borne disease outbreaks are also shared with 
the National Institute of Statistics (ISTAT), 
which produces official statistics on economic, 
social and health matters in Italy. The 
Piedmont and Lombardy regions, in the north 
of the country, have implemented two different 
Internet-based surveillance systems since 2002 
and 2004, respectively. The Piedmont system 
is dedicated to surveillance of food-borne 
diseases, with an emphasis on outbreaks 
(including but not limited to acute infectious 
gastroenteritis, as this can frequently be caused 
by food-borne pathogens), whereas the 
Lombardy system is aimed at improving the 
surveillance and reporting of all notifiable 
human infectious diseases, including acute 
infectious gastroenteritis and food-borne 
diseases. Both systems notify to the national 
surveillance system. As the two regions 
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together account for about a quarter of the 
Italian population (in 2009: Piedmont: 
4,432,571 inhabitants; Lombardy: 9,742,676; 
national: 60,045,068 [5]) estimates of disease 
incidence from these regional surveillance 
systems can be considered relevant for 
comparisons at the national level. 
At present, the national surveillance 
system does not collect notifications of acute 
infectious gastroenteritis as one syndrome; 
instead, laboratory-confirmed cases of 
diarrhoeal disease are generally notified in two 
categories: non-typhoid salmonellosis 
(hereafter referred to as salmonellosis) and 
infectious diarrhoea other than salmonellosis 
(hereafter referred to as infectious diarrhoea). 
These two categories therefore include 
diarrhoeal diseases caused by all identified 
enteric pathogens. For the purposes of this 
article, the official notifications of 
salmonellosis and infectious diarrhoea were 
used as proxies for acute infectious 
gastroenteritis, but we analysed the data 
separately due to the large difference in the 
number of cases in the two categories.  
Cases of salmonellosis and infectious 
diarrhoea are notified to the national 
surveillance system according to its criteria, 
which, for these diseases, are based on 
laboratory results [4]. Food-borne disease 
outbreaks are generally notified to the system 
as the occurrence of the same disease in two or 
more people belonging to the same community 
(family, school, etc.) or exposed to a common 
source of infection.  
The aim of our analysis was to 
describe the epidemiology of acute infectious 
gastroenteritis and food-borne disease 
outbreaks in Italy using official notification 
data collected in 1992–2009 and 1996–2009, 
respectively. We have also taken into account 
the contribution of the notification data from 
Piedmont and Lombardy and speculated on the 
impact that the notifications from the two 
regions could have at the national level. Our 
findings may help decision-makers in 
developing novel approaches aimed at 
improving the surveillance of acute infectious 
gastroenteritis and food-borne disease 
outbreaks in the general population. 
 
 
2. METHODS 
 
2.1. Data collection 
 
Notification data were obtained from 
the SIMI online databases from 1996 to 2009 
(for salmonellosis, infectious diarrhoea and 
food-borne disease outbreaks) [6] and the 
ISTAT from 1992 to 1995 (for salmonellosis 
and infectious diarrhoea) [7]. Data are 
available on request. 
The SIMI started publishing data in 
1996, while data of the previous four years 
were made available by the ISTAT only. There 
were no available data on food-borne disease 
outbreaks before 1996. Data on salmonellosis 
and infectious diarrhoea were collected per 
year, region, age group (0–14 years, 15–24 
years, 25–64 years, 65 years and older) and 
sex, while those on food-borne disease 
outbreaks were only available per year and 
region. Population data per year, region, age 
group and sex were also collected from the 
ISTAT.  
In order to obtain information on the 
two regional surveillance systems, we 
developed a questionnaire according to 
guidelines provided by the United States 
Centers for Disease Control and Prevention 
[8]. The questionnaire is available on request. 
It was completed by the heads of the two 
systems.  
 
2.2. Data analysis 
 
Annual notification rates (annual 
number of notified episodes per 100,000 
inhabitants) of salmonellosis and infectious 
diarrhoea (from 1992 to 2009) were calculated 
per region, age group and sex, while those of 
food-borne disease outbreaks (from 1996 to 
2009) were calculated per region only. Age- 
and sex-standardised annual notification rates 
of salmonellosis and infectious diarrhoea were 
then calculated per region using 2001 
population data. Rates were calculated for the 
Piedmont and Lombardy regions and for the 
country as a whole (calculated as the mean of 
the 20 Italian regions).  
Temporal trends in annual notification 
rates of salmonellosis, infectious diarrhoea and 
outbreaks of food-borne diseases were 
assessed using the Cuzick test [9]. Annual rates 
of salmonellosis and infectious diarrhoea were 
compared between the sexes using the Mann-
Whitney test and among age groups using the 
Kruskal-Wallis test. Post hoc paired 
comparisons after the Kruskal-Wallis test were 
tested using the Mann-Whitney test on each 
pair of age group and p-value adjustment 
according to Bonferroni's method [10].  
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To evaluate any difference in 
notification rates in Piedmont and Lombardy, 
compared with the national mean, the 
standardised annual notification rates of 
salmonellosis, infectious diarrhoea and food-
borne disease outbreaks in both regions were 
centred on (i.e. subtracted from) the 
corresponding national mean and then intra-
regionally compared between the periods 
before (Piedmont: 1992 or 1996 to 2001; 
Lombardy: 1992 or 1996 to 2003) and after the 
implementation of their respective systems 
(Piedmont: 2002–2009; Lombardy: 2004–
2009), using the Mann-Whitney test.  
Statistical analysis was performed with 
STATA 10.1 and Excel. Statistical significance 
was set at a p value of 0.05. 
 
2.3. Regional surveillance systems 
 
All regions other than Lombardy 
notify cases according to the SIMI criteria [4]. 
Cases notified to SIMI are not divided into 
possible, probable or confirmed cases, as in the 
European Union (EU) case definition [11]. The 
cases notified to the SIMI are later reported to 
the EU by the Ministry of Health through the 
European Surveillance System (TESSy). In 
contrast, Lombardy, uses the EU case 
definition, but the cases are then reported to 
the national surveillance system according to 
SIMI criteria. 
 
2.3.1. Piedmont 
 
The surveillance system of Piedmont is 
structurally independent of the SIMI. It 
collects data on all food-borne diseases, 
including episodes due to food-poisoning (e.g. 
those involving mushrooms, marine biotoxins 
and histamine) that are not notified to the 
SIMI. Basically, it is a passive system focused 
on the early detection of food-borne disease 
outbreaks, with the aim of improving the rapid 
alert and investigation of the outbreaks to 
prevent further cases.  
Data generated from the system are 
also used for: (i) monitoring of spatio-temporal 
trends in food-borne diseases, including 
identification of pathogens, food items 
involved, related risk factors and the at-risk 
population; (ii) driving the development and 
evaluation of control programmes (for 
prioritising resource allocation); (iii) detecting 
changes in the impact of acute gastroenteritis 
in response to public health actions; and (iv) 
providing a basis for epidemiological research. 
The system collects information on 
food-borne disease outbreaks and laboratory-
confirmed individual cases of food-borne 
diseases, thus including salmonellosis and 
other diarrhoeal pathogens, which are 
frequently transmitted by contaminated food 
(Figure 1). Reporting of food-borne diseases is 
managed separately from other diseases. Each 
local health unit in the region has dedicated 
staff who manually enter the received data 
(usually by fax, email or telephone) into an 
Internet-based database shared by local health 
units and the regional health authority. Entry of 
all validated data is performed on a weekly 
basis. One person in each local health unit is in 
charge of validating the data, ensuring that the 
data are entered and coordinating a 
multidisciplinary panel of experts to 
investigate every outbreak of food-borne 
diseases detected by the system. In the local 
health unit in the city of Turin, there is a 
regional coordinator who is in charge of 
coordinating all other local health units and 
report to the regional health authority. 
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Figure 1. Surveillance system of Piedmont region, Italy. 
 
2.3.2. Lombardy 
 
The surveillance system of Lombardy 
represents an Internet-based improvement of 
the SIMI and it is fully integrated with it. The 
system has primarily been implemented to 
improve aetiological diagnosis and data quality 
for individual cases. Its main objective is to 
provide data for real-time analyses on spatio-
temporal trends aimed at preventing secondary 
cases by means of prompt public health 
actions.  
The structure of the Lombardy system 
(Figure 2) is basically the same as that of the 
SIMI, which has a pyramidal structure from 
the bottom (physicians) to the top (regional 
health authorities) and finally to the Ministry 
of Health, which hosts the SIMI, but compared 
with the SIMI, the procedure for physicians 
reporting to local health units was modified by: 
(i) reducing the information requested to a 
minimum (additional information requested by 
the SIMI for completing the notification is 
provided by the local health units later on); (ii) 
shortening the deadline for reporting (e.g. for 
acute infectious gastroenteritis, notification of 
cases should be immediate instead of within 48 
hours, as required by Italian law) [4]; and (iii) 
defining different levels of detail required for 
cases detected at hospitals and for those 
detected by primary care or self-employed 
physicians. Data of the notified cases received 
by each local health unit are manually entered 
into an Internet-based database and 
automatically matched with the corresponding 
patient information stored in the regional 
health registry. Further epidemiological 
investigations are carried out when necessary. 
Cases are automatically validated and 
classified as notifiable to the SIMI or not 
notifiable. The database is shared among all 
local health units and the Lombardy regional 
health authority, which is in charge of the final 
data cleaning and analysis.  
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Figure 2. Surveillance system of Lombardy region, Italy. 
In both systems, access to the database 
is restricted to authorised staff of the local 
health units and regional health authority. All 
data are managed according to Italian 
legislation on privacy. Both systems regularly 
notify to the SIMI only those cases (divided 
into salmonellosis and infectious diarrhoea) 
and food-borne outbreaks that meet the SIMI 
notification criteria (the set of information that 
must be collected in order to notify the case to 
the system is described in the legislation [4]). 
 
 
3. RESULTS 
 
3.1. Epidemiology of acute infectious 
gastroenteritis and food-borne disease 
outbreaks in Italy 
 
During the period analysed (1992–
2009 for salmonellosis and infectious 
diarrhoea and 1996–2009 for food-borne 
disease outbreaks), a total of 222,277 cases of 
salmonellosis, 46,903 cases of infectious 
diarrhoea and 7,937 food-borne disease 
outbreaks were notified in Italy. Piedmont 
notified 16,431 cases of salmonellosis (7.4% of 
the total), 4,012 cases of infectious diarrhoea 
(8.6%), and 570 food-borne disease outbreaks 
(7.2%), while Lombardy notified 43,040 cases 
of salmonellosis (19.4%), 14,797 cases of 
infectious diarrhoea (31.5%), and 1,663 food-
borne disease outbreaks (21.0%). Annual 
notification rates of salmonellosis, infectious 
diarrhoea and food-borne disease outbreaks in 
Piedmont and Lombardy, together with the 
national mean, are shown in Figure 3. 
 
3.1.1. Salmonellosis notifications 
 
At the national level, salmonellosis 
notification rates significantly decreased from 
47.3 per 100,000 population in 1992 to 6.7 per 
100,000 population in 2009 (a decrease of 
86%). Statistically significant decreasing 
trends were also observed in Lombardy (–58%, 
from 46.2 per 100,000 population in 1992 to 
19.5 per 100,000 population in 2009) and 
Piedmont (–82%, from 47.4 per 100,000 
population in 1992 to 8.6 per 100,000 
population in 2009). 
 
3.1.2. Infectious diarrhoea notifications 
 
National notification rates of infectious 
diarrhoea increased significantly from 2.7 per 
100,000 population in 1992 to 5.8 in 2009 (an 
increase of 53%). From 1992 to 2009, the 
annual notification rates in Piedmont increased 
significantly from 0.9 per 100,000 population 
to 7.1 per 100,000 population (+87%) and 
from 1.3 per 100,000 population to 30.2 per 
100,000 population in Lombardy (+96%). 
Figure 3 shows that in both regions, 
notification rates of infectious diarrhoea were 
above the national mean from 2000 onwards. 
 
3.1.3. Food-borne disease outbreaks 
notifications 
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The mean national notification rates of 
food-borne disease outbreaks significantly 
decreased from 1.5 per 100,000 population in 
1996 to 0.4 per 100,000 population in 2009 (–
73%). No statistically significant trends were 
detected in Lombardy (–50%, from 2.2 per 
100,000 population in 1996 to 1.1 per 100,000 
population in 2009), where notification rates 
were below the national mean from 2000 to 
2006. From 1996 to 2009, there was no 
statistically significant trend in Piedmont, 
although the notification rate decreased from 
2.3 per 100,000 population in 1996 to 0.2 per 
100,000 population in 2009 (–91%). As shown 
in Figure 3, notification rates were above the 
national mean from 2003 to 2006, and then 
again in 2008, but were below the national 
mean in 2007 and 2009.  
Significant differences in notification 
rates of salmonellosis and infectious diarrhoea 
by age group were observed in Piedmont, 
Lombardy and the country as a whole (Table 
1). The highest notification rates were 
observed in children aged 0–14 years, in both 
regions and nationally. Apart from the 0–
14year-olds, the only significant difference 
was observed in elderly patients (≥65 years) in 
Lombardy for infectious diarrhoea; in this age 
group the notification rates was 14.10 cases per 
100,000 population in Lombardy, while in 
Italy and in Piedmont the rates were lower 
(2.84 and 4.36 per 100,000 population, 
respectively). No statistically significant 
differences were detected between male and 
female cases for either salmonellosis or 
infectious diarrhoea. 
 
 
Figure 3. Trends of annual notification rates of (A) non-typhoid salmonellosis (1992–2009), (B) infectious diarrhoea other than non-typhoid 
salmonellosis (1992–2009) and (C) food-borne disease outbreaks (1996–2009) in Piedmont and Lombardy regions and the Italian national 
mean. 
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Table 1. Mean annual notification rates by age group and sex of non-typhoid salmonellosis and infectious diarrhoea other than non-typhoid 
salmonellosis, Piedmont and Lombardy regions and Italian national mean, 1992–2009. 
Disease, by region or nationwide 
Average annual notification ratea 
Age groupb Sexc 
0–14 years 15–24 years 25–64 years ≥65 years Male Female 
Non-typhoid salmonellosis 
Piedmont 99.73 ± 6.09§ 24.06 ± 8.00† 21.73 ± 9.04† 14.92 ± 2.12† 41.98 ± 6.50 38.24 ± 6.12 
Lombardy 127.58 ± 5.9§ 19.49 ± 6.13† 19.11 ± 7.35† 18.11 ± 1.71† 48.03 ± 7.10 44.12 ± 6.63 
National average 98.20 ± 6.89§ 32.65 ± 12.41† 24.72 ± 9.93† 17.33 ± 2.60† 44.45 ± 7.26 42.00 ± 7.21 
Infectious diarrhoea other than non-typhoid salmonellosis 
Piedmont 25.80 ± 3.15§ 1.36 ± 0.18† 1.49 ± 0.30† 4.36 ± 0.67† 8.83 ± 1.76 7.68 ± 1.54 
Lombardy 32.43 ± 4.14§ 2.85 ± 0.39† 1.97 ± 0.30† 14.10 ± 3.77‡ 14.02 ± 2.62 11.66 ± 2.26 
National average 19.80 ± 1.04§ 1.97 ± 0.06† 1.22 ± 0.05† 2.84 ± 0.51† 7.04 ± 1.09 5.88 ± 0.89 
a. Mean number of cases per 100,000 population±standard error. 
b. Post hoc paired comparisons of mean annual notification rates between age groups were tested by the Mann–Whitney test. Symbols (§, † and 
‡) indicate the results of the pairwise comparisons: in the same row, age groups marked with different symbols are statistically different when 
compared (Bonferroni-adjusted p<0.05), while the same symbol in the same row indicates no difference between the age groups. 
c. No statistically significant differences between rates in male and female groups were observed (Mann-Whitney test p>0.05). 
 
3.2. Impact of the regional surveillance 
systems on acute infectious gastroenteritis 
notification rates 
 
Differences in notification rates from 
the two regions of salmonellosis, infectious 
diarrhoea and food-borne disease outbreaks 
with those of the whole of the country 
(national mean) before and after the 
implementation of the regional systems is 
described in Table 2. In Piedmont, after 
implementation of its system, there was a 
significant increase in notification rates of both 
salmonellosis (an increase of 1.6 cases per 
100,000 population per year) and infectious 
diarrhoea (an increase of 3.9 per 100,000 
population per year) compared with the 
national mean. In Lombardy, the increase after 
the implementation of its system was 
significant for both salmonellosis (an annual 
increase of 10.3 cases per 100,000 population) 
and infectious diarrhoea (an annual increase of 
13.3 per 100,000 population). The observed 
increases in the notification rate of food-borne 
disease outbreaks after the implementation of 
the two regional systems (annual increases of 
0.1 and 0.2 per 100,000 population in 
Piedmont and Lombardy, respectively) were 
not statistically significant. 
 
Table 2. Differences in annual notification rates of non-typhoid salmonellosis, infectious diarrhoea other than non-typhoid salmonellosis, and food-
borne disease outbreaks, Piedmont and Lombardy regions with the Italian national mean, before and after implementation of regional surveillance 
systems. 
 Differences in annual notification ratea,b 
Disease 
Piedmont Lombardy 
Before 
implementation 
(1992/1996-2001)c 
After 
implementation 
(2002-2009) 
p value 
Before 
implementation 
(1992/1996-2003)c 
After 
implementation 
(2004-–2009) 
p value 
Non-typhoid salmonellosis –4.05 ± 0.79 +1.58 ± 0.83 <0.01 –1.54 ± 2.79 +10.27 ± 1.87 <0.05 
Infectious diarrhoea other than 
non-typhoid salmonellosis 
–1.12 ± 0.89 +3.90 ± 0.61 <0.01 –0.25 ± 0.87 +13.34 ± 2.95 <0.01 
Food-borne disease outbreaksd –0.53 ± 0.49 +0.13 ± 0.08 >0.05 +0.16 ± 0.32 +0.22 ± 0.40 >0.05 
a. Mean number of cases per 100,000 population ± standard error. 
b. Reference value (national mean) = 0. 
c. From 1992 for salmonellosis and infectious diarrhoea and from 1996 for food-borne disease outbreaks. 
d. In Piedmont, includes also outbreaks due to food poisoning 
 
 
4. DISCUSSION AND CONCLUSIONS 
 
Analysis of the notifications of 
salmonellosis, infectious diarrhoea and food-
borne disease outbreaks showed important 
differences between the figures provided by 
the regional surveillance systems of Piedmont 
and Lombardy and those of the national 
surveillance system. When we compared the 
regional figures with the national mean, we 
found significantly higher notification rates of 
salmonellosis and infectious diarrhoea in the 
two regions after the implementation of their 
systems. In addition to these increased rates, 
the absence in these two regions of the 
significantly decreasing trend in food-borne 
disease outbreaks observed at the national level 
can be considered a positive performance of 
the systems.  
The better performance of the two 
regional systems could be related to increased 
motivation of those involved (e.g. physicians, 
epidemiologists, public health professionals 
and laboratory staff) to report cases of acute 
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infectious gastroenteritis, increased awareness 
of the disease and better coordination between 
laboratory and local health unit teams. In both 
regional systems, the web-based management 
and sharing of notification data have facilitated 
the reporting process and improved the 
completeness of the information collected. 
Web-based surveillance systems have become 
increasingly widespread and it is known that 
they can improve sensitivity [12–14]. 
Nonetheless, both Italian regional systems 
have major weaknesses, in particular: (i) 
limitations in events covered (the Piedmont 
system is focussed on food-borne diseases 
only); (ii) limitations in automatic outbreak 
detection (spatio-temporal clusters); and (iii) 
data entry is carried out far from the source. 
Points ii and iii, in particular, are consequences 
of the lack of real-time data collection and 
analysis and of the labour-intensive activity 
required by both systems. These two 
constraints could considerably be balanced out 
by full electronic reporting and management of 
notification data. 
Concerning the epidemiology of acute 
infectious gastroenteritis in Italy, we identified 
a significantly decreasing trend of 
salmonellosis over the period analysed, which 
has also been observed in other industrialised 
countries, possibly resulting from improved 
Salmonella control measures in the food chain 
[15,16]. Although the national trend is 
decreasing, salmonellosis rates in Lombardy 
and Piedmont showed a rise from 2006 and 
2007 onwards, respectively. In 2009, data 
provided to the European Food Safety 
Authority (EFSA) showed an increase in the 
number of Salmonella isolates from human 
cases in Italy of 22.2%, compared with those in 
2008 (from 3,232 to 4,156 isolates) [16]. This 
increase was detected one or two years in 
advance by the surveillance systems of 
Piedmont and Lombardy (in 2008 and 2007, 
respectively), but not by the national 
surveillance system. The difference between 
our data and those provided to EFSA can be 
explained by the different sources: our data are 
the official notification data, while the data 
provided to EFSA are from Enter-net, a 
laboratory-based surveillance network for 
enteric pathogens [17].  
In Lombardy, and to a lesser extent in 
Piedmont, the trend of salmonellosis observed 
during 2006 to 2009 seems related to the trend 
seen for food-borne disease outbreaks in the 
same period. Taking into account that in the 
EU most of the acute infectious gastroenteritis 
outbreaks in humans are caused by Salmonella 
[15,16], we can hypothesise that, at least in 
Lombardy, improved outbreak detection could 
have contributed to the increase of 
salmonellosis cases notified to the system.  
The observed trends of infectious 
diarrhoea notification rates suggest an 
increasingly prominent role of pathogens other 
than Salmonella - in particular Campylobacter 
jejuni - which is the most frequent cause of 
acute infectious gastroenteritis in the EU 
[15,16]. The increasing trend of infectious 
diarrhoea was particularly evident in 
Lombardy, but was also seen in Piedmont, and 
could be related to the improved routine 
laboratory capacity for the detection and 
notification of pathogens other than 
Salmonella. In both regions, improvement in 
laboratory capacity (particularly in Lombardy) 
was implemented at the same time the 
surveillance systems were introduced. This 
enabled the regional diagnostic and 
microbiology laboratories to extend the range 
of assays routinely performed and pathogens 
searched for, and to improve the timeliness of 
diagnosis and their communication with the 
staff of the local and regional health authorities 
involved in the system.  
Acute infectious gastroenteritis 
notification rates by age group confirmed the 
higher incidence of both salmonellosis and 
infectious diarrhoea in children (0–14 years), 
in line with what has been observed in the 
United States [18] and in other European 
countries [e.g. 19].  
Concerning the trend of food-borne 
disease outbreaks, Lombardy showed a very 
low notification rate between 2001 and 2006. 
This is probably related to the changes in the 
notification procedure of such outbreaks to the 
SIMI (but not the notification of single cases) 
that Lombardy made in 2001, during the period 
considered for the analyses. After 2006, 
however, the reporting of these outbreaks was 
redefined, in agreement with the SIMI 
definitions.  
In Lombardy, we observed that the 
implementation of the system improved 
notification rates of acute infectious 
gastroenteritis and food-borne disease 
outbreaks, with a reduction of the under-
reporting, and consequently gave a better 
estimate of the impact of acute infectious 
gastroenteritis on the population. The 
Piedmont surveillance system, which is 
dedicated to acute infectious gastroenteritis, 
allows broader collection of information that is 
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not easy to obtain in other ways, in particular 
concerning food-poisoning outbreaks.  
With regard to the extension of the 
surveillance systems of Piedmont and/or 
Lombardy to the other Italian regions, and 
even to other countries, decisions should be 
made on the basis of cost-benefit analyses that 
take into account the expected improvements 
in terms of efficacy of the surveillance and the 
resources needed to achieve them, as well as 
the long-term sustainability of the systems.  
In conclusion, improving the 
surveillance of acute infectious gastroenteritis 
at the Italian national level requires additional 
efforts, which can be defined by looking at the 
experience at the regional level, such as that of 
Lombardy and Piedmont. Such efforts should 
be focused on the integration and 
harmonisation of different surveillance 
activities and sources of information, as well as 
evaluation of such activities, to obtain the best 
achievable impact on the burden of acute 
infectious gastroenteritis in the population. 
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Distribution of Salmonella enterica serovars 
isolated from human cases in Italy, 1980–2012 
 
 
ABSTRACT 
 
We describe trends of Salmonella enterica serovars isolated from humans in Italy from  January 1980 
to June 2012. A total of 231,414 Salmonella isolates were reported. Serovars Enteritidis, 
Typhimurium, Infantis, Derby, 4,[5],12,:i:-, and Napoli accounted for 59% of these isolates. Temporal 
trends from 2000 to 2011 varied by serovar: Enteritidis and Infantis decreased significantly (–3.0% 
and –2.8% isolates on average per year, respectively); Typhimurium remained stable; while 
4,[5],12:i:-, Derby and Napoli increased significantly (+66.4%, +8.1% and +28.2%, respectively). 
Since 2000, Enteritidis fell consistently below Typhimurium, which is the most reported serovar in 
Italy in contrast to the international situation where Enteritidis still ranks at the top despite its 
significant decrease. Most serovars showed a marked seasonality, increasing over the summer months 
and peaking in August/September. Typhimurium, 4,[5],12:i:-, and Napoli were most likely to be 
isolated from children, whereas Enteritidis, Derby, and Infantis from adults. We concluded that the 
applied control measures are not equally efficient against the considered Salmonella serovars and that 
sources of infection other than those of Enteritidis (laying hens and eggs) have become increasingly 
important. Further investigations on the emerging serovars and on the causes related to their 
emergence are needed, in order to define and implement newly tailored control measures.  
 
 
1. INTRODUCTION 
  
In the European Union (EU), 
Salmonella infection is the primary cause of 
confirmed food-borne outbreaks and the 
second most reported zoonosis, behind 
Campylobacter infection [1]. Recently, it has 
been estimated that approximately 6.2 million 
cases of human salmonellosis occur in the EU 
general population each year, 298,000 of 
which occur in Italy (60 million population) 
[2]. 
More than 2500 serovars of 
Salmonella enterica have been described [3]. 
Although virtually all these serovars are 
capable of infecting humans, most human 
infections are caused by a limited number of 
serovars. S. Enteritidis and S. Typhimurium are 
amongst the serovars most frequently 
associated with human illness in the EU, 
accounting for up to 68% of confirmed human 
cases identified at serovar level [1]. Poultry, 
and particularly laying hens for table egg 
production, have long been identified as the 
primary source of human S. Enteritidis 
infection, whereas it is widely accepted that 
human S. Typhimurium infection primarily 
originates from pigs [4]. 
Salmonella serotyping is an important 
tool for surveillance purposes that allows for 
trends to be monitored over space and time. 
Serotyping is also a useful classification 
scheme to support the investigation of food-
borne outbreaks and the attribution of human 
cases to different sources of infection and 
routes of transmission [4]. 
In Italy, the laboratory-based 
surveillance system for human Salmonella 
infections has changed substantially over time 
to follow the evolution of the surveillance 
activities for infectious diseases undertaken at 
national and international level [5]. The former 
system was created in 1967 and was based on 
the Reference Centres for Enterobacteriaceae 
(RCE) [5,6], which became part of the 
European SALM-NET (Salmonella Network) 
project later in 1992 [5]. In 1997, SALM-NET 
has further changed into the actual ENTER-
NET (Enteric Pathogen Network) [7]. Italy's 
ENTER-NET is a passive, laboratory-based 
surveillance system for enteropathogens based 
on a network of more than 140 clinical 
microbiology diagnostic laboratories covering 
about 65% of the Italian territory and is 
complementary to the Italian National 
Surveillance System for Infectious Diseases 
(SIMI) [8,9].  Since October 2007, ENTER-
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NET has been coordinated by the European 
Centre for Disease Prevention and Control 
(ECDC), European Food- and Water-borne 
Disease and Zoonoses Surveillance Network 
(FWD-Net) [10].  
In Italy, ENTER-NET collects basic 
microbiological information (at least the 
serovar) on Salmonella isolates from human 
cases each year. These isolates correspond to 
approximately 50% of the total number of 
human salmonellosis cases notified to the SIMI 
[11]. Since 2002, the ENTER-NET 
laboratories are also invited to submit S. 
Enteritidis and S. Typhimurium isolates to the 
Istituto Superiore di Sanità (Italian National 
Institute of Health) for phage and molecular 
typing and antimicrobial susceptibility testing.  
The aim of this study was to describe 
the distribution of Salmonella serovars isolated 
from humans in Italy from  January 2012 to 
June 2012, with a focus on the six most 
frequently reported serovars. 
 
 
2. MATERIALS AND METHODS 
 
Data of Salmonella isolates from 
human cases were obtained from different 
laboratory-based surveillance systems 
depending on the considered time period. Data 
from 1980 to 1992 were obtained from 
published statistics of the RCE [6]. Data from 
1993 to 1997 were obtained from the SALM-
NET records 
(http://www.iss.it/salm/arch/index.php?lang=1
&tipo=4&anno=2012) and those from 1998 to 
June 2012 from ENTER-NET 
(http://www.iss.it/Ente). In all of these three 
systems, the common case definition was "an 
isolate of Salmonella enterica with identified 
serovar from a human specimen". 
For the purposes of this study, a 
minimum set of comparable information about 
each serotyped isolate was collected, including 
the patient sex, age and residence location, the 
laboratory that reached the microbiological 
diagnosis and the date of isolation thereof. This 
set of information was not systematically 
collected and made available since 2000; 
before 2000 only the serovar and the date of 
isolation were available.  
A data set including Salmonella 
isolates of the whole study period (1980–June 
2012) was created by merging the data 
obtained from the three systems (RCE, SALM-
NET, and ENTER-NET). For the year 2012 
only the data from 01 January to 31 June were 
available. This data set contained 256,022 
records (i.e. isolates) with information on the 
serovar and date of isolation.  
Another data set that included the 
isolates collected by ENTER-NET from 2000 
to June 2012 (58,150 records) was created. 
This data set contained a number of duplicate 
entries, i.e. different isolates from a same case 
(because of the follow-up of patients with 
Salmonella infection after the first isolation) 
that were not always indicated. Therefore, 
duplicate entries for an isolate that matched on 
serovar, laboratory reaching the 
microbiological diagnosis, and date of birth of 
the patient within the same or the consecutive 
month of isolation were discarded. The 
resulting data set included a total 33,545 
records. Data management procedures were 
performed using ACCESS, version 2002 
(Microsoft, Redmond, USA). 
The analysis was focussed on the six 
top reported serovars in the whole study 
period. The distribution of isolates over years 
was examined from 1980 to June 2012, 
whereas the distribution by sex, age group (<1, 
1–5, 6–14, 15–64, and >65 years) and month 
of isolation (January–December) was 
examined using the 2000–June 2012 data set. 
Average annual isolation rates per 100,000 
population were calculated by serovar, sex, age 
group, and province of residence standardised 
to the 2008 Italian reference population 
provided by the Italian National Institute of 
Statistics (ISTAT) (http://demo.istat.it/).  
The inter-annual trend in the number 
of isolates from 2000 to 2011 was tested for 
statistical significance using the Cuzick's test 
for trend [12] (alpha level: 0.05). Data analysis 
was performed using EpiInfo2000, version 
3.3.1 (CDC, Atlanta, USA), and STATA, 
version 11.2 (StataCorp, College Station, 
USA). 
Shapefile of Italy with provincial 
administrative boundaries was obtained from 
the ISTAT (ED-1950-UTM coordinate system, 
zone 32 N). Average annual isolation rates per 
100,000 population were presented using a 
choropleth map in ArcGis, version 9.0 (ESRI, 
Redlands, USA). 
 
 
3. RESULTS 
 
3.1. Inter-annual trends 
 
From 1980 to June 2012, a total of 
231,414 Salmonella isolates were reported. 
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The annual number of isolates decreased from 
10,286 isolates on average per year in 1980–
1995 to 3960 isolates on average per year in 
1996–June 2012, with a more marked 
reduction from 2000 onwards (2,564 isolates 
on average per year). 
During the whole study period, the top 
six reported serovars were S. Enteritidis 
(57,571 isolates; 24.8% of the total number of 
Salmonella isolates; average isolation rate: 
3.04 isolates per 100,000 population/year), S. 
Typhimurium (56,969; 24.6%; 3.01 per 
100,000/year), S. Infantis (10,134; 4.3%; 0.53 
per 100,000/year), S. Derby (8,298; 3.5%; 0.46 
per 100,000/year), S. 4,[5],12,:i:- (2,690; 1.2%; 
0.47 per 100,000/year) and S. Napoli (883; 
0.4%; 0.12 per 100,000/year). The other 
serovars accounted cumulatively for 94,869 
isolates (41.2%; 5.01 per 100,000/year) (Figure 
1).
 
 
Figure 1. Temporal trend of the top six reported Salmonella enterica serovars in Italy from 1980 to June 2012: S. Typhimurium and S. Enteritidis (A); S. 
Infantis, S. Derby, S. 4,[5],12,:i:-, and S. Napoli (B). "Other serovars" in graph (A) include all serovars other than S. Typhimurium and S. Enteritidis. 
 
S. Typhimurium was the predominant 
serovar from 1980 to 1988, but in 1989 S. 
Enteritidis overcame S. Typhimurium and 
dramatically increased in the following years, 
reaching a peak in 1992. Since then, S. 
Enteritidis started decreasing, and from 2000 
onwards S. Typhimurium returned to be the 
predominant serovar (Figure 1). 
S. Infantis alternated the position of the 
third most frequently reported serovar with S. 
Derby during the whole study period (Figure 
1). However, while S. Infantis showed a 
marked decrease from 2002 onwards (<100 
isolates per year), S. Derby increased since 
2003, doubling the number of S. Infantis 
isolates in the last period (2009 to 2011).  
In 2000 and 2003, S. Napoli and S. 
4,[5],12,:i:- emerged, respectively. S. Napoli 
increased from 31 isolates in 2000 to 134 
isolates in 2011. S. 4,[5],12,:i:- was isolated for 
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the first time in Italy in 2003 with 40 isolates 
(1.3% of the total number of isolates of that 
year). Since then, it increased steadily, 
reaching 762 isolates (39.1%) in 2011.  
The decreasing trends observed from 
2011 to 2012 (Figure 1)  is due to the fact that 
the data for 2012 are partial, covering only the 
first six months of the year. 
From 2000 to 2011, a significantly 
increasing temporal trend in the number of 
isolates was observed for S. Derby (+8.1% 
isolates on average per year, p<0.001; average 
isolation rate: 0.16 isolates per 100,000 
population/year), S. Napoli (+28.2%, p = 
0.032; 0.22 per 100,000/year) and S. 
4,[5],12:i:- (+66.4%, p<0.001; 0.33 per 
100,000/year), whereas a significantly 
decreasing temporal trend was observed for S. 
Infantis (–2.8%, p<0.001; 0.14 per 
100,000/year) and S. Enteritidis (–3.0%, 
p<0.001; 0.91 per 100,000/year) isolates. S. 
Typhimurium isolates did not show any 
significant trend from 2000 to 2011 (p = 0.11; 
1.58 per 100,000/year). 
 
3.2. Seasonal distribution 
 
The largest proportion of Salmonella 
isolates was observed in September (12.2%) 
and the smallest in February (6.0%). The mean 
number of isolates in these two months was 
330 and 160 respectively (Figure 2). Although 
this seasonal pattern was consistent for most 
serovars, S. Napoli and S. Derby showed slight 
variations. S. Napoli increased steeply in June 
(9 isolates, on average) and peaked in July (14 
isolates), remained at high levels from July to 
September (41 isolates) and then decreased 
rapidly in October (9 isolates). S. Derby 
peaked in September (11 isolates) but 
remained at a high level until October (11 
isolates), with a slight decrease from 
November to March (41 isolates) (Figure 2). 
 
 
Figure 2. Average number of isolates of the top six reported Salmonella enterica serovars by month of isolation, Italy, 2000–mid 2012. 
 
 
3.3. Age and sex distributions 
 
During the 2000–mid 2012 period, the 
highest isolation rate was for children aged 1–5 
years, at 32.37 isolates per 100,000 
population/year, followed by children aged <1 
year (13.69 per 100,000/year) and 6–14 years 
(7.98 per 100,000/year). In the other age 
groups, the average isolation rate was <3 
isolates per 100,000/year. There were no 
evident differences in isolation rates between 
males and females (4.01 and 4.55 isolates per 
100,000/year, respectively) (Table 1). 
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Table 1. Age and sex distribution of the annual isolation rate (number of isolates/100,000) of the top six 
reported Salmonella enterica serovars in Italy, 2000–June 2012.  
Serovar 0–11 months 1–5 years 6–14 years 15–64 years ≥65 years Female Male 
S. Typhimurium 3.89 14.07 3.18 0.42 0.77 1.40 1.69 
S. Enteritidis 2.61 6.32 2.03 0.42 0.47 0.92 0.97 
S. 4,[5],12:i:- 0.76 2.34 0.61 0.07 0.17 0.24 0.28 
S. Derby 0.44 0.84 0.16 0.06 0.19 0.14 0.15 
S. Infantis 0.36 0.67 0.17 0.06 0.13 0.13 0.15 
S. Napoli 0.67 1.04 0.21 0.02 0.09 0.10 0.12 
Other serovars 4.96 7.09 1.63 0.52 1.04 1.06 1.19 
Overall 13.69 32.37 7.98 1.58 2.85 4.01 4.55 
 
The 3.3% of isolates reported from 
2000 to 2010 were from cases aged <1 year, 
38.8% from cases aged 1–5 years, 17% from 
cases aged 6–14 years, 26.1% from cases aged 
15–64 years, and 14.6% from cases aged ≥65 
years.  
Considering the top six reported 
serovars, S. Typhimurium showed the highest 
isolation rate in all age groups, particularly in 
children (where it accounted for 28% and 43% 
of isolates from children aged 1–5 and 6–14 
years, respectively), but not in cases aged 15–
64 years (where S. Typhimurium and S. 
Enteritidis accounted for almost the same 
proportion of isolates: 27%). This is also 
evident for S. 4,[5],12:i:- that had a visibly 
higher isolation rate than S. Derby and S. 
Infantis in cases aged 1–5 years but not in 
cases aged 15–64 years, where S. 4,[5],12:i:-, 
S. Derby, and S. Infantis had almost the same 
isolation rate. Moreover, while S. Napoli was 
the fourth most isolated serovar in cases aged 
14 years, it was the least represented in those 
aged >14 years.  
 
3.4. Spatial distribution 
 
Figure 3 presents the distribution at the 
province level of the average annual isolation 
rate per 100,000 population of the top six 
reported serovars (2000 to mid 2012). Except 
for the southern province of Isernia, the highest 
incidence rates were observed in the northern 
provinces of the country, particularly in the 
provinces of Sondrio, Trento, and Varese, 
whereas the southern provinces showed 
considerably lower incidence rates. Such 
spatial distribution was also observed in the 
incidence rate of the different serovars. 
 
 
4. DISCUSSION 
 
Evidence that human salmonellosis in 
Italy has decreased since the late 1990s has 
previously been provided through the analysis 
of cases notified to the SIMI [9]. This study 
showed that, since 2000, this decrease has 
concerned only specific serovars, namely S. 
Enteritidis and S. Infantis, whereas other 
serovars have emerged (S. 4,[5],12:i:-, S. 
Derby, and S. Napoli) or remained fairly stable 
(S. Typhimurium) over time.  
After the global emergence of S. 
Enteritidis in the late 1980s that apparently 
filled the ecological niche vacated by the 
eradication of S. Gallinarum from poultry [13], 
a sustained decrease in the number of human S. 
Enteritidis infections has been observed in 
most countries since the late 1990s, e.g. [4,14–
17]. Several factors, including the 
implementation of new on-farm control 
measures against Salmonella in poultry (e.g. 
the introduction of live vaccines), improved 
hygiene and education of consumers and food-
workers, have probably contributed to this 
decrease [4,15]. Indeed, in 1992, the European 
Parliament issued a directive (Council 
Directive 92/117/EEC) establishing measures 
for protection against specified zoonotic agents 
in animals and foods of animal origin. This 
Directive proposed that the EU Member States 
establish monitoring systems and control 
measures in poultry breeding flocks. In 2003, 
to enforce these measures, the European 
Parliament and the EU Council introduced the 
Regulation No. 2160/2003 to ensure that 
proper and effective measures were undertaken 
to control Salmonella at all relevant stages of 
production, processing, and distribution. The 
observed decrease of S. Enteritidis suggests 
that these measures have succeeded in 
reducing the burden of human S. Enteritidis 
infection. 
In Italy, however, we observed a 
peculiar profile of serovars, as S. Enteritidis 
fell consistently below S. Typhimurium since 
2000, whereas in most other countries, despite 
the significant decrease of S. Enteritidis, S. 
Typhimurium has never become the most 
reported serovar, at least until the end of the 
2000s [17]. This is particularly evident in the 
EU, where few countries in addition to Italy 
have recently experienced this shift in the 
dominant serovar, i.e. Belgium, France and 
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Denmark [4]. However, S. Typhimurium has 
been predicted to become the most common 
serovar in England and Wales by 2012 as a 
result of the decrease of S. Enteritidis [18]. 
Given the distribution of serovars from 
humans and animal sources in the period 2007-
2009, it has been estimated that pig is the most 
important source of human salmonellosis in 
Italy, accounting for 73% of human infections 
[4]. This is in line with our results, as pig is in 
fact the most important reservoir of S. 
Typhimurium [4]. 
 
 
Figure 3. Maps (province level of detail) of the average annual isolation rates per 100,000 population of Salmonella in Italy in 2000-mid 2012 (all Salmonella 
isolates (A), S. Typhimurium (B), S. Infantis (C), S. Enteritidis (D), S. Derby (E), S. 4,[5],12:i:- (F), S. Napoli (G)). 
 
As laying hens are the most likely 
source of human S. Enteritidis infection in 
Europe [4], the drastic decrease of S. 
Enteritidis in Italy may be explained, to some 
extent, by the structure of the Italian poultry 
industry (that is highly integrated and 
vertically developed) and by the fact that 
poultry meat and table egg production in Italy 
is self-sufficient to meet the internal market 
demand. Moreover, since 2003, the level of 
biosecurity and hygiene practices in the Italian 
poultry industry have greatly been enhanced to 
address the legal requirements provided for the 
control of avian influenza epidemics [19]. 
These structural characteristics may have had a 
particularly significant impact on the 
effectiveness of the applied control measures 
against S. Enteritidis in the Italian poultry 
industry, as both the production and 
consumption of poultry products is vertical and 
rather closed to external influences. 
The monophasic variant of S. 
Typhimurium, S. 4,[5],12:i:-, characterised by 
the antimicrobial resistance to Ampicillin, 
Streptomycin, Sulphonamide, and Tetracycline 
(pattern ASSuT) is emerging and extensively 
circulating in Italy, Denmark, and the UK 
[11,20]. In Italy, S. 4,[5],12:i:-, showed a 
dramatic increase since 2003, both in humans 
and in food-producing animals, particularly 
pigs and bovines [21]. Also S. Napoli is an 
emerging serovar in Europe, with most of the 
cases (87%) occurring in Italy, France, and 
Switzerland. It has been suggested that the 
environment can act as the main reservoir for 
S. Napoli, and from there it can spill over to 
animals and humans [10]. 
Most serovars showed a marked 
seasonality, increasing over the summer 
months and peaking in August/September, and 
then decreasing gradually. Although the 
reasons of this pattern are not entirely known, 
it may be related to the parallel Salmonella 
shedding trend in animal hosts, insufficient 
refrigeration and mishandling of foods during 
the warm months [22,23]. 
As expected, isolation rates were 
highest in children. This may be due to the 
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greater proportion of symptomatic infections 
amongst the young but also to the higher 
propensity to take samples by paediatricians 
(i.e. detection bias) [23]. However, consistent 
with other studies [10,11,23], we observed that 
cases with S. Typhimurium, S. 4,[5],12:i:-, or 
S. Napoli infection were most likely to be 
children, whereas cases with S. Enteritidis, S. 
Derby, or S. Infantis infections were more 
likely to be adults. This may be due to the 
different serovar-specific risk factors to which 
individuals are exposed at varying age groups 
[24].  
This study is based on reported data 
from laboratories that are not homogenously 
distributed in the Italian territory; thus, there 
may be differences in representativeness of the 
data from different regions. It has been showed 
that the surveillance systems of northern 
regions of Italy are generally more sensitive in 
detecting cases of infectious gastroenteritis, 
leading to significantly higher notification 
rates of salmonellosis compared to the national 
average [9]. Moreover, diagnostic capacity for 
enteropathogens differs from laboratory to 
laboratory in Italy [25]. These may be the 
reasons as to why we observed that the 
isolation rates were considerably lower in the 
southern part of the country.  
With regard the selection of isolates 
included in our analyses we deleted duplicates 
but we cannot avoid including outbreak-related 
cases because epidemiological information on 
the origin of the isolates were not available. 
This condition could have biased the relative 
percentages of the Salmonella serovars in case 
of relevant outbreaks. 
In conclusion, Salmonella serotyping 
is useful for informing and addressing public 
health actions, providing data about the 
emerging serovars (which may reveal the 
presence of a previously unrecognised source 
of infection) and the efficacy of intervention 
measures. 
We found that S. Enteritidis has 
decreased dramatically in Italy and that S. 
Typhimurium has become again the most 
reported serovar as from 2000. It is noteworthy 
that while S. Enteritidis and S. Infantis 
decreased, S. Typhimurium remained stable 
and S. 4,[5],12:i:-, S. Derby, and S. Napoli 
increased. This suggests that the applied 
control measures are not equally efficient 
against the considered serovars and that other 
sources of infection have probably become 
increasingly important (e.g. unconventional, 
wild and free-rage animals, fruit and 
vegetables, etc.). Therefore, further 
investigation into potential causes of the spread 
of the emerging serovars against which newly 
tailored control measures should be 
implemented is warranted. 
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Attribution of human Salmonella infections to 
animal and food sources in Italy (2002–2010): 
adaptations of the Dutch and modified Hald 
source attribution models 
 
 
ABSTRACT 
 
The Dutch and modified Hald source attribution models were adapted to Italian Salmonella data to 
attribute human infections caused by the top 30 serotypes between 2002 and 2010 to four putative 
sources (Gallus gallus, turkeys, pigs and ruminants), at the points of animal reservoir (farm), exposure 
(food), and both combined. Attribution estimates were thus compared between different models, time 
periods and sampling points. All models identified pigs as the main source of human salmonellosis in 
Italy, accounting for 43–60% of infections, followed by Gallus gallus (18–34%). Attributions to 
turkeys and ruminants were minor. An increasing temporal trend in attributions to pigs and a 
decreasing one in those to Gallus gallus were also observed. Although the outcomes of the two models 
applied at farm and food levels essentially agree, they can be refined once more information will 
become available, providing valuable insights about potential targets along the production chain..  
 
 
1. INTRODUCTION 
 
Salmonellosis is a major cause of 
human bacterial gastroenteritis and the second 
most reported food-borne zoonosis in the 
European Union (EU), after 
campylobacteriosis [1]. Humans can become 
infected with Salmonella from several sources 
and via different pathways, including direct 
contact with live animals, environmental and, 
to a lesser extent, anthroponotic transmission. 
However, the most common source is by far 
contaminated food, with 86–95% of cases 
estimated to be food-borne [2,3]. In recent 
years, human cases of salmonellosis reported 
by Italian general practitioners have decreased 
spectacularly, passing from 47 to 7 cases per 
100,000 population in less than two decades 
[4]. This decrease has mainly concerned 
infections with S. Enteritidis, while infections 
with other serotypes have increased (e.g., S. 
Typhimurium monophasic variant 4,[5],12:i:- 
and S. Derby) or have remained fairly stable 
(e.g., S. Typhimurium) [5], suggesting that the 
relative importance of the different sources of 
human salmonellosis has changed over time.  
Attributing human Salmonella 
infections to specific sources is crucial to 
prioritize and implement targeted interventions 
in the food chain, as well as to measure the 
impact of such interventions [6]. The term 
"source" is often used as a collective term to 
cover any point along the transmission 
pathway, such as the animal reservoirs or 
amplifying hosts (e.g., chicken, cattle, pig, 
etc.), the vehicles or exposures (e.g., food, 
water, direct contact with animals, etc.) and 
even specific food items (e.g., pork, milk, 
eggs, etc.). Several methods have been 
proposed for source attribution of food-borne 
diseases [7,8]. In particular, the microbial 
subtyping approach, based on the comparison 
of the frequency distributions of pathogen 
subtypes isolated from humans with those 
isolated predominantly from putative animal, 
food and environmental sources, has received 
considerable attention since the development 
of the Hald model for Salmonella source 
attribution in Denmark [9]. The Hald model, a 
Bayesian adaptation of the earlier frequentist 
Dutch model [10], attributes stochastically 
human Salmonella infections to each putative 
source, to travelling abroad and to outbreaks, 
while accounting for differences among the 
different Salmonella subtypes and sources to 
cause human infection [9]. The Hald model has 
successfully been adapted to salmonellosis in 
several countries [6,11–15]. Yet, to further 
improve its identifiability and to handle with 
uncertainty in data of poorer quality, a 
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modified Hald model has also been proposed 
[16].  
While the Dutch model uses a 
straightforward approach, providing 
transparent insights into the functionality of the 
attribution process [15], the Hald model is a 
more complex model that fits parameters with 
no clear biological interpretation, therefore 
considered a sort of "black box" model [11]. 
So far, these two models have been applied  to 
single points of the farm-to-fork continuum 
only, e.g. point of reservoir, point of exposure, 
or both combined (undifferentiated). The 
comparative application of these two models to 
different points of attribution may further 
inform us about the most promising targets on 
which risk management strategies should be 
focused. 
The main aim of this study was to 
adapt the Dutch and Hald source attribution 
models to Italian Salmonella data in order to 
estimate the proportions of domestic, sporadic 
human Salmonella infections in Italy 
attributable to four putative sources (Gallus 
gallus, turkeys, pigs and ruminants), which 
have been monitored for a period of nine years 
(2002–2010) both in animals and in foods of 
animal origin. Moreover, we explored the 
extent to which the comparison of attribution 
estimates between the point of farm and that of 
food is useful in informing risk managers. 
 
 
2. MATERIALS AND METHODS 
 
2.1. Laboratory surveillance of Salmonella 
in humans 
 
In Italy, testing for Salmonella 
infection is usually performed on patients with 
gastroenteritis seeking for medical care or on 
people requiring periodic testing regardless of 
symptoms (e.g., food handlers, healthcare 
workers, etc.). Irrespective of symptomatology, 
Salmonella isolates from humans are reported 
to Enter-net Italia, a passive, laboratory-based 
surveillance system for human 
enteropathogens based on a network of more 
than 140 peripheral laboratories with 
approximately 65% coverage of Italian 
territory, concentrated mainly on the northern 
part of the country. Enter-net Italia is 
complementary to the Italian National 
Surveillance System for Infectious Diseases 
(SIMI) [17]. From the peripheral laboratories, 
Enter-net Italia collects demographic and 
microbiological information (at least the 
serotype) on Salmonella isolates of ~50% of 
human cases of salmonellosis notified to the 
SIMI [18]. Information on travel history or link 
to outbreaks concerns approximately 15% of 
serotyped isolates. At present, Salmonella 
isolates reported to Enter-net Italia are virtually 
indistinguishable between symptomatic and 
asymptomatic human infections. For the 
purposes of this study, a human Salmonella 
infection was considered to be: 1) travel-
related if the person has travelled abroad 
during the incubation period; and 2) outbreak-
related if the person has had contacts with 
people with gastroenteritis and/or there have 
been other epidemiologically-linked infections. 
 
2.2. Veterinary surveillance of Salmonella  
 
Findings of Salmonella in animals and 
foods of animal origin as part of diagnostic or 
monitoring activities are notifiable to Italian 
veterinary authorities. All major food-
producing animals and foods of animal origin 
in Italy are tested for Salmonella according to 
official control programmes (Directive 
2003/99/EC, Regulations EC 2160/2003 and 
882/2004). Positive samples are reported to 
Enter-vet, the Italian veterinary surveillance 
system for Salmonella. Enter-vet was 
established in 2002 and is based on a network 
of 10 peripheral laboratories covering the 
whole country through the regionally 
competent Institutes for Animal Health (Istituti 
Zooprofilattici Sperimentali). Approximately 
5000 Salmonella serotyped isolates from 
animals and foods of animal origin are 
reported to Enter-vet each year and classified 
by animal species and sampling point (farm or 
food). 
 
2.3. Salmonella data included in the models 
 
The input dataset for the Salmonella 
attribution models included surveillance data 
over nine years (from January 2002 to 
December 2010) collected by Enter-net and 
Enter-vet. Based on the most frequently 
isolated Salmonella serotypes from humans in 
common with at least one of the sources, the 
following 30 serotypes were included in the 
models: Typhimurium and its monophasic 
variant 4,[5],12:i:-, Enteritidis, Derby, Infantis, 
Muenchen, Hadar, London, Bredeney, 
Brandenburg, Rissen, Panama, Thompson, 
Virchow, Goldcoast, Give, Blockley, Newport, 
Heidelberg, Agona, Anatum, Saintpaul, Coeln, 
Montevideo, Kapemba, Mbandaka, Kedougou, 
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Meleagridis, Senftenberg and Livingstone. The 
selected serotypes accounted for 20890 human 
infections, corresponding to 87% of all human 
Salmonella infections reported in the study 
period. The remaining 13% of human 
infections caused by less frequent serotypes 
were excluded from the models and were not 
further considered in this study. A closer look 
at the data revealed that the excluded 
infections were often associated with travel 
and their serotypes were rarely, if ever, 
detected in the considered sources. Duplicate 
entries, i.e. different Salmonella isolates from a 
same person because of the follow-up of 
people with Salmonella infection after the first 
isolation, were discarded. Therefore, the 
models attributed only those human 
Salmonella infections that, during the entire 
study period and irrespective of clinical 
manifestations, were caused by the 
aforementioned top 30 Salmonella serotypes 
found both in humans and in the considered 
animal and food sources. 
Frequencies of human infections were 
merged with the animal and food isolates by 
serotype, sampling point and year. Based on 
data availability, the following sources were 
considered: Gallus gallus, turkeys, pigs, and 
ruminants (cattle, sheep and goats, combined). 
These sources were consistently sampled at the 
level of farm (live animals) and at that of retail 
(food of animal origin) during the entire study 
period. Differentiation of Gallus gallus 
between broilers and layers/eggs was not 
possible because the data were available at the 
species level only.  
To avoid sparse data that may lead to a 
low precision of the serotype prevalence 
estimates [16], the merged dataset was 
arranged in three 3-year periods (2002–2004, 
2005–2007 and 2008–2010) . The resolution of 
phage typing data was very low and did not 
allow for the use of this information in the 
analysis. Serotype frequencies in humans and 
in animal and food sources are reported in 
Table 1. 
 
2.4. Overview of the models 
 
A modified version of the Dutch model 
and a Hald model accommodating for temporal 
dimension [11] with some further adjustments 
as proposed by Mullner et al. [16] were 
developed to estimate the proportions of 
domestic, sporadic human Salmonella 
infections in Italy attributable to the four 
putative sources at farm (reservoir) level, at 
food (exposure) level, and at both these levels 
combined. Domestic and sporadic infections 
are defined as infections acquired in Italy and 
not implicated in outbreaks.  
Where the 95% credible intervals (CIs) 
of the attribution estimates did not overlap 
each other, these were considered to be 
significantly different from one another at the 
5% level of significance. 
 
2.4.1. Modified Dutch model 
 
The original Dutch model compares 
the number of human Salmonella infections 
caused by a particular serotype with the 
relative occurrence of that serotype in each 
source [10]. The expected number of human 
infections (λijt) caused by serotype i from 
source j in period t is given by: 
 
it
j ijt
ijt
ijt e
r
r



 
 
where rijt is the relative occurrence of serotype 
i from source j in period t, and eit is the 
estimated number of sporadic and domestic 
human infections of serotype i in period t (see 
Table 2 for notations and estimation of eit). A 
sum over serotypes gives the total number of 
infections expected from source j in period t, 
denoted by: 
  
 i ijtjt   
 
In this study, the Dutch model was 
modified to incorporate prevalence uncertainty 
and food consumption weights. Prevalence was 
modelled using the novel approach proposed 
by Mullner et al. [16] based on the assumption 
that pijt  = j   rijt, where pijt is the prevalence 
of serotype i from source j in period t, j is the 
overall prevalence of all Salmonella serotypes 
in source j, and
 
rijt is the relative occurrence of 
serotype i from source j in period t. 
Uncertainty was introduced in the estimates of 
the prevalence by assuming the following 
probability distributions: 
 
 r1jt, r2jt,…, 1– rijt
I-1
i=1
 ~ Dirichlet (X1jt, X2jt,…, XIjt) 
 
where Xijt (with i = 1, 2,…, I) are the source 
isolates of serotypes i from source j at time t, 
and  
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πj ~ Beta (αj+1, βj+1), 
 
where αj are the Salmonella-positive sampling 
units from source j and j = N  αj, with N 
being the total number of sampling units from 
source j that have been tested for Salmonella 
spp. The number of tested sampling units and 
respective positivity percentages in different 
animal reservoirs in Italy were provided by 
Pires et al. [14] by collating available 
information from the EU Salmonella 
prevalence baseline survey and from the EU 
Summary Reports on Trends and Sources of 
Zoonoses, Zoonotic Agents and Food-Borne 
Outbreaks, as published annually by the 
European Food Safety Authority from 2006 to 
2009. These data were provided at 
animal/sample level for broilers, bovines and 
pigs, and at flock/herd level for layers and 
turkeys. 
Average per capita daily food 
consumption (g/person/day) for source j in 
period t in Italy, denoted as mjt, was obtained 
from the Eurostat database 
(http://epp.eurostat.ec.europa.eu/portal/page/po
rtal/food/data/database) for ruminant and pig 
meats. As the Eurostat database provides data 
on poultry consumption as a whole with no 
differentiation between Gallus gallus 
(meat/eggs) and turkey, we used the data from 
the National Association of Poultry Producers 
(http://www.unionenazionaleavicoltura.it/prod
cons.aspx). Uncertainty was introduced in the 
estimates of mjt  by assuming that log(mjt) ~ 
Normal(μjt, σjt), where μjt and σjt are 
respectively the mean and standard deviation 
of the per capita daily food consumption for 
source j in period t. Using the above notations 
and those in Table 2, the modified Dutch 
model we used is denoted by: 
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The model was implemented in @Risk 
by setting 100000 iterations with the Latin 
hypercube sampling technique and a seed of 1.  
 
2.4.2. Modified Hald model 
 
The Hald model compares the number 
of human infections caused by different 
serotypes with their prevalence in the different 
sources, accounting for the amount of food 
consumed and incorporating serotype- and 
source-dependent factors [9]. By using a 
Bayesian approach, this model can explicitly 
incorporate prior information and quantify the 
uncertainty around each of the parameters. We 
applied the modified version of the Hald model 
as described elsewhere [16]. Using the above 
notations and those reported in Table 2, we 
assumed that 
 
)(~  j ijtit Poissono   
 
and that 
 
jiijtjtijt aqpm   
 
where oit is assumed to be Poisson distributed; 
pijt was modelled using the aforementioned 
novel approach of Mullner et al. [16]; qi is the 
serotype-dependent factor, which putatively 
accounts for differences in survivability, 
virulence and pathogenicity of serotypes i; and 
aj  is the source-dependent factor, which 
putatively accounts for the ability of the 
sources j to act as vehicles for Salmonella 
(e.g., differences in pathogen load, source 
characteristics influencing pathogen growth, 
preparation/handling procedures, differences in 
sensitivity of surveillance programmes and 
randomness of sampling schemes).  
In accordance with Mullner et al. [16], 
both qi and ai were assumed to be constant 
over time and qi was modelled hierarchically 
as log(qi) ~ Normal(0, ), where  is given by a 
fairly diffuse Gamma(0.01, 0.01) distribution. 
Parameter aj was defined as uninformative 
Uniform(0, 100) distribution. Parameter qi for 
S. Typhimurium monophasic variant 
4,[5],12:i:- was set to be equal to that of S. 
Typhimurium. Yet, exploratory analyses 
revealed that setting different qi parameters for 
S. Typhimurium and its monophasic variant 
4,[5],12:i:- had no influence on model results. 
Posterior distribution was obtained by 
a Markov Chain Monte Carlo simulation 
implemented in WinBUGS 1.4. Five 
independent Markov chains were run for 
30,000 iterations after a burn-in period of 
10,000 iterations, which proved able to provide 
convergence as monitored by the method 
developed by Gelman and Rubin [19]. 
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Table 1. Frequencies of Salmonella serotypes isolated from humans and from animal and food sources, at farm and  food level, in (I) 2002-2004, (II) 2005-2007, and (III) 2008-2010, Italy. 
Serotype 
Humans 
Gallus gallus Pigs Turkeys Ruminants 
 Farm Food Farm Food Farm Food Farm Food 
I II III I II III I II III I II III I II III I II III I II III I II III I II III 
Typhimurium 3140 2667 2919 129 188 161 45 274 35 456 535 371 796 502 398 108 195 10 73 60 52 199 160 175 90 112 77 
4,[5],12:i:- 136 300 1324 9 9 74 6 88 22 138 263 817 106 175 609 4 11 16 4 5 24 5 28 100 4 12 35 
Enteritidis 2181 1453 1212 159 244 377 167 100 82 1 16 3 10 159 8 1 1 6 1 5 28 3 5 6 11 6 20 
Derby 239 253 344 5 6 8 16 159 17 159 359 164 577 310 331 26 14 4 20 8 10 6 16 22 26 12 13 
Infantis 245 232 185 40 31 60 47 30 23 6 23 41 99 63 32 1 1 0 0 0 12 1 2 4 2 1 9 
Muenchen 144 67 145 0 24 193 2 5 44 0 2 14 22 19 3 0 1 0 1 1 10 0 0 3 0 4 2 
Hadar 141 60 127 187 148 224 215 50 93 3 8 2 12 48 2 59 16 7 46 19 41 6 0 1 9 3 2 
Rissen 54 52 124 0 6 13 10 32 5 0 85 46 77 76 93 0 1 0 0 0 0 0 2 1 4 5 30 
London 103 61 103 8 0 5 32 39 4 9 36 61 139 66 67 1 0 0 1 0 0 3 2 5 8 0 9 
Bredeney 108 60 96 0 0 0 25 53 90 0 0 0 124 116 24 0 0 0 10 41 31 0 0 0 12 7 5 
Newport 36 41 96 0 0 15 0 0 12 0 0 1 0 0 5 0 0 74 0 0 95 0 0 9 0 0 2 
Goldcoast 74 30 89 0 0 0 0 0 0 0 0 0 37 0 0 0 0 0 1 0 0 0 0 0 1 0 0 
Brandenburg 97 58 84 132 101 161 1 1 0 53 44 26 67 27 0 3 103 22 0 0 0 6 22 4 1 1 0 
Give 44 71 74 3 0 1 0 29 0 2 19 11 17 0 14 0 0 0 1 0 0 15 1 7 0 3 0 
Panama 110 40 72 0 0 0 0 0 0 0 0 0 46 0 0 0 0 0 0 0 0 0 0 0 4 0 0 
Thompson 79 68 62 63 50 186 29 24 19 1 11 2 1 65 1 1 1 0 0 1 0 5 1 8 3 0 2 
Coeln 11 15 58 0 2 12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16 0 0 0 0 0 0 
Agona 61 30 50 13 13 61 27 14 0 0 4 3 19 10 0 36 26 1 22 34 0 1 0 1 5 8 0 
Saintpaul 60 22 48 5 2 0 50 1 19 0 1 0 6 1 6 13 22 0 39 6 58 1 1 0 10 1 4 
Virchow 89 60 46 256 135 0 68 1 0 4 0 0 4 51 0 1 0 0 1 0 0 4 0 0 1 2 0 
Anatum 54 44 41 10 3 14 8 73 0 67 54 21 123 40 0 33 4 0 41 7 0 3 4 3 14 4 0 
Livingstone 71 47 39 0 0 0 129 93 21 0 0 0 73 192 5 0 0 0 0 2 9 0 0 0 2 3 1 
Kapemba 9 13 38 0 0 0 0 0 0 0 0 0 0 0 18 0 0 0 0 0 0 0 0 0 0 0 4 
Blockley 118 34 22 62 34 13 56 26 0 9 1 1 8 21 0 148 40 5 99 27 0 8 3 1 9 1 0 
Montevideo 24 27 21 0 42 110 9 0 45 0 1 0 1 0 7 0 0 5 1 0 0 0 0 2 1 0 1 
Heidelberg 118 27 18 109 42 96 64 16 0 8 8 0 5 37 0 92 143 1 45 115 0 1 3 0 4 4 0 
Mbandaka 10 3 12 0 37 129 0 15 0 0 1 0 0 58 0 0 0 0 0 1 0 0 2 0 0 1 1 
Kedougou 9 2 9 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 0 1 0 0 0 0 0 0 
Meleagridis 9 4 5 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
Senftenberg 5 5 2 23 19 22 12 0 3 0 1 0 3 0 0 2 1 1 0 0 3 0 0 2 1 0 2 
Total 7579 5846 7465 1213 1136 1935 1018 1123 535 916 1472 1584 2372 2036 1626 529 580 152 406 332 390 267 252 354 222 190 219 
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Table 2. Parameters used to estimate the number of domestic and sporadic human Salmonella infections attributable to the animal and food sources 
Notation Description Estimation 
i Salmonella serotype (30 serotypes) Data 
j Animal or food source (4 sources) Data 
t 3-year period (2002-2004, 2005-2007, 2008-2010) Data 
oit Observed infections with serotype i in period t Data 
oytit 
Observed infections with serotype i in period t reporting to have travelled abroad in the incubation 
period 
Data 
ontit 
Observed infections with serotype i in period t reporting to have not travelled abroad in the incubation 
period 
Data 
outit Observed infections with serotype i in period t with unknown travel history Data 
ptit Probability that a person infected with serotype i in period t with unknown travel history did travel Beta(oytit + 1, ontit + 1) 
etit Estimated number of additional infections with serotype i in period t that had travelled Binomial(outit, ptit) 
dcit Estimated total number of domestic infections with serotype i in period t oit – oytit – etit 
oybit Observed infections with serotype i in period t known to be outbreak-related Data 
oubit Observed infections with serotype i in period t with no information on relationships with outbreaks Data 
pbit Probability that a person infected with serotype i in period t is outbreak-related Beta(oybit + 1, outit – oybit + 1) 
ebit Estimated number of additional domestic infections with serotype i in period t that are outbreak-related Binomial(dcit, pbit) 
eit Estimated total number of domestic and sporadic infections with serotype i in period t dcit – oybit – ebit 
 
 
3. RESULTS 
 
3.1. Modified Dutch model 
 
Mean percentages and respective 95% 
CIs of human Salmonella infections attributed 
to each of the sources, to travelling abroad and 
to outbreaks by the modified Dutch model are 
reported by time period in Figure 1. Overall 
(2002–2010), pigs were the source causing the 
highest percentage of human Salmonella 
infections attributed at the levels of farm, i.e. 
animals (43%, 95% CI: 42–44%), food (45%, 
44–46%) and both combined (44%, 43–45%), 
followed by Gallus gallus (farm: 34%, 32–
35%; food; 32%, 31–33%; farm + food: 33%, 
32–34%), turkey (4%, 4–5% at all levels) and 
ruminants (2%, 2–3% at all levels). Infections 
estimated to be travel- and outbreak-related 
amounted to 16% (15–17%) and 1% (1–1%), 
respectively.  
A significant decrease in the 
percentage of infections attributed to Gallus 
gallus was observed from 2002–2004 to 2008–
2010 (–6%, –4% and –4%, on average, per 
each 3-year period in animals, food and both 
combined, respectively), whereas the 
percentage of infections attributed to pigs 
increased significantly (+4%, +2% and +3%, 
on average, per each 3-year period in animals, 
food and both combined, respectively). 
Percentages of infections attributed to the other 
sources, to travelling abroad and to outbreaks 
did not vary significantly over time (Figure 1). 
 
3.2. Modified Hald model 
 
Percentages of human Salmonella 
infections attributed to each of the sources, to 
travelling abroad and to outbreaks by the 
modified Hald model are reported by time 
period in Figure 1. Pigs were again the source 
that accounted for the highest percentage of 
infections attributed to animals (60%, 95% CI: 
48–72%), food (47%, 41–52%) and both 
combined (47%, 42–52%), followed by Gallus 
gallus (farm: 18 %, 4–31%; food: 33%, 28–
38%; farm + food: 32%, 27–37%). Turkeys 
were the third most important source at farm 
level (3%, 0–7%) and at both farm and food 
levels combined (2%, 0–5%), but it was the 
fourth at food level (1%, 0–4%), behind 
ruminants (farm: 2%, 0–5%; food: 0–3%; farm 
+ food: 0–3%). Infections estimated to be 
travel- and outbreak-related amounted to 16% 
(15–17%) and 1% (1–1%), respectively.  
From 2002–2004 to 2008–2010, 
percentages of infections attributed to Gallus 
gallus decreased by –4% (animals), –5% 
(food) and –5% (both animals and food 
combined), on average, per each 3-year period, 
whereas those attributed to pigs increased by 
+2% (animals), +2% (food) and +4% (both 
animals and food combined). However, none 
of these trends was significant as the CIs of 
attribution estimates were largely overlapping. 
Percentage of cases attributed to the other 
sources, to travelling abroad and to outbreaks 
did not vary significantly over time (Figure 1). 
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Figure 1. Percentages of human salmonellosis cases attributed to each putative source at farm and/or food level estimated by the modified Dutch and Hald models. 
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4. DISCUSSION 
 
In this study, two models were 
developed to attribute domestic and sporadic 
human Salmonella infections caused by the 30 
most frequently reported serotypes in Italy 
between 2002 and 2010 to four putative 
sources at the points of reservoir (food-
producing animals), exposure (foods of animal 
origin), and both combined. This allowed us to 
compare the obtained attribution estimates 
between different models, sampling points and 
time periods.  
Pigs stood out as the largest 
contributors to human salmonellosis in Italy, 
being responsible for about half of the 
infections relative to the other sources, to 
travelling abroad and to the outbreaks during 
the entire study period. This finding was 
consistent over different models, time periods 
and sampling points, and it was also in line 
with previous estimates based on the (original) 
Hald model applied to a rather different input 
dataset in which 73% of human Salmonella 
infections that occurred in Italy between 2007 
and 2009 had indeed been attributed to pigs 
[14].  
Besides Italy, another seven (out of 24) 
European countries considered by Pires et al. 
[14] have identified pigs as the most important 
source of human salmonellosis. These included 
Belgium, Cyprus, Finland, France, Ireland, 
Poland and Sweden, with very similar 
proportions of infections attributed to poultry 
and to pigs in the Netherlands [14]. Also in 
New Zealand pigs have been identified as the 
major source of human salmonellosis, 
accounting for 60% of infections, followed by 
poultry [16]. It is therefore becoming 
increasingly difficult to ignore that pigs play a 
paramount role as source of human 
salmonellosis, at least in the EU, and that 
(mis)handling and consumption of 
contaminated pork is the most likely food-
borne pathway involved.  
We observed an increasing temporal 
trend in the percentages of infections attributed 
to pigs and a concurrent reduction of those 
attributed to Gallus gallus. The decreasing 
importance of Gallus gallus is mainly driven 
by the drastic decrease in the number of human 
S. Enteritidis infections (Table 1), for which 
Gallus gallus, and particularly layers, are the 
major reservoir [14,20]. Such decrease has 
been observed in most European countries, 
including Italy, since the late 1990s as a result 
of the implementation of new on-farm control 
measures in poultry (e.g. introduction of live 
vaccines), improved hygiene, and education of 
consumers and food workers [14,21–24], 
especially after the implementation of national 
control programmes for Salmonella in poultry 
according to EU Regulation (EC) No. 
2160/2003. Conversely, the increasing 
importance of pigs is mainly driven by the 
predominance of human infections caused by 
S. Typhimurium and its monophasic variant 
4,[5],12:i:-, as well as by the increase of those 
caused by S. Derby (Table 1). Indeed, pigs are 
the most likely reservoir for S. Typhimurium, 
its monophasic variant 4,[5],12:i:- and S. 
Derby [14,20], and since 2000 in Italy, human 
S. Enteritidis infections fell consistently below 
those caused by S. Typhimurium, which has 
therefore become the most frequently isolated 
serotype from humans [5]. 
In all periods and sampling points, the 
two models have identified turkeys and 
ruminants as minor sources, accounting for 1–
5% of human Salmonella infections. This is in 
line with previous estimates indicating that 
~3% of all human Salmonella infections in the 
EU are attributable to turkeys relative to 
broilers, layers and pigs [6]. Ruminants have 
seldom been included as a putative source in 
attribution studies conducted in the EU, mainly 
because of data availability issues [14]. 
Although ground beef seems to be an 
important source of human salmonellosis in the 
US [13], there is also some evidence that 
ruminants do not play such a significant role 
[11,12,16].  
Both our model adaptations retained 
much of the original methodology. Modelling 
the prevalence using the methodology of 
Mullner et al. [16] allowed us to take into 
account the overall probability of finding 
Salmonella in a given source (parameter j) in 
addition to the relative frequency of the 
different serotypes within each source 
(parameter rijt, reflecting our best guess of the 
within-source serotype probability 
distribution). This is a necessary step towards 
compensating the absence of intensive 
surveillance data for all relevant sources as 
required by the original Hald model [9]. 
Moreover, uncertainty around such estimates 
could not be ignored without overestimating 
the level of precision [16]. Therefore, by 
incorporating this additional stratum of 
information and uncertainty, the model can 
now make use of the best possible estimate of 
the prevalence. Nevertheless, concerns remain 
about the adequacy of the priors used for 
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modelling the parameter j, as these originated 
from both individual- and flock-level sampling 
schemes [14] and did not change either over 
attribution points or over time periods. This 
implied that the overall probability of finding 
Salmonella in a given source, as expressed by 
pooling the available data at different 
resolutions, was assumed to be a property of 
the sources themselves and to be relatively 
stable over time and along the farm-to-food 
continuum. Changes in the prevalence were 
therefore primarily due to changes in the 
within-source serotype distribution. 
As reliable food consumption data 
were available and environmental, 
anthroponotic or unknown sources were not 
included in the models, food consumption 
weights were incorporated to take into account 
the human exposure to the different sources. 
The importance for human Salmonella 
infection of food-borne exposure is 
unquestionable [2,3]; thus, by incorporating 
food consumption data the models are better 
informed and can more closely reflect the 
chance of a given source to act as a vehicle for 
Salmonella. This incorporation is particularly 
relevant in the modified Dutch model because 
this model no longer assumes that within each 
subtype the impact of the different sources is 
equal and proportional to rijt only, as sources 
taking higher j and mjt values can therefore 
result in more infections attributed to that 
source. 
Attribution estimates of the modified 
Dutch model seemed to be more precise and 
consistent between farm and food levels 
compared to those of our modified Hald 
model, which seemed to be more sensitive to 
changes in within-source serotype frequency 
distribution between farm and food levels. 
Discrepancies in the estimates between the two 
models may be explained by the different 
computational methods they use, as also 
pointed out elsewhere [15,16,25]. A 
heterogeneous distribution of the frequently 
occurring serotypes among the sources is a 
prerequisite for the Hald model to find the 
solution with the highest probability of 
occurrence. Violating such heterogeneous 
distribution would result in a very diffuse 
posterior distribution, as the frequency of the 
so-called "indicator serotypes" on which 
source attribution relies would be little 
informative for the model [9]. In our modified 
Hald models, although converge was 
adequately achieved, we noted signs of this, as 
the distributions of the infections attributable 
to Gallus gallus and pigs were rather wide, 
especially at farm level. In particular, 
attribution estimates drifted from Gallus gallus 
to pigs at farm level, and away from pigs and 
turkeys at food level, thereby letting the 
contribution of Gallus gallus to human 
salmonellosis increase considerably from farm 
to food. This may be due to the fact that 
serotypes predominating in Gallus gallus and 
pigs (at least in animals) were also frequently 
found in other sources (Table 1), but this is 
also suggestive of an important role of hygiene 
practices in modifying the within-source 
serotype distribution along the food chain. 
Indeed, attribution at the point of production 
would identify the animal reservoirs of on-
farm microbiological contamination prior or 
during harvesting, whereas attribution at the 
point of consumption would identify foods as 
they are prepared and eaten. Thus, because 
salmonellas may enter the food chain at 
different points, the contribution of the 
different sources to human infections is also 
reasonably expected to vary from one point to 
another. 
High sensitivity of the Hald model to 
changes in prior information, particularly for 
the serotype-dependent parameter qi, has been 
claimed [15]. We chose to model qi 
hierarchically as a random effect with its 
variation controlled by the hyper-parameter  
like in the modified Hald model [16]. This, 
together with the use of data split into multiple 
periods while estimating pooled qi and aj 
parameters over all periods, was expected to 
improve identifiability and robustness of the 
model, as reported elsewhere [11,16]. Inherent 
to the way by which these parameters were 
estimated is the assumption that the ability of 
the different serotypes and sources to cause 
infection in humans are properties of the 
serotypes and sources themselves and do not 
change over time. Temporal differences were 
therefore expected to be explained entirely by 
the serotype frequency distributions, food 
consumption patterns and sampling 
uncertainty. 
Attributions made here have some 
limitations related to data availability in need 
of further investigations. These were the lack 
of distinction between broilers and layers/eggs 
within Gallus gallus and the lack of more 
discriminatory typing data than serotypes only. 
Furthermore, concerns remain about the 
heterogeneous distribution of human 
Salmonella infections across the country, as 
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southern regions are usually more prone to 
underreporting than northern regions [4,5].  
 
 
5. CONCLUSIONS 
 
With some differences in consistency 
and precision of attribution estimates over time 
periods and sampling points, both our 
adaptations of the modified Dutch and Hald 
source attribution models to Italian Salmonella 
data identified pigs as the main source of 
human salmonellosis in Italy, followed by 
Gallus gallus, whereas the contributions of 
turkeys and ruminants were estimated to be 
only minor. This ranking provided us with 
valuable insights about the relative 
contribution of these sources to the burden of 
human salmonellosis in Italy. The increasing 
importance of pigs and the decreasing one of 
Gallus gallus as sources of human 
salmonellosis suggest that the applied control 
measures have been successful in poultry but 
there is an urgent need to focus attention on 
pigs. Despite data limitations and uncertainty 
in the results, our attribution estimates can be 
considered valid as a first indication of which 
sources are becoming increasingly important in 
Italy. These results are expected to be useful 
for the delineation of future risk management 
strategies in Italy. Although both our models 
applied at farm and food levels reached similar 
conclusions, more detailed data collected at 
varying levels of the transmission chain may 
further inform policy makers about the most 
critical points on which control efforts should 
be targeted. 
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Practicalities of using non-local or non-recent 
multilocus sequence typing data for source 
attribution in space and time of human 
campylobacteriosis 
 
 
ABSTRACT 
 
In this study, 1208 Campylobacter jejuni and C. coli isolates from humans and 400 isolates from 
chicken, collected in two separate periods over 12 years in The Netherlands, were typed using 
multilocus sequence typing (MLST). Statistical evidence was found for a shift of ST frequencies in 
human isolates over time. The human MLST data were also compared to published data from other 
countries to determine geographical variation. Because only MLST typed data from chicken, taken 
from the same time point and spatial location, were available in addition to the human data, MLST 
datasets for other Campylobacter reservoirs from selected countries were used. The selection was 
based on the degree of similarity of the human isolates between countries. The main aim of this study 
was to better understand the consequences of using non-local or non-recent MLST data for attributing 
domestically acquired human Campylobacter infections to specific sources of origin when applying 
the asymmetric island model for source attribution. In addition, a power-analysis was done to find the 
minimum number of source isolates needed to perform source attribution using an asymmetric island 
model. This study showed that using source data from other countries can have a significant biasing 
effect on the attribution results so it is important to carefully select data if the available local data lack 
in quality and/or quantity. Methods aimed at reducing this bias were proposed. 
 
 
1. INTRODUCTION 
 
Campylobacter is the most common 
cause of bacterial gastroenteritis in the western 
world [1]. Several source attribution studies 
have been performed to quantify the relative 
contributions of different sources of infection 
to human campylobacteriosis. The results of 
these studies can be used for identifying those 
sources of infection that are the most 
promising targets for Campylobacter-reducing 
intervention efforts, as well as for measuring 
the impact of such efforts at varying levels of 
the transmission chain. Chicken has been 
indicated as the major contributor to the 
disease burden of human campylobacteriosis in 
most countries where source attribution studies 
pertaining to those geographical regions have 
been performed [2–5]. However, in other 
countries, ruminants have also been found to 
be important [6,7]. As new Campylobacter 
sequence types (STs) emerge and the relative 
occurrence of the established ones change 
continually, attribution results may vary over 
time [8]. In addition, the human exposure to 
Campylobacter may vary as well, for example, 
because of international travel and trade, 
changes in food consumption patterns and 
eating habits, either over space or time. 
To estimate the proportion of human 
Campylobacter infections attributable to 
different sources, differences in the relative 
occurrence of bacterial subtypes in individual 
sources may be used. The Campylobacter spp. 
subtypes found in human cases and in food and 
environmental sources are compared to 
attribute human campylobacteriosis cases to 
sources. Multilocus Sequence Typing (MLST) 
[9] has been used as the typing method of 
choice in most recent studies [3–5,7] as it 
displays a reasonable level of heterogeneity of 
Campylobacter STs among the different 
sources. Thus far, most published studies on 
Campylobacter source attribution have been 
performed in countries in which a relatively 
large number of local and recent 
Campylobacter spp. strains from animal and 
environmental sources have been isolated and 
typed with MLST. Yet, the set up of intensive 
sampling schemes and the examination of the 
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collected samples to obtain Campylobacter 
MLST data from multiple sources is costly. As 
a result, Campylobacter MLST data and 
related source attribution studies are lacking in 
many countries. It has been noted that, 
although surprisingly robust [10], the use of 
non-recent or non-local data in attribution 
studies may introduce bias into the attribution 
results for human cases of campylobacteriosis 
within a country [11]. In addition, the use of a 
small-sized human or source dataset may result 
in uncertain and, therefore, less generalizable 
estimates. 
In the Netherlands, Campylobacter 
MLST data have been collected from humans 
between 2002–2003 and 2010–2011 and from 
chickens between 2000–2007 and 2010–2011. 
In this study, we present these data and 
compare them with other published data from 
different countries. In addition, we analyze 
temporal changes in MLST frequencies of such 
data. Only a small number of local 
Campylobacter MLST reference strains were 
available from other sources than chicken. A 
method was proposed to select MLST datasets 
representing sources other than chicken from 
international studies to be used for source 
attribution purposes. 
The aim of this study was to better 
understand the consequences of using non-
local or non-recent MLST data for attributing 
domestically acquired human infections to 
their putative sources of origin. We 
investigated how the source attribution model 
used performs in absence of local or recent 
data, or when few data are available. Based on 
these analyses, we give recommendations 
about which and how many data from other 
countries should be used for obtaining reliable 
source attribution estimates if the available 
local data lack in quality and/or quantity. 
 
 
2. MATERIALS AND METHODS 
 
2.1. Data 
 
2.1.1. Campylobacter MLST data from the 
Netherlands 
 
Data of laboratory-confirmed human 
cases of Campylobacter jejuni and C. coli 
infection in the Netherlands were obtained for 
two different periods. Between April 2002 and 
April 2003, stool samples were collected from 
2858 C. jejuni and 257 C. coli human cases 
during a case-control study on risk factors for 
indigenous campylobacteriosis and 
salmonellosis, the so-called CaSa study [12]. 
Of these, 948 C. jejuni and 66 C. coli isolates 
were subsequently successfully typed with 
MLST [9] to be used for source attribution and 
source-specific risk characterization [2]. Of 
these, 743 cases (699 C. jejuni and 44 C. coli) 
were domestic cases, as the other cases had a 
recent history of foreign travel. 
Isolates from more recent domestic 
human cases of campylobacteriosis routinely 
identified by the Dutch Regional Public Health 
Laboratories through passive surveillance were 
obtained between June 2010 and June 2011. In 
total, another 423 C. jejuni and 42 C. coli 
strains were typed using MLST. 
In addition, 218 Campylobacter 
isolates from fresh retail chicken meat of 
Dutch origin, sampled between 2000 and 2007, 
were obtained. More recent chicken isolates of 
Dutch origin were obtained between 2010 and 
2011. These consisted of 158 isolates from 
retail chicken meat and 24 isolates from layer 
hens, pooled together assuming that layers and 
chickens are a single reservoir (Gallus gallus). 
Isolates from other Campylobacter sources in 
the Netherlands were obtained between 2000 
and 2006 (cattle, n = 9; pigs, n = 13; 
environmental water, n = 106). These isolates 
were also typed using MLST [9]. 
In this study, cases with a recent 
history of foreign travel were excluded and C. 
jejuni/coli data were given at the species level 
for humans but not for chicken isolates. 
 
2.1.2. Campylobacter MLST data from 
international studies 
 
A literature review was conducted to 
identify published studies that provide MLST 
data for Campylobacter isolates from human 
cases and from various sources in countries 
other than the Netherlands. It was required that 
the data in such studies were representative of 
the natural strain diversity and relative 
frequencies therein, in those countries. 
Therefore, studies presenting isolates which 
are subject to any form of selection (e.g. 
reporting of novel strains only) were excluded. 
Isolate collections used in this study are shown 
in Table 1. 
 
2.2. Comparison of datasets 
 
2.2.1. Analysis of diversity 
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The distributions of ST frequencies in 
different datasets were compared visually by 
stacking the frequency bars of the most 
common STs found in the different studies 
next to each other. In addition, the frequency 
distributions of the most common STs and 
clonal complexes (CCs) in different datasets 
were compared with one another to allow for 
genetically close relationships between STs 
within the same CC to be evidenced. 
Approximate confidence intervals (CIs) for the 
ST or CC frequencies were calculated using 
bootstrapping [13]. 
The proportional similarity index (PSI, 
or Czekanowski index) [14] was used to 
measure the similarity of frequencies of STs 
between the different datasets. The PSI is 
expressed as PSI = 1 – 0.5 ∑k |Pk – Qk|, where 
|Pk – Qk| is the absolute value of the difference 
in the relative frequency of MLST genotype k 
in dataset P compared to its frequency in 
dataset Q. The values of PSI range from 0 to 1, 
with 0 indicating that both distributions have 
no types in common and 1 that both 
distributions are completely equal. CIs for the 
PSI were also calculated using bootstrapping 
[13]. 
 
2.2.2. Principal component analysis 
 
In addition to the numerical 
similarities measured by the PSI between 
datasets, a principal component analysis (PCA) 
[15] provides additional insights towards 
which STs are the main contributors to the 
differences observed between the different 
datasets. Briefly, the original coordinate 
system, in which each axis represents the 
relative frequency of one ST in the datasets, is 
linearly transformed by PCA. In the 
transformed coordinate system, most 
variability is explained by the first coordinate 
(the first principal component), the second 
largest variability is explained by the second 
coordinate, etc. The proportion of the 
variability that is explained by the nth 
coordinate equals the fraction of the nth 
eigenvalue out of the summed total of all 
eigenvalues of the transformation matrix. A 
plot of the transformed axes shows which STs 
are most relevant for explaining the differences 
between the datasets. If the first dimensions of 
the transformed system explain the majority of 
variability, only these need to be plotted. 
 
2.3. Source attribution 
 
2.3.1. Asymmetric Island model 
 
The large effective population size of 
Campylobacter causes frequent mutation 
despite a relatively low mutation rate per allele 
[16]. Also, Campylobacter recombines [17] 
and migrates from one host to another [18]. 
With the Asymmetric Island (AI) model [5], 
the parameters describing these genetic 
changes within, and drift between, the source 
populations are inferred using Bayesian 
inversion. Subsequently, they are used for 
comparing one group of isolates (the 
attributable population) to other groups (the 
source populations). For each case, the AI 
model estimates a relative assignment posterior 
probability (Pr) to originate from each source. 
The proportion of human infections attributed 
to a given source is calculated as the average 
Pr over all cases. The AI model has been used 
for source attribution in a number of published 
studies [5,19,20] and has been reported to 
provide results with a relatively high level of 
confidence [19]. 
 
2.3.2. Baseline attribution analysis 
 
In the baseline attribution analysis, the 
attributable population consisted of the 1208 
non-travel related Dutch human cases in 2002–
2003 and 2010–2011. The source populations 
were defined by the available MLST source 
data from the Netherlands supplemented with 
MLST source data from a selection of other 
published studies. Supplementary source data 
were used from countries where the human 
isolates were most similar to Dutch human 
isolates, as indicated by the PSI. Isolates that 
were used in the baseline attribution analysis 
are printed in bold in Table 1. The augmented 
dataset is composed in such a way that there 
were 168 isolates for cattle, 160 for sheep, 133 
for pig and 289 for the environment. Chicken 
data from countries other than the Netherlands 
were not used because sufficient Dutch data 
were available for this source. 
 
2.3.3. Advanced attribution analyses 
 
Typically, the available 
Campylobacter MLST data for source 
attribution are imperfect [2]. Source data are in 
fact scarcer than human data in many countries 
because these are not collected routinely. To 
verify the impact of imperfect source data, the 
following scenarios were tested: 
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 Source attribution with non-local source 
data. 
 Source attribution with limited source data. 
The impact of using non-local source 
data was assessed by performing the following 
source attribution analyses of Dutch human 
cases and comparing their results to the 
baseline attribution results. First, chicken data 
from countries relatively close to the 
Netherlands (UK, here Scotland and England, 
and Switzerland) were used instead of the 
domestic chicken data. The effect of using 
chicken data from countries further away from 
the Netherlands (New Zealand, Finland and the 
US) was also investigated. Ultimately, 
domestic chicken and chicken from Scotland, 
England and Switzerland were considered as 
distinct sources in the attribution analysis. 
The impact of using non-local source 
data was further studied by letting non-local 
chicken isolates be the attributable population, 
and attributing these using the source 
populations as defined in the baseline 
attribution analyses (bold numbers in Table 1). 
This type of analysis is called self-attribution, 
and can also be used to test the statistical 
power of the attribution model [19]. In this 
case, a high similarity between the non-local 
and local chicken isolates and a high statistical 
power of the model should result in a self-
attributed proportion of the chicken isolates 
that is close to 1. 
Self-attribution was also used to study 
the impact of using source data with a limited 
sample size. Of the 400 chicken isolates used 
in the baseline attribution, 250 were randomly 
selected to be the attributable population. 
Experiments indicated that the effect of 
modifying this initial split of the chicken data 
on the attribution results was negligible; thus, 
only one random split was considered in the 
following experiments. The remaining 150 
chicken isolates and 150 randomly selected 
isolates from the remaining source populations 
(as defined in the baseline attribution model) 
were the reduced source populations. 
Subsequently, self-attribution was carried out. 
Self-attribution of the same 250 chicken 
isolates was also done with random subsets of 
100, 75 and 50 isolates from each source 
population to explore the effects of using 
smaller-sized source datasets. To account for 
variability in the attribution results caused by 
the random subset selection, self-attribution 
was done 10 times for every subset of the 
source population, while keeping the 
attributable population of 250 chicken isolates 
constant. 
Finally, a source attribution analysis 
based on the minimum possible non-recent and 
non-local data was performed. This was made 
by letting the human cases in 2002-2003 be the 
attributable population and using the 
corresponding Dutch source data (NL1 dataset 
in Table 1) supplemented with only the most 
similar non-Dutch source data (SC dataset in 
Table 1). 
 
Table 1: Number of isolates in published human (h) and source (s) datasets and (last column) bootstrapped similarities of the human data 
with the human data in the NL1 dataset 
Set Ref.a Country (region) Year Human Chicken Cattle Sheep Pig Environnent 
PSI (95%CI)b 
of human data 
to human data 
of NL1 
NL1 [2] Netherlands 
h: 2002–2003; 
s: 2000–2007 
743 218 9 0 13 106  
NL2 Data Netherlands 2010–2011 465 182 0 0 0 0 0.41 (0.36–0.44) 
SC [4] Scotland (Grampians) 2005–2006 278 239 90 88 15 133 0.40 (0.36–0.43) 
CH2 [29] Switzerland 2009 383 0 0 0 0 0 0.35 (0.31–0.38) 
CH [24] Switzerland 
h: 1993–2003; 
s: 2001–2002 
76 77 23 0 100 0 0.31 (0.24–0.38) 
CH3 [22] Switzerland 2008 136 0 0 0 0 0 0.31 (0.27–0.35) 
EN [9] England 
h: 1977–2001; 
s: 1983–1999 
355 73 46 72 5 50 0.30 (0.26–0.33) 
NL3 [9] Netherlands 
h: 1996–1998; 
s: 1990–1999 
76 53 3 0 0 0 0.29 (0.22–0.36) 
NZ1 [3] New Zealand (Manawatu) 2005–2008 502 331 99 140 0 104 0.26 (0.22–0.29) 
SP [6] Spain 
h: 2003–2009; 
s: 2003–2006 
71 36 80 44 0 0 0.22 (0.15–0.27) 
FI [30] Finland 
h: 1996, 2002–2003; 
s: 2003 
305 36 20 0 0 0 0.21 (0.18–0.25) 
NZ2 [31] New Zealand 2006 112 0 0 0 0 0 0.20 (0.15–0.26) 
CUR [26] Curacao 1999–2000 205 0 0 0 0 0 0.19 (0.15–0.23) 
AU [27] Australia (New South Wales) 1999–2001 153 0 0 0 0 0 0.18 (0.14–0.23) 
US [32] USA (Michigan) 2003 17 13 0 0 0 0 0.14 (0.06–0.21) 
a. The datasets are ordered in decreasing similarity of the human isolates with the NL1 human data. Numbers of isolates that are written in bold were used 
in the baseline source attribution analysis. 
b. Proportional Similarity Index, with 95% confidence intervals. 
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3. RESULTS 
 
3.1. Temporal variation 
 
A large variety of STs was found in the 
Dutch human and chicken data. In Figure 1, 
the contributions of those CCs including STs 
that were found in the human data of 2002–
2003 in proportions over 1% (accounting for 
83% of all isolates) are represented together 
with the contributions of the same STs within 
these CCs for chicken data of 2000–2007 and 
for human and chicken data of 2010–2011; 
these CCs accounted for 65%, 67% and 52% 
of all isolates, respectively.  
 
 
Figure 1. Most common STs in human and chicken isolates in The Netherlands in two time periods. Only the contributions of those CCs including STs that 
were found in the human data of 2002–2003 in proportions over 0.01 are represented. The contributions of less frequent STs within these CCs are summed 
and presented by the “+” symbol; the contributions of other CCs are omitted. For the human data of 2002–2003 the presented CCs make up for 83% of all 
isolates. For the chicken data of 2000–2007 and the human and chicken data of 2010–2011, these CCs make up for 65%, 67% and 52% of all data, 
respectively. 
 
Among the 743 human isolates from 
2002–2003, 161 different STs were observed. 
The five most frequent STs were ST53 (9.2%), 
ST50 (6.8%), ST21 (6.1%), ST45 (4.4%) and 
ST48 (4.3%). Among the 218 chicken isolates 
from 2000–2007, 87 different STs were found, 
the five most common STs being ST2483 
(7.8%), ST53 (6.9%), ST50 (5.0%), ST584 
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(4.6%) and ST464 (4.6%). In the 465 human 
isolates from 2010–2011, 129 different STs 
were observed. The five most frequent STs 
were ST48 (10.7%), ST21 (9.9%), ST572 
(9.3%), ST257 (6.7%) and ST50 (4.2%). 
Among the 182 chicken isolates from 2010-
2011, 82 different STs were found, the five 
most common STs being ST2274 (11.5%), 
ST572 (9.3%), ST50 (4.4%), ST45 and ST257 
(3.8%). 
The PSI was used as a tool to quantify 
the (dis)similarity between recent and non-
recent isolates. Figure 2 indicates that the STs 
isolated from chicken and human cases are 
increasingly dissimilar as the period between 
which the samples were taken increases. The 
linear decrease is borderline significant with a 
mean slope of –0.011 (95% CI: –0.018 to –
0.003). PSI was also calculated for chicken 
data between 2000–2004 and 2005–2007 (PSI 
= 0.24, 95% CI: 0.11–0.38), between 2000–
2004 and 2010–2011 (0.20, 0.07–0.33), and 
between 2005–2007 and 2010–2011 (0.34, 
0.22–0.46). Although the 95% CIs overlap one 
another, a trend is notable towards 
dissimilarity of chicken data as the period 
between which the samples were taken 
increases.
 
 
Figure 2. Similarity of STs in chicken and in human isolates from samples collected in different years. The x-axis gives the 
absolute difference between years in which the isolates from human cases and chicken were obtained. To enhance the size of 
the sample subsets, chicken isolates collected between 2000 and 2004 were aggregated and assigned to be collected in 2002, 
those collected between 2005 and 2007 were assigned to be collected in 2006, and those collected in 2010–2011 were assigned 
to be collected in 2010. Human isolates were arranged in three groups: 2002, 2003, and 2010–2011. The y-axis represents the 
PSI between those isolates collections. 
 
3.2. Geographical variation 
 
The frequency distributions of the 
most common CCs in human datasets 
published in the international literature are 
shown in Figure 3. The most commonly found 
CC in England is CC21, followed by CC45, 
CC48 and CC257. For the Dutch human data, 
these were also important CCs in 2002-2003 as 
well as in 2010–2011. CC21 was less common 
in human cases in other countries, in particular 
in Australia and in the US. CC48 was 
remarkably prominent in New Zealand. This is 
mainly due to CC48 member ST474, which 
accounted for 30% and 29% of all human cases 
in the two New Zealand studies, respectively. 
ST45, the founder strain of CC45 was by far 
the most common ST in Finland, accounting 
for 28% of the human cases. CC354 member 
ST528, which is frequently reported in New 
South Wales, Australia, was not reported in the 
other studies. 
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Figure 3. Bar chart of frequency distributions of the most prevalent CCs in 12 human datasets. Only CCs of which a prevalence higher than 10% was found 
are plotted. 
 
The analysis of similarity of the Dutch 
human data from 2002-2003 with the human 
data from other datasets shows that they are 
most similar to Dutch human data from 2010–
2011, followed by human data from Scotland, 
England and Switzerland (Table 1). In general, 
the Dutch human data were less similar to data 
from Finland, Spain and the considered non-
European countries. This was expected 
because of the differences in geographical 
distance. All international datasets were 
significantly different from the Dutch human 
data from 2002–2003, as can be seen by the 
fact that the similarity 95% CI within these 
Dutch data does not overlap any other 
similarity confidence interval (Table 1). 
In Figure 4, the first three dimensions 
of the PCA transformed system of ST 
frequency vectors are plotted. ST474 sets the 
datasets from New Zealand apart from other 
datasets and ST21 sets datasets from 
Switzerland slightly apart from other datasets. 
The Finnish dataset is set apart from other 
datasets by a high prevalence of ST45 and the 
dataset from Curacao is set somewhat apart 
from other datasets due to a high prevalence of 
ST508. Evaluation of the eigenvalues of the 
transformation matrix obtained in the PCA 
showed that the first three dimensions of the 
transformed coordinate system explain about 
73% of the variability of ST frequencies 
between the datasets. 
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Figure 4. PCA transformed vectors of CC frequencies in 12 human datasets. The first, second and third PCA transformed dimensions explain together 73% 
of the total variability in the data. Weighted sums of the CC frequency distributions of the human isolates in the different datasets reported in Table 1 are 
plotted in the first two (upper graph) and in the second two (lower graph) dimensions of the PCA transformed space. 
 
3.3. Attribution analyses 
 
In the baseline attribution analysis 
(Figure 5A), of all 1208 human cases of 
campylobacteriosis, 68% (95% CI: 61–74%)  
was attributed to chicken, 24% (18–31%) to 
cattle, and 6% (2–10%) to the environment, 
while the contributions of sheep and pig were 
only minor (2% together). If the Dutch chicken 
data were replaced by chicken data from 
Scotland, England and Switzerland (Figure 
5B), then the importance of chicken for human 
disease decreased to 45% (37–52%), whereas 
the contributions of non-chicken sources 
increased. Replacement of the Dutch chicken 
data by chicken data from New Zealand, 
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Finland and the US (Figure 5C) greatly 
reduced the inferred role of chicken for human 
disease (20%, 14–25%), leading to cattle being 
the most important source (45%, 36–55%), 
followed by the environment (32%, 23–40%). 
When data from domestic chicken and data 
from Scottish, English and Swiss chicken were 
considered as separate sources in the model 
(Figure 5D), then it is evident that there is 
much more overlap of MLST genotypes 
between the domestic chicken and Dutch 
human isolates (63%, 55–70%) rather than 
non-Dutch chicken (17% together).  
 
 
Figure 5. Overall mean probability (%) and 95% confidence interval for human C. jejuni and C. coli infections to originate from chicken, cattle, pig, sheep, 
and the environment. A. Baseline attribution results (see main text); B. Attribution results with Dutch chicken isolates replaced by chicken isolates from 
Scotland, the UK and Switzerland; C. Attribution results with Dutch chicken isolates replaced by chicken isolates from New Zealand, Finland and USA; D. 
Attribution results with Dutch, Scottish, English and Swiss chicken isolates as separate Campylobacter reservoirs. 
 
If the self-attribution analysis were 
done with domestic chicken as the attributable 
population and the source populations the same 
as in the baseline attribution analysis, then 
89% (81–95%) of these isolates were attributed 
to the right source. If chicken isolates from 
Scotland, England and Switzerland were 
assigned as the attributable population, then 
the percentage of correct self attribution was 
62% (47–75%). Similarly, if chicken isolates 
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from New Zealand, Finland and the US were 
assigned as the attributable population then 
62% (49–73%) of these isolates were attributed 
to the right source.  
Figure 6 shows the impact of using 
limited source data. It is seen that the 
variability over the mean attributed proportions 
(caused by randomly generating reduced 
datasets) increases for smaller subsets of the 
original source data. This is evident as the 
random effects increase for these smaller 
subsets. Also the statistical power of the AI 
model decreases if fewer data are available, 
which leads to a larger uncertainty. This 
implies that the confidence of the attribution 
results decreases as fewer data are available. 
The statistical power of the attribution model 
was fairly robust for smaller-sized source 
datasets until a minimum number of 100 
isolates per source. If fewer than 100 isolates 
are available per source then the statistical 
power of the attribution model decreased 
substantially. For an average 2.5% confidence 
over 50% of correct source attribution, it is 
advisable that more than 25 isolates per source 
are used. 
In the attribution analysis based on the 
minimum possible non-recent and non-local 
data (where the word "minimum" here refers to 
the supplementary non-Dutch source data used 
in the model and not to the sample size), 63% 
(95% CI: 56–69%) of the 743 human cases of 
2002-2003 was attributed to chicken, 25% 
(19–32%) to cattle, and 11% (6–15%) to the 
environment, while the contributions of sheep 
and pig were again minimal (1% together). 
 
 
 
Figure 6. Statistics of the self-attributed proportions of 250 chicken isolates for reduced source datasets of size n (on x-axis). Every reduced 
dataset is generated from the original dataset by randomly removing isolates from an original set of 150. The boxes indicate variability in the 
mean attributed proportions over the 10 different reduced datasets per model and per reduction factor. Indicated are the minimal, maximal 
and average means. The whiskers indicate the average 2.5% and 97.5% confidence limits over the different reduced datasets. The star-
symbols represent the minimum 2.5% limit and the maximum 97.5% limit. 
 
 
4. DISCUSSION 
 
We presented the results of a study in 
which Campylobacter isolates from Dutch 
human patients (n = 1208) and Dutch chicken 
(n = 400) collected between 2002–2003 and 
2010–2011 were typed using MLST. The large 
size of this dataset provided the opportunity to 
perform a multitude of analyses aimed at 
defining the effect of time and geographical 
location on the diversity of the Campylobacter 
population. Other reservoirs for 
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Campylobacter were less well sampled in the 
Netherlands. Therefore, non-local source data 
were used to supplement the Dutch ones in 
order to attribute the human infections to the 
different sources. A practical method was also 
proposed to select such supplementary data 
with the aim of minimizing potential biases of 
the attribution estimates. This method is based 
on the assumption that if the human data 
between different countries and time periods 
resemble one another (as revealed by PSI and 
PCA), then also will their respective source 
data, which may therefore be borrowed 
interchangeably for the purposes of source 
attribution. Inherent to this way of choosing 
the source data is the assumption that the 
consumption patterns and exposure pathways 
from sources to humans are similar in the 
Netherlands and in the countries/time periods 
from which the supplementary source data 
were collected, and that diversity between the 
human datasets can only be explained by 
intrinsic differences in the genotype 
distribution and by sampling uncertainty.  
The attribution analyses showed that 
chicken was the most important source of 
human campylobacteriosis in the Netherlands, 
accounting for 61–74% of the human cases in 
the baseline model where the two human 
datasets for 2002–2003 and 2010–2011 were 
pooled based on their high similarity and the 
fact that the corresponding source data covered 
on average the whole time period. This is in 
line with findings from previous source 
attribution studies conducted in several other 
countries [2,3,7,21,22]. Nevertheless, our 
analyses suggest that the high proportion of 
human cases attributed to chicken and the 
smaller proportions of cases attributed to non-
chicken sources (which are less intensively 
sampled in the Netherlands) may depend on 
the origin of the source data included in the 
model. When domestic chicken data were 
replaced by chicken data from countries 
showing the closest possible human MLST 
profiles to those of the Netherlands, i.e. 
Scotland, England and Switzerland, the 
ranking of sources remained the same as that 
of the baseline model but the contribution of 
chicken to human cases decreased 
considerably. This was more evident and the 
ranking of sources was even reversed when 
domestic chicken data were replaced by 
chicken data from countries with human 
MLST data less similar to those of the 
Netherlands, i.e. New Zealand, Finland and the 
US. Moreover, when Dutch, Scottish, English 
and Swiss chicken data were included as 
separate sources, it became apparent that 
domestic chicken is much more important than 
foreign chicken in accounting for domestic 
human cases. Together these findings suggest 
that the further in region and time one takes the 
source data, the more their MLST profiles will 
differ, and the smaller will be the estimated 
proportions of human cases attributable to 
those sources that were sampled less close in 
time and space to the human cases.  
ST50 is shared as a common ST 
among the human and chicken isolates 
collected in the periods 2002–2003 and 2010–
2011, and results from the AI model showed 
that human cases with ST50 had a 90% 
probability of having been infected by chicken 
or by strains with chicken origin. This ST 
belongs to CC21, which is reported to have a 
relatively wide distribution across many host 
species but slightly more dominant in 
ruminants [23]. Other STs belonging to this 
complex are ST21 and ST53. ST21 was more 
common in human cases than in chicken in 
both periods. Results of the AI model showed 
that human cases with ST21 were slightly 
more likely to have been infected by ruminants 
(Pr = 0.51) than by chicken (Pr = 0.43). The 
decline of ST53 in samples from chicken, 
being the most frequent ST in samples from 
2000–2007 but a minor ST in samples from 
2010–2011, coincided with a decline of this ST 
in the human samples as well. A similar 
decline was seen for ST584 in the chicken and 
in the human samples. This may indicate the 
importance of chicken as the source for 
campylobacteriosis caused by these STs. 
Results of the AI model confirmed that the 
probability that these STs originated from 
chicken was 0.84 and 0.97 for ST53 and ST 
584, respectively. In contrast, ST2274 was 
increasingly common in chicken samples, 
which coincides with an increase of this ST in 
the human samples. Results from the AI model 
showed that human cases with ST2274 were 
most likely to have been infected by chicken 
(Pr = 0.97). The predominant STs in human 
data in the Netherlands in 2002–2003 were 
ST53 and ST50, both belonging to CC21. Also 
in other studies [7,20,21,24], these strains were 
reported to be common in human patients.  
By comparing the human datasets from 
several countries to the Dutch human data, it 
was concluded that the importance of the 
differences in ST frequencies is correlated with 
the geographical distance between the 
countries, with the data from nearby European 
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countries being generally more similar than 
data from more distant countries with respect 
to the Netherlands, such as New Zealand, 
Australia and the US. PCA was proposed as a 
method to show in a visually appealing way 
the difference in occurrence of STs in different 
studies. The transformed vector representing 
the Dutch human data is relatively close to the 
origins of these PCA plots. This indicates that 
the 2002–2003 Dutch human dataset does not 
contain one or more CCs in markedly different 
frequencies than the average frequency 
distribution over all datasets that were 
considered. This may be caused by the ease of 
traveling and trade within the European Union, 
which leads to a larger exposure to 
Campylobacter from reservoirs present in 
European countries. However, limited 
exposure to this international diversity of 
Campylobacter strains may occur in people 
living in countries where there is a less open 
national market such as New Zealand or 
Australia, or where less international 
importation of meat products, including 
poultry meat, takes place, such as Spain or 
Finland. Indeed, approximately 8% and 11% of 
the total amount of meats available for 
consumption in 2000–2009 in Spain and 
Finland were imported, respectively, and these 
figures are considerably lower than those for 
the Netherlands (~45%), the UK (~30%), and 
Switzerland (~16%) [25]. Human isolates from 
Curacao were taken from Guillain-Barré cases 
[26], which is a particular subset of 
campylobacteriosis cases. These may be 
reasons that studies in these countries show 
different frequencies of certain CCs compared 
to the averaged frequencies over all studies, 
which may be seen by the larger distance from 
the origins in the PCA plots. Also the CCs that 
set the studies from these countries apart from 
other studies are shown in the PCA plots. 
Indeed, CC48, in particular the CC48 member 
ST474, is reported in New Zealand more 
frequently than in other countries [20], ST528, 
belonging to CC354, is more frequently 
reported in New South Wales, Australia [27], 
and the CC45 member ST45 is more 
frequently reported in Finland [7]. 
The PCA shows only those CCs which 
explain the largest variation between the 
different datasets. Yet, in many studies the 
same STs (e.g. ST21, ST22, ST48 and ST 257) 
turn up as the predominant strains. This 
provides evidence to the suggestion made by 
Mickan et al [27] that some STs have a global 
distribution, while others are restricted in their 
distribution to a more local environment, 
however the "local STs" may be more 
associated with countries with less 
international travel and trade [28]. 
The results of our study show that it is 
recommended to have over 100 isolates per 
food source to perform source attribution using 
the AI model in order to have satisfactory 
statistical power. More detailed research 
questions with respect to attribution estimates 
might ask for more precision, hence a larger 
strain set. If this amount of data is not available 
for each potential source when using only 
recent and domestic data, then the investigator 
may be forced to use non-recent or non-local 
data. We have shown that the MLST data 
supply for Campylobacter within a food source 
is subject to dynamic changes in time and over 
geographical location; thus, in principle, this 
introduces temporal and geographical bias into 
the study. 
As the AI model is based on a 
population genetics approach, source data 
collated from studies that show large variations 
between isolates obtained from the same 
sources but from different datasets may distort 
the gene frequencies upon which source 
attribution relies [5]. Sample size may impact 
on such variation by letting certain sources to 
exhibit relatively more unique (with respect to 
humans and the other sources) genotypes than 
others; thus, more intense sampling of small-
sized sources is generally desirable, as 
oversampling certain sources relative to the 
others does not seem to affect the point 
estimates but only their accuracy [5]. Indeed, 
the source dataset becomes denser and better 
defined in terms of representative genotypes by 
increasing the number of samples. Therefore, 
notwithstanding the distortion of gene 
frequencies due to the pooling of source 
datasets from different studies, this may 
become less important with increasing sample 
size. 
In conclusion, we have shown that, 
even on a small time-scale, MLST data within 
two sources become increasingly dissimilar as 
the time between different datasets are 
collected increases so that the AI model may 
underestimate the importance of a source 
whose data are not collected 
contemporaneously with the human cases to be 
attributed. Temporal bias can be minimized by 
choosing the most recent data that are available 
for a source. In addition, the AI model may 
underestimate the importance of sources from 
which non-local source data were used. A 
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coarse rule is that this bias increases with the 
geographical distance between the countries in 
which the attribution is performed and from 
which source data are used. Nevertheless, our 
results show that geographical distance is not 
the only factor, and it may act together with 
factors related to travel and trade between 
countries. It also has been found that 
association of genotypes to a particular host is 
reported to be stronger than their association to 
a geographical location [10]. Our results show 
that, although this may make the consequences 
of geographically biased data less severe, it 
does not fully compensate for them (Figure 5). 
In general, the extent to which this bias is a 
matter of  concern depends on how detailed (in 
time and region) is the research question to be 
addressed. A method based on the comparison 
of human isolates from different studies using 
PSI and PCA was proposed to select non-
recent and non-local MLST datasets for the 
purposes of source attribution while 
minimizing potential biases. 
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Risk factors for campylobacteriosis of chicken, 
ruminant, and environmental origin:  
a combined case-control and  
source attribution analysis 
 
 
ABSTRACT 
 
Background: Campylobacteriosis contributes strongly to the disease burden of food-borne pathogens. 
Case-control studies are limited in attributing human infections to the different reservoirs because they 
can only trace back to the points of exposure, which may not point to the original reservoirs because of 
cross-contamination. Human Campylobacter infections can be attributed to specific reservoirs by 
estimating the extent of subtype sharing between strains from humans and reservoirs using multilocus 
sequence typing (MLST). 
Methodology/Principal Findings: We investigated risk factors for human campylobacteriosis caused 
by Campylobacter strains attributed to different reservoirs. Sequence types (STs) were determined for 
696 C. jejuni and 41 C. coli strains from endemic human cases included in a case-control study. The 
asymmetric island model, a population genetics approach for modeling Campylobacter evolution and 
transmission, attributed these cases to four putative animal reservoirs (chicken, cattle, sheep, pig) and 
to the environment (water, sand, wild birds) considered as a proxy for other unidentified reservoirs. 
Most cases were attributed to chicken (66%) and cattle (21%), identified as the main reservoirs in The 
Netherlands. Consuming chicken was a risk factor for campylobacteriosis caused by chicken-
associated STs, whereas consuming beef and pork were protective. Risk factors for campylobacteriosis 
caused by ruminant-associated STs were contact with animals, barbecuing in non-urban areas, 
consumption of tripe, and never/seldom chicken consumption. Consuming game and swimming in a 
domestic swimming pool during springtime were risk factors for campylobacteriosis caused by 
environment-associated STs. Infections with chicken- and ruminant-associated STs were only partially 
explained by food-borne transmission; direct contact and environmental pathways were also 
important. 
Conclusion/Significance: This is the first case-control study in which risk factors for 
campylobacteriosis are investigated in relation to the attributed reservoirs based on MLST profiles. 
Combining epidemiological and source attribution data improved campylobacteriosis risk factor 
identification and characterization, generated hypotheses, and showed that genotype-based source 
attribution is epidemiologically sensible. 
 
 
1. INTRODUCTION 
 
Virtually all people in The Netherlands 
(~16 million population) possess serological 
evidence of multiple exposures to 
Campylobacter spp. during the course of their 
lives, although most infections pass with no, or 
mild, symptoms [1]. With an estimated 90,000 
symptomatic infections occurring annually, 
campylobacteriosis is the most frequent cause 
of acute bacterial gastroenteritis in The 
Netherlands [2–4]. In 2010, the incidence of 
laboratory-confirmed campylobacteriosis was 
50 per 100,000 inhabitants, the highest ever 
recorded in the Dutch population since 1996. 
Up to 88% of these infections were acquired 
domestically. Hospitalization was required in 
approximately a quarter of laboratory-
confirmed cases [5]. Most infections occur 
sporadically, with outbreak-related cases 
representing less than one percent of the total 
number of Campylobacter infections [6]. 
Apart from acute gastroenteritis, 
campylobacteriosis may lead to more severe, 
occasionally long-term, sequelae, such as 
Guillain-Barré syndrome, reactive arthritis, and 
irritable bowel syndrome [7,8], causing 
considerable morbidity and economic impact 
on the Dutch population [2,4,8]. 
Campylobacter spp. are commensally 
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widespread in the intestines of wild and 
domesticated animals, resulting in 
contamination of the environment, including 
water sources [9]. Although Campylobacter 
spp. are mostly perceived as food-borne 
pathogens, there is evidence for other 
transmission pathways, including direct and 
indirect contact with infectious animals, 
people, and environments [10–13]. 
Evidence of host-adapted 
Campylobacter strains exists [14]. However, 
the relative importance of each reservoir in 
zoonotic transmission remains unclear. Novel 
host-associated adaptive mutation and 
recombination events are frequent in 
Campylobacter spp., resulting in populations 
that are not strongly structured into 
differentiated clusters; thus, predicting host 
from genotype is challenging [14]. 
Several case-control studies have 
evidenced that consumption of chicken is an 
important risk factor for human 
campylobacteriosis [10–13,15]. Poultry and 
avian species in general are the preferential 
host for Campylobacter spp., and during 
processing retail poultry carcasses may 
become contaminated [6,9,16,17]. As 
Campylobacter strains of chicken origin may 
reach humans through pathways other than 
food [18], the consumption and handling of 
chicken may account for up to 40% of human 
infections, while up to 80% may be attributed 
to the chicken reservoir as a whole [9]. 
Case-control studies are insufficient 
for attributing human infections to the different 
reservoirs because they can only trace back to 
the points of exposure (e.g. food items 
consumed), which may not point to the original 
(amplifying) reservoirs because of cross-
contamination. Attributing human infections to 
specific reservoirs is crucial to prioritize, 
implement, and measure the impact of targeted 
interventions [19]. Human Campylobacter 
infections can be attributed to specific 
reservoirs by estimating the extent of subtype 
sharing between strains isolated from humans 
and reservoirs [19]. Multilocus sequence 
typing (MLST) [20,21] is a typing 
methodology that is widely used 
internationally for this purpose [14,21–25]. 
MLST allows for the identification of genetic 
lineages in Campylobacter populations by 
indexing the variation present in seven 
housekeeping genes. A unique sequence 
pattern is assigned to a sequence type (ST), 
while closely related STs sharing the same 
alleles at different loci are considered as 
belonging to the same clonal complex (CC), 
the members of which possess a common 
ancestor [20]. Several modeling approaches 
can then be applied to MLST data to attribute 
Campylobacter strains from human cases to 
different reservoirs, e.g. [23]. 
With a focus on The Netherlands, the 
aims of this study were: 1) to attribute human 
Campylobacter infections to four putative 
animal reservoirs (chicken, cattle, sheep, and 
pig) and to the environment; 2) to combine the 
available case-control data [10] with the results 
of the attribution analysis to explore risk 
factors at the point of exposure for human 
campylobacteriosis caused by strains highly 
associated with the different reservoirs. 
 
 
2. MATERIALS AND METHODS 
 
2.1. Human data 
 
We used Campylobacter data from the 
so-called CaSa study, a large case-control 
study on risk factors for sporadic salmonellosis 
and campylobacteriosis conducted in The 
Netherlands between April 2002 and April 
2003. A detailed description of the 
methodology and results of the CaSa study is 
available elsewhere [10,26]. 
A total of 2858 C. jejuni and 257 C. 
coli cases were identified by the Dutch 
Regional Public Health Laboratories (RPHL) 
and assigned to species using molecular 
methods [27,28] at the Central Veterinary 
Institute (CVI) in Lelystad, The Netherlands. 
Cases were interviewed by means of a 
questionnaire sent by the RPHL together with 
the laboratory test results to the prescribing 
physician who forwarded these to the 
corresponding patient. After exclusion of cases 
who: 1) did not return or complete successfully 
the questionnaire (1679 cases); and 2) had a 
recent or unknown history of foreign travel, 
and/or lived outside The Netherlands (338 
cases), 1019 C. jejuni and 79 C. coli cases 
were enrolled in the study. 
Based on historic surveillance data of 
the number of Campylobacter and Salmonella 
infections in the RPHL service areas, the 
expected numbers of cases by age (0–4, 5–17, 
18–29, 30–44, 45–59, and ≥60 years), sex, 
degree of urbanization (urban: >2500 
addresses/km2; urbanized: 500–2500 
addresses/km2; rural: <500 addresses/km2), and 
season (April–June 2002, July–September 
2002, October–December 2002, January–April 
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2003) were obtained. Controls were randomly 
selected from population registries within the 
RPHL service areas by frequency matching 
(aiming at two controls per case) according to 
the expected number of cases by age, sex, 
degree of urbanization, and season. A total of 
10250 controls were approached in 
anticipation of an expected response rate of 
25%. Of these, 3409 (33%) controls returned 
the postal questionnaire. After exclusion of 
controls who: 1) had travelled abroad (244 
controls);or 2) did not provide reliable 
information (46 controls), 3119 controls were 
enrolled in this study. 
Cases and controls were asked to fill in 
the aforementioned questionnaire to collect 
information regarding food consumption, 
kitchen hygiene, food processing, contact with 
animals, occupational exposure, history of 
travel, recreational water activity, medication 
use, history of chronic diseases, and contact 
with people with gastroenteritis. Questions 
covered the 7 days prior to symptoms onset 
(cases) or completion of the questionnaire 
(controls). Parents were asked to complete the 
questionnaire on behalf of their children. 
Missing values were handled using multiple 
imputation [29]. 
Isolates from 980 cases (919 C. jejuni 
and 61 C. coli) identified by the RPHL were 
successfully typed with MLST as described 
elsewhere [20,21]. Of these, 737 cases (696 C. 
jejuni and 41 C. coli) were cases enrolled in 
the study, as the other 243 typed cases were 
not eligible for enrollment because they had 
travelled abroad or did not return/complete 
successfully the questionnaire. Purification and 
sequencing of PCR products were done by 
Macrogen Inc, Korea. The software 
Bionumerics 5.10 was used to analyze 
sequence data. 
Differences in relative frequencies of 
the five most frequently reported STs (ST-53, 
ST-50, ST-21, ST-48, and ST-45) and CCs 
(CC-21, CC-45, CC-206, CC-257, and CC-48) 
were examined for the variables age, sex, 
degree of urbanization, and season, using 
Pearson's χ2 test (α-level: 0.05). 
 
2.2. Animal and environmental data 
 
As only few Dutch Campylobacter 
reference strains typed with MLST were 
available for the animal reservoirs (232 strains) 
and for the environment (106 strains) [30] 
(Table 1), other reference strains from the 
United Kingdom (UK) [21], Scotland [25], and 
Switzerland [31] were used to supplement the 
Dutch ones. These data sets were identified 
among other published data sets from New 
Zealand, Australia, Curaçao, United States of 
America, and Finland (references available 
upon request), accessible in PubMLST 
(http://pubmlst.org/). The data sets from the 
UK, Scotland, and Switzerland were identified 
based on the similarity of the C. jejuni and C. 
coli ST frequency distributions of human 
isolates in these countries with those of human 
isolates in The Netherlands. The Euclidean 
distance was used as similarity metric in 
principal component analysis (PCA) [32]. The 
PCA revealed that the human isolates from 
The Netherlands were indeed most similar to 
the human isolates from the UK, Scotland, and 
Switzerland [33]. 
 
Table 1. Campylobacter strains used to feed the asymmetric island model for source attribution. 
Country Human Chicken Cattle Sheep Pig Environment Reference 
The Netherlands 980† 210 9 0 13 106 (water) [30] and data‡ 
United Kingdom 0 0 46 72 5 50 (sand) [21] 
Scotland 0 0 90 88 15 133 (wild birds) [25] 
Switzerland 0 0 23 0 100 0 [31] 
Total 980 210 168 160 133 289  
†Obtained from the CaSa study [10]. 
‡Provided by the Central Veterinary Institute (CVI) in Lelystad, The Netherlands. 
 
For the purposes of this study, the 
identified reservoir data [21,25,31], and those 
available for The Netherlands (i.e. [30] and 
additional data supplied by the CVI) were 
pooled and arranged in five groups: 1) chicken; 
2) cattle; 3) sheep; 4) pigs; and 5) the 
environment (Table 1). Environmental strains 
were those sourced from water, sand, and wild 
birds, and were treated as a “reservoir” as well 
in the attribution analysis. Although the 
environment cannot be considered as a single 
amplifying host for Campylobacter spp. but 
only as a “pseudo-reservoir” collecting strains 
from a variety of different hosts, the STs found 
in environmental samples have hardly ever 
been found in other reservoirs [23,34]. 
Therefore, the environment was considered as 
a proxy for other unidentified reservoirs, 
putatively of primarily wildlife origin [23,34]. 
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2.3. Attribution analysis 
 
The Asymmetric Island (AI) model 
[22] was used to attribute human 
Campylobacter infections to the four putative 
animal reservoirs and to the environment. The 
AI model is a coalescent-based model derived 
from a generalization of the Wright's island 
model. It incorporates a Bayesian approach for 
modeling the genetic evolution and zoonotic 
transmission of the Campylobacter strains 
using their allelic profiles, accounting for 
relatedness among STs. The model estimates 
the mutation and recombination rates within 
the reservoirs, as well as the migration rates 
between reservoirs and from each reservoir to 
the human population. These migration rates 
are used to estimate the relative contribution of 
each reservoir to human infections [22]. By 
modeling the evolutionary processes of 
mutation and recombination, the AI model 
accounts for the occurrence of novel alleles, or 
novel combinations of alleles, in strains from 
humans that are unobserved in reservoir 
populations [22]. 
For every case, the AI model estimates 
a relative assignment posterior probability (Pr) 
to originate from each reservoir. The 
proportion of human infections attributed to a 
given reservoir is calculated as the sum of its 
Pr over cases divided by the total number of 
cases. 
For each reservoir, differences in Pr 
were tested among age groups, degrees of 
urbanization, and seasons using the Kruskal-
Wallis test (KW); and between genders using 
the Mann-Whitney U test (MW) (α-level: 
0.05). 
 
2.4. Risk factor analysis 
 
We repeated the analysis of risk factors 
for human campylobacteriosis as previously 
applied [10], using the 737 cases typed with 
MLST and the 3119 controls enrolled. C. 
jejuni and C. coli infections were analyzed 
together. For preliminary significance testing, 
we assessed the association of 131 putative 
risk factors with Campylobacter infection 
using unconditional logistic regression with the 
matching variables and the level of education 
(categorized as: low = primary, lower 
vocational or lower secondary education; 
intermediate = intermediate vocational, 
intermediate secondary or higher secondary 
education; high = higher vocational and 
university education) included as covariates, 
which is the method of choice for frequency-
matched data [35]. Factors showing a p-value 
lower than 0.10 for the association with the 
outcome in the single-variable analysis were 
selected for inclusion in a multivariable 
logistic regression model. A backward 
stepwise selection procedure was applied and 
variables with a p-value lower than 0.05 were 
retained in the final model. The population 
attributable risk (PAR) and the population 
preventable risk (PPR) of each significant 
factor were calculated based on multivariable 
odds ratios (OR) and the prevalence of 
exposure in cases. Similarly, confidence 
intervals of PARs and PPRs were derived from 
the confidence intervals of the multivariable 
ORs [10]. 
To investigate risk factors for human 
campylobacteriosis caused by Campylobacter 
strains highly associated with the different 
reservoirs, we constructed several logistic 
regression models that included separate 
subsets of cases assigned to the different 
reservoirs on the basis of the ranking of their 
estimated Prs. The assignment of cases to the 
different reservoirs was performed similarly to 
previous case-studies [36,37]. The distribution 
of Pr for each reservoir was assessed and a 
cut-off point was determined to provide a 
reasonable balance between the number of 
cases assigned to each reservoir and the 
confidence as to their correct assignment 
derived by the highest possible Pr. 
For infections of probable chicken, 
ruminant (cattle plus sheep), and 
environmental origin, separate logistic 
regression models that included only those 
cases with at least 50% probability (cut-off: 
Pr≥0.50) of originating from each of these 
reservoirs were constructed. For infections of 
probable chicken and ruminant origin, further 
logistic regression models were constructed for 
a range of other consecutive cut-off points at 
regular intervals of 0.05, from Pr≥0.50 to 
Pr≥0.95 for chicken, and from Pr≥0.50 to 
Pr≥0.80 for ruminants (Figure 1 and Table 2). 
The low numbers of the remaining cases did 
not allow for the construction of further 
models based on successive cut-off points. For 
the environment, it was only possible to 
construct a logistic regression model using the 
cut-off point of Pr≥0.50 (Figure 1 and Table 2) 
because there were too few cases with a higher 
Pr to enable consistent estimation. 
 
Mughini Gras, Smid, Wagenaar, et al. PLoS ONE 2012; 7 (8): e42599 
79 
 
 
Figure 1. Rank ordered assignment source probability per human case (vertical columns). The white vertical columns indicate the cut-off points beyond 
which cases were selected for inclusion in the risk factor analysis. Cases are in ascending order according to the source probability to aid visualization. 
 
The final cut-off points represented the 
best trade-off between the increasing Pr for a 
given reservoir (i.e. increase in reservoir 
specificity) and the decreasing number of cases 
includable in the models (i.e. decrease in 
statistical power and failure of the model to 
converge). For infections of probable chicken 
origin, 143 cases with a mean Pr for chicken of 
0.96 (range: 0.95–0.99) were selected. For 
infections of probable ruminant origin, 67 
cases with a mean Pr for ruminant of 0.87 
(range: 0.80–0.96) were selected. Finally, for 
infections of probable environmental origin, 34 
cases with a mean Pr for environment of 0.76 
(range: 0.50–0.98) were selected (Figure 1 and 
Table 2). 
For infections of probable pig and 
sheep origin, the construction of any regression 
model was technically possible, yet 
epidemiologically inappropriate, because there 
were no or just two cases with Pr≥0.50 for 
sheep and pig, respectively. Moving the cut-off 
point to a Pr<0.50 for sheep and pig would 
have resulted in the inclusion of many cases 
nearly equally attributed to the different 
reservoirs, making the risk factor analysis 
unclear and relatively uninformative. For the 
risk factor analysis, cattle and sheep were thus 
combined into ruminants as done previously 
[36,37]. This option appears to be justified by 
the weak discrimination of Campylobacter 
strains from sheep and cattle when using 
MLST [14,22]. 
To explore if the risk factors of the 
multivariable logistic regression models 
differed according to age, sex, degree of 
urbanization, season, and level of education we 
also tested the significance of their 
interactions. The final multivariable logistic 
regression models were therefore expanded to 
include significant interaction terms. 
For simplicity, only the results of the 
final multivariable regression models based on 
the aforementioned final cut-off points were 
presented. Although food and non-food related 
risk factors were estimated together, they were 
presented separately to improve readability of 
the tables. All regression models maximized to 
the Pr for a given reservoir showed an overall 
statistical significance (likelihood ratio χ2 test, 
p<0.05) and an acceptable goodness-of-fit 
(Hosmer-Lemeshow test, p>0.05). 
For all risk factor analyses, the 
controls were used as common comparison 
group. The matching variables and the level of 
education were always included as covariates 
in all regression models to control for 
confounding, as the Pr-based selection of cases 
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slightly skewed them from the controls with 
respect to these confounders. To support the 
accuracy of inferences of regression models 
with <5 cases per variable, bias-corrected 
bootstrap confidence intervals were also 
calculated (1000 replications) and compared 
with the standard ones [38]. As these 
confidence intervals did not differ 
significantly, the standard ones were reported. 
Statistical analyses were performed using 
STATA 11.2. 
 
Table 2. Campylobacter sequence types of human 
cases assigned to chicken, ruminant, and the 
environment in the risk factor analysis. 
Chickena Ruminantsb Environmentc 
44 19 350 
227 22 447 
230 38 508 
290 61 586 
353 104 587 
354 206 637 
400 270 696 
443 403 710 
584 432 861 
606 475 1080 
775 658 1539 
801 1519 2123 
859 2156 2130 
875 2288 2151 
883 2187  
978 3015  
1073 3130  
1191 4276  
1583 4279  
1600 4282  
1707 4300  
1728 4307  
1957 4308  
2034 4314  
2183   
2324   
2553   
2807   
2808   
2844   
2882   
2899   
3016   
4269   
4271   
4280   
4283   
4292   
a. 143 cases, mean Pr for chicken = 0.96; range: 0.95–
0.99.  
b. 67 cases, mean Pr for ruminants = 0.87; range: 0.80–
0.96. 
c. 34 cases, mean for environment Pr = 0.76; range: 
0.50–0.98. 
 
 
3. RESULTS 
 
3.1. Human multilocus sequence types and 
clonal complexes 
 
Overall, the 737 Campylobacter strains 
were assigned to 154 STs belonging to 28 CCs. 
Twenty-eight STs were unassigned to a 
previously identified CC. The frequency of 
genotypes was highly skewed, with ST-53, ST-
50, ST-21, ST-48, and ST-45 accounting for 
more than a quarter of all isolates, and CC-21, 
CC-45, CC-206, CC-257, and CC-48 
accounting for more than half of all isolates 
(Figure 2). The attribution analysis revealed 
that ST-50, ST-53, ST-48, and ST-45 were 
predominantly related to chicken, with a 
substantial contribution from cattle in ST-48 
and ST-45 (Figure 3). ST-21 was mostly 
related to cattle and chicken (Figure 3). 
Chicken was also the predominant source for 
isolates belonging to CC-257, CC-206, CC-21, 
CC-45, and CC-48, but a substantial 
contribution from cattle was also found in CC-
48 and CC-21, and from the environment in 
CC-45 (Figure 3). 
For C. jejuni, the frequencies of STs 
and CCs followed the same ranking as the 
aforementioned ones; whereas for C. coli, the 
five most frequent STs were ST-825, ST-827, 
ST-1614, ST-854, and ST-1600, all belonging 
to CC-828, which accounted for 68% of C. coli 
isolates and was predominantly related to 
chicken (Pr = 0.69) and cattle (Pr = 0.16). 
Significant age relationships were 
found for ST-53 (χ2 test, p<0.001) and its CC, 
CC-21 (χ2 test, p = 0.002). The highest relative 
frequency of ST-53 was found in children and 
adolescents (0–4 and 5–17 years, which 
accounted together for 48% of ST-53 isolates), 
whereas that of CC-21 (24% of CC-21 
isolates) was found in young adults (18-29 
years). ST-21 was significantly over-
represented in urbanized areas (53%; χ2 test, p 
= 0.036). Significant seasonal effects were 
found for ST-48 (χ2 test, p = 0.023) and its CC, 
CC-48 (χ2 test, p = 0.028), which showed the 
lowest relative frequencies in the spring (3% 
and 4%, respectively), peaked in the summer 
(43% and 40%, respectively) and had 
intermediate frequencies (23–31%) during 
autumn-winter months. 
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Figure 2. Human Campylobacter strains per clonal complex and sequence type assigned with MLST. The category „others‟ includes clonal complexes and 
sequence types with less than five isolates. 
 
 
Figure 3. Attributed probability (%) for the five most represented sequence types and clonal complexes to 
originate from chicken, cattle, sheep, and the environment. The probability for pigs is not viewable because it is 
<1%. 
 
3.2. Attribution of human infections 
 
Overall, the AI model estimated that 
the majority of human infections (489; 66.2%) 
originated from chicken, followed by cattle 
(153; 20.7%), environment (74; 10.1%), sheep 
(19; 2.5%), and pigs (2; 0.3%). The 696 C. 
jejuni cases were attributed as follows: 
chicken, 66.1% (460 cases); cattle, 21.2% 
(148); environment, 10.2% (71); sheep, 2.4% 
(17); and pigs, 0.01% (<1) (Figure 4). The 41 
C. coli cases were attributed as follows: 
chicken, 69.6% (29 cases); cattle, 12.2% (5); 
environment, 8.9% (3); sheep, 5.0% (2); pigs, 
4.9% (2) (Figure 4). 
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Figure 4. Overall mean probability (%) and 95% confidence interval for human C. jejuni (n = 696) and C. coli (n = 41) infections to 
originate from chicken, cattle, pig, sheep, and the environment. 
 
The Prs for cattle and pig were 
significantly different between C. jejuni and C. 
coli (cattle: MN, p = 0.001; pig: MN, 
p<0.001). Significant effects of urbanization 
were found for the chicken reservoir (KW, p = 
0.023), which showed the highest median Pr 
(0.84) in cases from urbanized areas. A 
significantly (MN, p = 0.018) higher Pr for 
chicken was also found for young children 
aged 0–4 years living in urban areas (median 
Pr: 0.86; n = 15) compared with those living in 
rural areas (median Pr: 0.59; n = 33). A 
significant seasonal effect (KW, p = 0.020) 
was found in Pr for the environmental 
reservoir, which peaked in the spring followed 
by a trough in the summer and autumn, with a 
small peak in the winter. 
 
3.3. General risk factors for 
campylobacteriosis 
 
In contrast to the previous study [10], 
we used a smaller sample of cases and C. 
jejuni and C. coli were analyzed together. 
Nevertheless, the direction and strength of the 
factors associated with campylobacteriosis in 
the final multivariable model (Table 3 and 
Table 4) were comparable with the previous 
results [10]. With a PAR of 28%, consumption 
of chicken was the most important risk factor, 
followed by consumption of barbecued (18%) 
and undercooked (16%) meats, and eating in a 
restaurant (11%) (Table 3). However, a 
significantly higher risk was observed only 
when barbecued meat was consumed by 
patients living in non-urban areas (Table 3).Of 
the non-food risk factors (Table 4), strong 
associations were found for recent use of 
proton-pump inhibitors (22%), and having a 
chronic gastrointestinal disease (20%). 
With a PPR of 34%, consumption of 
pasteurized dairy products other than milk and 
cheese (i.e. mostly yoghurt) was the most 
important protective factor, followed by 
consumption of chocolate (22%), pasteurized 
milk (15%), seafood (14%), fruit (13%), nuts 
(13%), meat in paste (8%), and salad (7%) 
(Table 3). Of the non-food protective factors, 
contact with dogs owned by other people was 
the most important one (8%) (Table 4).
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Table 3. Multivariable odds ratios and percent PAR or PPR (and 95% confidence intervals) for food-related risk factors for human 
campylobacteriosis according to the attributed origin of the Campylobacter strain (chicken, ruminant, and the environment). 
Risk factor (% imputed missing values*) Overalla Chickenb Ruminantsc Environmentd 
Food consumption     
Chicken (1) 1.5 (1.2–1.9) 1.9 (1.2–2.9) ns ns 
 28% (13–41%) 42% (14–60%)   
Beef (1) ns 0.6 (0.4–0.9) ns ns 
  30% (7–44%)   
Pork (2) ns 0.7 (0.5–0.9) ns ns 
  16% (5–26%)   
Tripe (1) ns ns 4.0 (1.1–14.2) ns 
   12% (1–37%)  
Game (0) ns ns ns 3.3 (1.4–7.8) 
    37% (10–64%) 
Undercooked meat (5) 2.1 (1.6–2.7) ns ns ns 
 16% (10–23%)    
Barbecued, grilled, or microwaved meat (5) 18% (10–25%) ns 63% (41–78%) ns 
in urban areas 1.2 (0.7–2.2)ns ns 0.8 (0.1–7.3)ns ns 
in urbanized areas 1.7 (1.3–2.2) ns 7.1 (3.2–15.6) ns 
in rural areas 3.0 (1.8–4.9) ns 4.1 (1.3–14.2) ns 
Meat in paste (croquette, meat roll, pastry) (5) 0.8 (0.6–1.0) ns 0.5 (0.2–0.8) ns 
 8% (0–13%)  14% (1–22%)  
Pasteurized milk (1) 0.8 (0.6–0.9) ns ns ns 
 15% (6–29%)    
Pasteurized dairy other than milk or cheese (2) 0.6 (0.5–0.7) 0.4 (0.3–0.7) 0.5 (0.3–0.9) 0.3 (0.1–0.8) 
 34% (25–42%) 41% (20–48%) 37% (7–51%) 48% (13–61%) 
Stir–fried vegetables (3) ns ns ns 0.3 (0.1–0.9) 
    11% (2–16%) 
Salad (2) 0.7 (0.6–0.9) ns 0.4 (0.2–0.9) ns 
 7% (2–9%)  10% (2–13%)  
Fruit with peel (2) 0.7 (0.6–0.8) ns ns ns 
 13% (9–17%)    
Chocolate (2) 0.6 (0.5–0.7) 0.5 (0.4–0.7) ns ns 
 22% (17–28%) 22% (17–34%)   
Nuts (3) 0.6 (0.5–0.8) ns 0.5 (0.3–0.9) ns 
 13% (6–16%)  16% (0–22%)  
Seafood (4) 0.5 (0.4–0.7) 0.6 (0.4–0.9) ns ns 
 14% (8–16%) 13% (3–20%)   
Eating habits     
Eating in a restaurant (0) 1.3 (1.1–1.6) ns ns ns 
 11% (4–20%)    
Vegetarian diet (0) 0.4 (0.2–0.9) ns ns ns 
 1% (0–1%)    
Eating chicken once a month or less (3) ns ns 1.7 (1.0–2.9) ns 
   25% (1–47%)  
Kitchen hygiene     
Not cleaning a knife when using it for raw meat and other foods 
(1) 
1.7 (1.1–2.6) 
 
ns ns ns 
 4% (6–9%)    
Washing hands before food preparation (0) 0.6 (0.4–0.9) ns ns ns 
 1% (0–2%)    
Multivariable odds ratios are also adjusted for age, sex, degree of urbanization, season, and level of education. PAR (population attributable risk) and PPR 
(population 
preventable risk) are based on the multivariable odds ratios. Risk factors are in bold, protective factors in normal font. 
ns = not significant (p.0.05). 
*Fraction of imputed missing values in the whole dataset. 
a. 737 cases; mean Pr for chicken = 0.66 (range: 0.00–0.99); mean Pr for ruminants = 0.23 (range: 0.00–0.96); mean Pr for environment = 0.10 (range: 
0.00–0.98). 
b. 143 cases; mean Pr for chicken = 0.96; range: 0.95–0.99. 
c. 67 cases; mean Pr for ruminants = 0.87; range: 0.80–0.96. 
d. 34 cases; mean Pr for environment = 0.76; range: 0.50–0.98. 
 
3.4. Risk factors for chicken-associated 
campylobacteriosis 
 
For chicken-associated 
campylobacteriosis, consumption of chicken 
was the most important risk factor (PAR 42%) 
(Table 3), followed by recent use of proton-
pump inhibitors (34%), having a chronic 
gastrointestinal disease (12%), and contact 
with people with gastroenteritis symptoms 
outside the household (10%) (Table 4). 
Important protective factors were consumption 
of yoghurt (PPR 41%), beef (30%), pork 
(16%), and seafood (13%) (Table 3). 
 
3.5. Risk factors for ruminant-associated 
campylobacteriosis 
 
With a PAR of 63%, consumption of 
barbecued meat was the most important risk 
factor for ruminant-associated 
campylobacteriosis (Table 3). However, the 
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risk posed by the consumption of barbecued 
meat was significantly higher only for patients 
living in non-urban areas. Other important risk 
factors were: consumption of tripe (12%), 
eating chicken rarely, i.e. once a month or less 
(25%) (Table 3), recent use of proton-pump 
inhibitors (34%), and occupational exposure to 
animals (17%) (Table 4). Important protective 
factors were consumption of yoghurt (PPR 
37%), nuts (16%), and meat in paste (14%) 
(Table 3). 
 
 
Table 4. Multivariable odds ratios and percent PAR or PPR (and 95% confidence intervals) for non-food related risk factors for human campylobacteriosis 
according to the attributed origin of the Campylobacter strain (chicken, ruminant, and the environment). 
Risk factor (% imputed missing values*) Overalla Chickenb Ruminantsc Environmentd 
Contact with animals     
Contact with dog(s) owned by other people (3) 
0.6 (0.5–0.8) 
 
ns ns ns 
 8% (4–10%)    
Contact with pets and/or farm animals outside the 
household (1) 
ns ns ns 
0.4 (0.2–1.0) 
 
    17% (1–22%) 
Ownership of several dogs, at least one dog < 1 
year–old (0) 
2.5 (1.1–5.8) 
 
ns ns ns 
 2% (1–7%)    
Ownership of several dogs, all dogs > 1 year–old (0) ns ns ns 3.5 (1.0–12.0) 
    33% (1–54%) 
Ownership of cat(s) (1) 1.4 (1.2–1.8) ns ns ns 
 10% (5–17%)    
Recent use of medication      
Antibiotics (0) 0.4 (0.2–0.8) ns ns ns 
 1% (0–2%)    
Proton–pump inhibitors (0) 3.7 (2.5–5.5) 4.7 (2.4–9.1) 5.7 (2.2–16.3) ns 
 22% (14–33%) 34% (11–53%) 34% (11–58%)  
Other     
Swimming in a domestic swimming pool (0) ns ns ns 28% (2–64%) 
in the spring season ns ns ns 16.8 (2.6–107.6) 
in the summer, winter or autumn seasons ns ns ns 2.5 (0.4–14.4)ns 
Contact with people with gastroenteritis symptoms 
outside the household (3) 
1.5 (1.1–2.1) 1.8 (1.1–3.0) ns 3.4 (1.3–8.7) 
 6% (1–12%) 10% (1–23%)  35% (6–63%) 
Having a chronic gastrointestinal disease (0)§ 
2.4 (1.8–3.2) 
 
1.8 (1.1–3.1) 
 
ns 
5.0 (2.1–12.1) 
 
 20% (13–28%) 12% (2–27%)  50% (22–74%) 
Occupational exposure to animals (0) ns ns 3.2 (1.2–9.0) ns 
   17% (2–41%)  
Multivariable odds ratios are also adjusted for age, sex, degree of urbanization, season, and level of education. PAR (population attributable risk) and PPR 
(population 
preventable risk) are based on the multivariable odds ratios. Risk factors are in bold, protective factors in normal font. 
ns = not significant (p.0.05). 
*Fraction of imputed missing values in the whole dataset. 
a. 737 cases; mean Pr for chicken = 0.66 (range: 0.00–0.99); mean Pr for ruminants = 0.23 (range: 0.00–0.96); mean Pr for environment = 0.10 (range: 
0.00–0.98). 
b. 143 cases; mean Pr for chicken = 0.96; range: 0.95–0.99. 
c. 67 cases; mean Pr for ruminants = 0.87; range: 0.80–0.96. 
d. 34 cases; mean Pr for environment = 0.76; range: 0.50–0.98. 
§Includes Crohn‟s disease, irritable bowel disease (IBD), irritable bowel syndrome (IBS), or celiac disease. 
 
3.6. Risk factors for environment-associated 
campylobacteriosis 
 
Consumption of game was the only 
food-related risk factor for campylobacteriosis 
of probable environmental origin (PAR 37%) 
(Table 3). Other important risk factors were: 
having a chronic gastrointestinal disease 
(50%), contact with people with gastroenteritis 
symptoms outside the household (35%), 
swimming in a domestic swimming pool 
(28%), and ownership of several adult dogs 
(33%) (Table 4). However, a significantly 
higher risk was observed only when patients 
swam in a domestic swimming pool during the 
spring (April–June), but not during the other 
seasons (the risk of swimming during the 
summer, autumn, and winter months was 
equally insignificant; thus, these strata were 
combined, Table 4). Important protective 
factors were consumption of stir-fried 
vegetables (PPR 11%) (Table 3) and contact 
with pets and/or farm animals outside the 
household (17%) (Table 4). 
 
 
4. DISCUSSION 
 
This is the first case-control study in 
which risk factors at the point of exposure for 
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human campylobacteriosis are investigated in 
relation to the attributed reservoirs based on 
MLST profiles. Previous studies [36,37] 
examined risk factors for reservoir-associated 
campylobacteriosis in a similar, albeit more 
limited, way, as only a small number of risk 
factors about demographic characteristics (e.g. 
age, sex, resident location, etc.) were 
investigated and a case-case approach was 
used. 
 
4.1. Campylobacter multilocus genotypes 
 
Campylobacter populations are 
regarded as genetically highly diverse, even 
when considering their core-genome using 
MLST [9]. With 154 STs identified among 737 
human cases, our results indicate that 
considerable variety exists also in the Dutch 
Campylobacter population. Rare STs were also 
considerably represented, as STs occurring 
once accounted for 46% of all STs. Besides 
this large variety, there was some evidence 
indicating that certain genotypes can emerge 
and predominate in specific age groups, areas, 
and seasons, although most of the commonest 
genotypes were broadly distributed and 
recurrent over time. 
The main STs and CCs identified here 
have been reported worldwide [21,23,25,39–
44] and were typical of previous reports from 
The Netherlands [20,30]. Most of these 
studies, however, were geographically and 
temporally limited; thus, the extent to which 
the predominant genotypes, both in humans 
and reservoirs, correspond to stable 
geographical structuring or to a transient 
expansion could not be investigated. 
In our study, CC-21 was the most 
represented CC and was predominated (32%) 
by ST-53, which was also the most common 
ST in the whole data set. Although both CC-21 
and ST-53 were primarily attributed to 
chicken, they were over-represented among 
cattle isolates in Scotland [25] and Finland 
[40], and among cattle and chicken isolates in 
the UK [21] and multi-country collections 
[43]. To a lesser extent, there is also evidence 
for sheep and environment to be involved 
[21,22,25,40,43,44]. This also applies to the 
ubiquitously sourced ST-50, ST-21, ST-48, 
and ST-45, although they seem to be 
predominant in chicken (ST-50 and ST-45) and 
cattle (ST-21 and ST-48) [21,23,40,43]. 
Differences in host preference among 
Campylobacter genotypes observed in this 
study may be due to niche adaptation, 
geographic separation, host-related factors 
(e.g. immunity, behaviors with respect to 
potential exposures, etc.), or barriers to genetic 
exchange [40]. 
 
4.2. Attributed reservoirs of human 
campylobacteriosis 
 
Chicken was estimated to be the most 
important reservoir of human 
campylobacteriosis in The Netherlands, 
accounting for approximately 66% of 
infections. This is in line with other studies 
conducted in industrialized countries using the 
AI model [22–24]. The proportion of cases 
attributable to chicken, however, varied 
considerably among these studies (56% [22] 
and 76% [23,24]). Besides variations in local 
epidemiology, such divergences are mostly due 
to the consideration of different reservoirs, 
which may affect the proportions of attributed 
infections. For instance, Mullner et al. [23] did 
not consider pigs; Sheppard et al. [24] kept 
wild birds, environment, and turkey as 
separated sources; Wilson et al. [22] included 
also rabbit and kept wild birds, sand, and water 
separated. 
We found that Prs for pig and cattle 
were significantly different between C. jejuni 
and C. coli strains. A higher Pr for cattle was 
found in C. jejuni compared with C. coli, 
whereas a higher Pr for pig was found in C. 
coli compared with C. jejuni. This supports 
evidence indicating that C. jejuni is more 
prevalent than C. coli in cattle and that the 
inverse situation holds for pigs [9]. We also 
found that chicken was the major reservoir for 
campylobacteriosis in young children living in 
urban areas compared with their rural 
counterparts, for which cattle seemed to be 
more important, although the difference for 
cattle was not clearly significant (data not 
shown). The same finding was previously 
observed in Scotland [25] and New Zealand's 
North Island [37], supporting the hypothesis 
that the main source of campylobacteriosis for 
young children depends on residence location: 
chicken (consumption) is a more important 
source of infection in urban dwellers, while 
infection from cattle seems to be more likely to 
occur in rural areas, possibly via 
environmental pathways [25]. In The 
Netherlands, cattle density has also been 
associated with an increased risk for Shiga 
toxin-producing Escherichia coli (STEC) 
O157 infection in young children living in 
rural areas [45]. Together these results suggest 
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that the risk of encountering and becoming 
diseased with enteropathogens putatively shed 
by cattle is considerable in young children 
living in rural areas. 
A significant seasonal effect was found 
for the environmental reservoir. 
Campylobacter is widespread in the 
environment where it generally gives clues to 
recent fecal contamination, agricultural run-
off, and sewage effluent [46]. Although 
intestinal carriage of Campylobacter is 
ubiquitous in animals, the environmental 
contamination varies seasonally depending on 
factors such as stress, changes in diet, and 
indoor/outdoor housing of animals [46]. The 
significant seasonal pattern of 
campylobacteriosis of probable environmental 
origin may reflect both the year-round 
variation in Campylobacter die-off rates in 
varying environments and the increased 
propensity of people for outdoor recreational 
activities, especially water activities, during 
the warm season, which may entail 
transmission from outdoor-reared animals and 
so far unidentified wildlife reservoirs. 
 
4.3. Reservoir-specific risk factors for 
campylobacteriosis 
 
While the attribution analysis 
quantified the relative contributions of the 
considered reservoirs to human infections, the 
risk factor analysis identified the excess risks 
for infections that were highly associated with 
these reservoirs, allowing for the identification 
of the possible pathways by which 
Campylobacter infection may be acquired 
from a given reservoir, as well as their 
quantification in terms of PAR. For instance, 
only up to 42% (14–60%) of the highly 
chicken-associated infections could be ascribed 
to consumption of chicken, supporting the 
hypothesis that a considerable part of 
infections originating from chicken is acquired 
by pathways other than food, such as the 
environment [18], or by cross-contamination to 
commodities, utensils, and foods other than 
chicken [47]. Indeed, it has been suggested that 
sporadic campylobacteriosis is more likely to 
occur because of cross-contamination from 
raw poultry products than because of 
consumption per se [12]. 
Some factors may be significantly 
associated with infections attributed to a given 
reservoir just because these infections have a 
residual contribution from reservoirs other than 
those to which they were attributed. Although 
the selection of cases for the risk factor 
analysis was based on the highest possible Prs, 
residual attributions were 4%, 13%, and 24% 
in chicken-, ruminant-, and environment-
associated infections, respectively. 
Nevertheless, all risk factors were associated in 
an epidemiologically plausible way according 
to the reservoir in question. For instance, 
consumption of chicken was a risk factor for 
infections of chicken origin whereas the 
consumption of beef and pork appeared to 
protect against chicken-associated infections. 
Plausibly, a person may be “protected” against 
infection with the most chicken-associated 
Campylobacter strains when exposed to 
reservoirs other than chicken, such as pig and 
cattle. Furthermore, consumption of tripe, 
barbecued meat, and seldom or never 
consumption of chicken were risk factors for 
infections attributed to ruminants. Possibly, 
people consuming chicken rarely may 
consume meats and other edible products from 
ruminants more frequently. Although we did 
not have any information about the type of 
meat cooked at the barbecue, it is clear that red 
meats are more likely to be consumed rare 
when barbecued, and thus more likely to 
harbor viable Campylobacter due to 
incomplete cooking. Besides undercooking, 
barbecuing usually provides many 
opportunities for re- and cross-contamination. 
The fact that the risk posed by barbecued meat 
was higher in patients living in non-urban 
areas, and insignificant in those living in urban 
ones, is supportive of the aforementioned 
hypothesis that ruminant-associated infections 
are more likely to occur in the countryside 
[25,37]. Working with animals was also a risk 
factor for infections attributed to ruminants, 
supporting another hypothesis stating that 
these infections may be acquired, to a 
considerable extent, through animal contact 
rather than food [23,24]. 
Consumption of game and swimming 
in a domestic swimming pool increased the 
risk for infections of probable environmental 
origin. In our study, the environmental 
reservoir included strains from wild birds, 
water, and sand. Although water and sand 
cannot be considered as amplifying hosts, they 
can act as vehicles delivering an exposure 
possibly from primary wildlife reservoirs 
[23,34]. In The Netherlands, Campylobacter is 
commonly found in recreational water [48] and 
domestic swimming pools mainly consist of 
temporary outdoor inflatable swimming pools 
of limited capacity, which can easily become 
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contaminated by bird feces. Moreover, it is 
likely for cleaning and maintenance procedures 
of swimming pools (e.g. water chlorination) to 
be less strictly applied in a domestic context. 
However, we found that the risk posed by 
domestic swimming pools was only significant 
in the spring but not in the other seasons. This 
is in accordance with our other finding 
indicating that the importance of the 
environmental reservoir varies seasonally, with 
a major peak in the spring. While most 
(outdoor) swimming pools are unusable during 
autumn-winter months, several British studies 
(reviewed by Jones [46]) have evidenced that 
there is a negative correlation between hours of 
sunshine and Campylobacter presence in 
recreational water, with significantly lower 
isolation rates in the summer compared to the 
other seasons corresponding to elevated 
ultraviolet radiation levels and higher 
temperatures, two conditions that greatly affect 
the survival of Campylobacter spp. outside the 
host. Moreover, it is possible that swimming 
pools are cleaned more frequently in the 
summer as a result of their more frequent use, 
or that other exposures and reservoirs play 
competitively a more prominent role in the 
summer. 
We found that recent use of proton-
pump inhibitors, having a chronic 
gastrointestinal disease, and contact with 
people with gastroenteritis symptoms outside 
the household were risk factors for infections 
attributed to different reservoirs. It is 
conceivable that the neutralizing effect of 
proton-pump inhibitors on gastric acidity may 
enhance Campylobacter survival during its 
passage through the stomach and that a 
disturbed intestinal function may facilitate 
infection [10]. However, it is also possible that 
Campylobacter infections are more likely to be 
diagnosed in people affected by chronic 
gastrointestinal diseases, as these people may 
be under more frequent medical attention 
(closer surveillance) and diagnostic 
thoroughness. Person-to-person transmission is 
uncommon for campylobacteriosis but it 
probably occurs with no particular preference 
for the primary reservoir of the Campylobacter 
strain involved. However, it is worth 
mentioning that this risk was particularly 
pronounced for Campylobacter strains of 
probable environmental origin. Considering 
that our environmental strains were sourced 
from water and sand among others, and that 
person-to-person transmission seems 
particularly important in children [10], it can 
be speculated that sand (particularly the one in 
playground sand-boxes) and recreational water 
can act as a vehicle for transmission among 
humans as well. 
Consumption of several non-meat 
foods, including fruits, vegetables, dairy 
(mostly yoghurt), and seafood, were protective 
against infections attributed to different 
reservoirs. It is believed that these foods may 
have genuinely beneficial effects on general 
health by inhibiting bacterial growth, 
enhancing general immunity to infection, and 
altering the intestinal flora in a way that 
prevents infection [10,12,13,15]. 
 
4.4. Limitations and possible sources of bias 
 
We supplemented Dutch data of 
reservoirs with data from other countries, an 
approach that has previously been applied 
[14,24], but could introduce bias in the 
attribution estimates. However, it has been 
shown that the association of multilocus 
genotypes with specific hosts transcends 
geographical variations [49]. Therefore, 
although greater accuracy of attribution 
estimates is possible with reference data 
closely sampled in space and time, these are 
not essential, and reference data from other 
regions can be used where local data are not 
available. To address this, we performed a 
PCA on human data from different countries to 
identify the corresponding reservoir data that 
were expected to be close to those present in 
The Netherlands in 2002–2003 [32]. The 
underlying assumption was that, if the ST 
frequency distribution of the human population 
of The Netherlands resembles that of the 
human population from another study, then the 
Dutch reservoir data may well resemble the 
reservoir data from that study. Apart from the 
reservoirs and their ST frequency distributions, 
consumption patterns and exposure pathways 
were assumed to be comparable, an 
assumption that has some plausibility among 
northern European countries. A detailed 
description of the results of the PCA will be 
provided in another manuscript that is in 
preparation.  
This study was restricted to C. jejuni 
and C. coli. These two species, however, 
account for up to 98% of infections 
characterized at species level in The 
Netherlands [10]; thus, the impact of the other 
species on attribution estimates was expected 
to be minimal. It is clear that when exposures 
are aggregated for C. jejuni and C. coli 
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infections, the contribution of risk factors 
primarily associated with C. coli may be 
masked by the numerical superiority of C. 
jejuni. However, cases were split according to 
Pr, and C. jejuni and C. coli could potentially 
originate from a same reservoir. The primary 
outcome of interest was thus to explore 
reservoir-specific risk factors for 
campylobacteriosis rather than accounting for 
Campylobacter species-specific risk exposure 
characteristics. Another limitation concerns the 
residual contribution to Pr by reservoirs other 
than those to which infections were attributed. 
To address this in the risk factor analysis, we 
constructed regression models (when not 
limited by sample size) that were restricted to 
subsets of cases with the highest possible Pr 
for each reservoir. The residual contribution, 
although minimized, creates “noise” which 
could have masked or diluted some 
associations, or led to some additional 
associations, in the risk factor analysis. The 
latter option could be the case of the ownership 
of several adult dogs as a risk factor for 
environment-associated strains. Nonetheless, 
dogs are often tested positive for 
Campylobacter spp. and it has been suggested 
that dogs housed in group have a higher 
prevalence, possibly due to dog-to-dog 
transmission [50]. Moreover, dog owners may 
be particularly exposed to Campylobacter 
strains of environmental origin while walking 
their dogs, and adult dogs living in a group are 
also more likely to have (unsupervised) 
outdoor access and can therefore act as a 
vehicle for Campylobacter strains of 
environmental origin, possibly acquired upon 
ingestion of contaminated water, predation, 
necrophagy, and coprophagy. While dog 
ownership increases the risk for environment-
associated infections, contacting an animal 
outside the household appears to be protective. 
We speculated that contacting animals other 
than their own encourages individuals to 
undertake protective actions, such as hand 
washing. 
Many isolates from the cases included in the 
previous case-control study [10] were no 
longer viable and could not be cultured and 
typed with MLST for the purposes of this 
study. This could be due to underlying 
differences in survival among the different 
Campylobacter strains. However, we were able 
to replicate the results of the previous study 
[10], suggesting that our subset of cases was 
not biased and that the non-typed isolates were 
missed at random. 
It has been postulated that repeated 
exposure to different Campylobacter strains 
may lead to sufficient immunity to provide 
protection against (severe) clinical illness 
[1,51]. In case-control studies, this protective 
immunity would lead to misclassification, as 
some controls could have been infected with 
Campylobacter spp. asymptomatically. As 
cases were identified by passive surveillance, 
they were likely to represent the most severe, 
symptomatic infections that occurred in the 
population. Thus, the identified risk factors 
especially represent risk factors for severe 
campylobacteriosis. Other concerns in case-
control studies are recall and selection bias. 
Specifically in this study the recall period for 
cases was longer than for controls, and controls 
returning the postal questionnaire could be 
particularly motivated people with a generally 
healthier lifestyle, a fact that provides an 
alternative explanation of why, for example, 
eating fruits and vegetables were protective 
factors. Nevertheless, similarly to the previous 
study [10], these possible biases were explored 
by conducting multiple imputation checks and 
case-case analyses (data not shown), which 
revealed that both recall and selection bias had 
limited impact on our results. 
 
 
5. CONCLUSIONS 
 
A number of case-control studies have 
explored risk factors for Campylobacter 
infection while other studies have used MLST 
data to attribute Campylobacter infections to 
animal or environmental reservoirs, as well as 
used a case-case approach to characterize the 
risk of becoming infected with Campylobacter 
strains of different origins. Our study attempts 
to bridge this gap by exploring risk factors at 
the point of exposure for campylobacteriosis of 
different origins, using a combined case-
control and source attribution analysis. 
Our results lend weight to the 
suggestion that human campylobacteriosis in 
The Netherlands could greatly be reduced by 
focusing interventions on chicken and cattle. 
Chicken seems to be the major reservoir of 
campylobacteriosis for people living in cities, 
whereas cattle seems to be more important in 
their rural counterparts. The importance of the 
chicken and cattle reservoirs, however, was 
only partially consistent with food-borne 
transmission, as alternative pathways, such as 
direct contact and environmental 
contamination, do play a role as well, 
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particularly for infections attributed to 
ruminants. 
This study showed that risk factors for 
Campylobacter infection depend upon the 
attributed reservoir and that the exposure may 
plausibly direct to the original reservoir when 
considering those Campylobacter strains that 
are indeed highly associated with the reservoir 
in question. Combining epidemiological and 
genotype-based source attribution data was 
helpful in enhancing risk factor identification 
and characterization for human 
campylobacteriosis and in providing a valuable 
approach for supporting and generating 
hypotheses. In a broader perspective, our 
results also indicate that the general concept of 
genotype-based source attribution modeling for 
campylobacteriosis makes sense 
epidemiologically. More Dutch reference 
strains from other animal reservoirs, such as 
dogs and cats, as well as different 
categorizations of food-producing animals, 
will provide a better discrimination of 
Campylobacter reservoirs and possibly 
stimulate novel epidemiological insights 
towards reservoir-specific risk factors and 
transmission pathways for human 
campylobacteriosis. 
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Increased risk for Campylobacter jejuni and C. 
coli infection of pet origin in dog owners and 
evidence for genetic association between 
strains causing infection in humans and  
their pets 
 
 
ABSTRACT 
 
We compared Campylobacter jejuni/coli multilocus sequence types (STs) from pets (dogs/cats) and 
their owners and investigated risk factors for pet-associated human campylobacteriosis using a 
combined source attribution and case-control analysis. 132/687 pet stools were Campylobacter-
positive, resulting in 499 strains isolated (320 C. upsaliensis/helveticus, 100 C. jejuni, 33 C. 
hyointestinalis/fetus, 10 C. lari, 4 C. coli, 32 unidentified). 737 human and 104 pet C. jejuni/coli 
strains were assigned to 154 and 49 STs, respectively. Dog, particularly puppy, owners were at 
increased risk of infection with pet-associated STs. In 2/68 cases versus 0.134/68 expected by chance, 
a pet and its owner were infected with an identical ST (ST-45, ST-658). Although common sources of 
infection and directionality of transmission between pets and humans were unknown, dog ownership 
increased significantly the risk for pet-associated human C. jejuni/coli infection and isolation of 
identical strains in humans and their pets occurred significantly more often than expected. 
 
 
1. INTRODUCTION 
 
Dogs and cats are popularly kept for 
companionship in industrialized countries. In 
the Netherlands (16.5 million population), 
there were approximately 1.5 million dogs and 
3 million cats in 2010, with 21% and 34% of 
households owning at least one dog or cat, 
respectively [1]. 
Ownership of dogs and cats (hereafter 
referred to as pets) is beneficial to the owner’s 
psychological and physical health, promoting a 
less sedentary lifestyle, emotional protection 
and social interaction [2]. However, pets 
frequently enjoy great freedom in their owner’s 
home, which may include occupying their 
owner’s bed [3]. A recent survey in the 
Netherlands indicated that among 159 
households with pets, 45% of the dogs and 
62% of the cats were allowed on the bed [4]. 
Half of the owners allowed the dogs to lick 
their face and 45% allowed the cats to jump 
onto the kitchen sink. This close interaction 
between pets and humans raises concerns 
regarding the potential zoonotic risks. 
Campylobacteriosis, a frequently 
occurring foodborne infection in the 
Netherlands [5], is potentially transmissible 
between pets and humans via the faecal-oral 
pathway [6]. Owning a pet, especially a puppy, 
has been identified as a risk factor for 
Campylobacter jejuni and C. coli infection [7]. 
Campylobacter may cause both symptomatic 
and asymptomatic infections in pets [6], with 
similar isolation rates in both diarrhoeic and 
healthy animals [8, 9]. Symptomatic infections 
mainly occur in young animals and are often 
caused by C. jejuni [6]. 
Although infection in pets and humans 
from a common source is possible, there is also 
evidence for transmission between pets and 
humans from molecular studies of C. jejuni 
using amplified fragment length polymorphism 
[10], and pulsed-field gel electrophoresis [11].  
Multilocus sequence typing (MLST) 
[12] is widely used for the purposes of source 
attribution of human Campylobacter infections 
[13–17], and has not yet been used to 
investigate the genetic relatedness of strains 
from pets and their owners. In this study, we 
investigated MLST profiles of C. jejuni and C. 
coli strains isolated from pets and their owners. 
We also estimated the probability that these 
human strains originated from pets or other 
putative reservoirs by conducting a source 
attribution analysis. Finally, we combined 
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case-control and source attribution data to 
explore risk factors at the point of exposure for 
human campylobacteriosis of probable pet 
origin. 
 
 
2. METHODS 
 
2.1. Epidemiological data 
 
Data from the CaSa study, a large case-control 
study on risk factors for human 
campylobacteriosis and salmonellosis 
conducted in the Netherlands between April 
2002 and April 2003, formed the basis of this 
study. A detailed description of the CaSa study 
is available elsewhere [7,18]. 
A total of 2858 C. jejuni and 257 C. 
coli laboratory-confirmed human cases were 
identified by the Dutch Regional Public Health 
Laboratories (RPHL) through passive 
surveillance of diarrhoeic patients seeking for 
medical attention. Isolates were sent to the 
Central Veterinary Institute (CVI) in Lelystad, 
the Netherlands, for C. jejuni and C. coli 
species determination using molecular methods 
[19,20]. Cases that did not return or complete 
successfully the questionnaire used to collect 
epidemiological information (1679 cases, 
54%) and/or had a recent or unknown history 
of travel and/or lived abroad (338 cases, 11%), 
were excluded, leaving 1019 C. jejuni and 79 
C. coli cases (35%) enrolled in the study. 
Isolates from 737 (67%) enrolled cases were 
typed using MLST [12]. 
Controls were randomly selected from 
population registries within the RPHL service 
areas by frequency matching (aiming at two 
per case) according to the expected number of 
Campylobacter/Salmonella cases (based on 
historic surveillance data) by age (0–4, 5–17, 
18–29, 30–44, 45–59, ≥60 years), gender, 
urbanization degree (urban: >2500, urbanized: 
500-2500, rural: <500 addresses/km2), and 
season (April–June 2002, July–September 
2002, October–December 2002, January–
March 2003). A total of 10250 controls were 
approached and 3409 (33%) returned the 
questionnaire. After exclusion of controls that 
travelled abroad and/or did not complete 
successfully the questionnaire, 3119 (91%) 
controls were enrolled. 
Cases and controls were asked to fill in 
a questionnaire regarding food consumption, 
kitchen hygiene, contact with animals, 
occupation, recreational activity, medication 
use, history of chronic diseases, and contact 
with people with gastroenteritis. Questions 
covered the seven days prior to symptoms 
onset (cases) or questionnaire completion 
(controls). Parents completed the questionnaire 
for their children. Missing values were handled 
using multiple imputation [21]. 
Cases owning a pet were asked to 
submit a faecal sample of their pets to be tested 
for Campylobacter spp. and typed with MLST 
if they were positive for C. jejuni or C. coli 
using the same methods as for human cases. 
Pet faecal samples were submitted by mail: an 
envelope was sent to the owners including a 
container without transport medium together 
with instructions for collecting and returning 
the material. A minimum amount of faeces was 
requested as to minimize the die-off due to dry 
conditions. Samples were transported 
overnight and processed the following day. A 
total of 687 pet faecal samples were submitted. 
The sample origin (dog or cat) could be 
determined for only 424 (62%) samples (315 
from dogs and 109 from cats) because this 
information was not always indicated by the 
submitting owner, nor could it be inferred from 
the patient's questionnaire because of 
cohabitation of dogs and cats in the same 
household. A median of 32 days (interquartile 
range (IQR) = 13, min-max: 10–71) separated 
human and pet faecal sampling. The software 
Bionumerics 5.10 was used to analyse 
sequence data. The expected probability (P) of 
finding an identical sequence type (ST) x in a 
human case and a pet living in the same 
household by purely random chance was 
calculated as: P(human ST = pet ST) = 
∑x{P(human ST = x | human sample = positive 
for C. jejuni or C. coli) × [P(pet ST = x | pet 
sample = positive for C. jejuni or C. coli) × 
M]}, where ∑x is the summation over all STs 
found in both pets and humans and M is the 
overall prevalence of C. jejuni and C. coli 
found in our pet sample. 
The Proportional Similarity Index 
(PSI) [15] was used to measure the similarity 
between sequence type (ST) frequency 
distributions of pets, pet owners, and non-pet 
owners. PSI values range between one 
(identical frequency distributions) to zero 
(distributions with no common ST). 
 
2.2. Attribution analysis 
 
MLST data from Campylobacter 
strains obtained from chicken, cattle, sheep, 
pig, pets, and the environment (water, sand, 
and wild birds) were supplied by the CVI and 
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supplemented with other data from the UK 
[12], Scotland [17], and Switzerland [22] to 
provide a representative dataset for each 
reservoir (Table 1). As environmental strains 
have rarely been found in the other reservoirs 
[15], they were treated as proxy for other 
unidentified reservoirs, putatively of wildlife 
origin [15]. 
The Asymmetric Island (AI) model, a 
Bayesian population genetics algorithm for 
modelling Campylobacter evolution and 
transmission [14], was used to estimate the 
posterior probability (Pr) for each human ST 
to originate from the considered reservoirs. 
Two separate AI models were developed, one 
including and one excluding pets as reservoir. 
The overall proportion of human infections 
attributed to a given reservoir was calculated 
as the sum of its Pr over cases divided by the 
total number of cases. 
Differences in Pr for pets (Prp) were 
tested for the variables age, sex, urbanization 
degree, season, and pet ownership using the 
Kruskal-Wallis or the Mann-Whitney tests, as 
appropriate (alpha: 0.05). 
 
Table 1. Reference Campylobacter strains used to feed the asymmetric island model for source attribution 
Country Chicken Cattle Sheep Pig Pets* Environment Reference 
The Netherlands 236 0 9 0 13 106 (Water) Data† 
United Kingdom 73 46 46 72 5 50 (Sand) Dingle et al. [12] 
Scotland 239 90 90 88 15 133 (Wild birds) Strachan et al. [17] 
Switzerland 77 23 23 0 100 0 Korczak et al. [22] 
Total 625 168 168 160 133 289  
*Include isolates from dogs and cats. 
†Provided by the Central Veterinary Institute (CVI) in Lelystad, the Netherlands. 
 
2.3. Risk factor analysis 
 
Risk factor analysis was restricted to 
human campylobacteriosis caused by STs of 
probable pet origin and to human 
campylobacteriosis as a whole (all 737 typed 
cases, non-specific to probable pet origin). 
Risk factors for campylobacteriosis as a whole 
and for campylobacteriosis caused by STs 
attributable to reservoirs other than pets have 
been reported previously [23]. 
STs were assigned to pets based on 
their Prp. This was made the same way as 
previous studies [23–25]: the Prp distribution 
was assessed and a cut-off was determined to 
optimise the number of cases assigned to pets 
and the confidence as to their correct 
assignment derived by the highest possible Prp. 
A logistic regression analysis was then 
conducted to investigate risk factors for human 
campylobacteriosis caused by STs with at least 
60% probability (cut-off Prp0.60) of 
originating from pets. This cut-off Prp resulted 
in the selection of 76 cases with a median Prp 
of 0.62 (mean Prp = 0.65, IQR = 0.08, min-
max: 0.60-0.74) and represented the best trade-
off between the increasing Prp (i.e. increase in 
pet specificity) and the decreasing number of 
cases includable in the analysis (i.e. decrease 
in statistical power and failure of the model to 
converge).  
For preliminary significance testing, 
we assessed the association of 131 risk factors 
using a single-variable logistic regression 
analysis: variables with p0.10 were selected 
for inclusion in a multivariable logistic 
regression model. A backward stepwise 
selection procedure was applied and variables 
with p<0.05 were retained in the final model. 
The frequency matched variables and the level 
of education [18] were always included as 
covariates. Multivariable odds ratios (ORs) and 
corresponding 95% confidence intervals (CI) 
of risk factors for pet-associated human 
campylobacteriosis were presented together 
with those of a multivariable model built in the 
same fashion including all 737 typed cases that 
has been reported previously [23] and is 
presented here in abbreviated format to 
facilitate comparison.  
The effect of the assignment cut-off 
Prp was checked by sensitivity analysis by 
repeating the analysis for a range of cut-off 
Prp, looking for significant changes in the risk 
factors in the reduced model. The low number 
of cases did not allow for the construction of 
models based on cut-off Prp larger than 0.60. 
Overall model significance and goodness-of-fit 
were verified by likelihood ratio chi-square 
and Hosmer-Lemeshow tests, respectively. 
Statistical analysis was performed using 
STATA 11.2. 
 
 
3. RESULTS 
 
3.1. Multilocus sequence types 
 
Isolates from the 737 typed human cases were 
assigned to 154 STs (Figure 1). Of the 687 pet 
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faecal samples examined, 132 (19%) tested 
positive for Campylobacter spp. 
Campylobacter prevalence was 18% in 
samples specified of either dog or cat origin 
and 23% in the 263 samples of unspecified 
origin. A total of 499 isolates were recovered 
from the 132 positive samples (3.8 isolates per 
sample). Only 248 isolates had their origin 
specified (205 from dogs and 43 from cats).
 
Figure 1. Sequence types identified among 737 Campylobacter jejuni/coli strains from human cases, subdivided by pet (dog and cat) ownership. Category 
„others‟ includes sequence types that occurred fewer than five times.   
 
Overall, 320 isolates (64%) were C. 
upsaliensis and C. helveticus, 100 (20%) C. 
jejuni, 33 (7%) C. hyointestinalis and C. fetus, 
10 (2%) C. lari, 4 (1%) C. coli, and 32 (6%) 
unidentified. The 205 isolates from the dogs 
were: 158 (77%) C. upsaliensis and C. 
helveticus, 19 (9%) C. jejuni, 25 (12%) C. 
hyointestinalis and C. fetus, and 3 (2%) 
unidentified. The 43 strains from the cats were: 
21 (49%) C. upsaliensis and C. helveticus, 21 
(49%) C. jejuni, and 1 (2%) unidentified. The 
104 C. jejuni and C. coli isolates from pets 
belonged to 49 STs: ST-45, ST-403, and ST-22 
were the most represented (>25%, Figure 2); 
ST-403 was the most represented in the dogs 
(4 strains out of 19) and ST-45 in the cats (4 
strains out of 21). 
The PSI for STs of pet owners and 
non-pet owners (Figure 1) was 0.69 (95% CI 
0.50–0.88). PSI for STs of pets and pet owners 
was 0.39 (95% CI 0.27–0.51) and that for pets 
and non-pet owners was 0.33 (0.20–0.45). PSI 
for pets and dog owners was 0.43 (95% CI 
0.26–0.60) and that for pets and puppy owners 
was 0.51 (95% CI 0.30–0.64). 
In 68 cases, isolates were typed from 
both pets and patients living in the same 
households. Of these, two owners (2.94%) 
were infected with the same ST found in their 
pets. These were a 44-year-old man and his 
dog infected with ST-45 and a 47-year-old 
man and his pet infected with ST-658. Given 
our ST distributions in humans and pets and 
the overall prevalence of C. jejuni and C. coli 
in pets, the expected probability of finding an 
identical ST in humans and pets in a one-to-
one relationship purely by random chance was 
0.198%, which corresponds to an expected 
0.134 cases out of 68. The difference between 
the observed (2) and expected (<<1) co-
isolation of identical STs in humans and pets 
was statistically significant (binomial 
probability test, p = 0.008). 
 
Figure 2. Sequence types identified among 104 Campylobacter 
jejuni/coli strains from dogs and cats owned by people with 
Campylobacter jejuni/coli infections. Category „others‟ includes 
sequence types that occurred once.   
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3.2. Attribution of human infections 
 
The AI model without pets (Figure 3) 
estimated that 77% (95% CI 75–79%) of 
human infections originated from chicken, 
followed by cattle 18% (95% CI 16–19%), 
environment 2% (95% CI 1–3%), sheep 2% 
(95% CI 1–3%), and pigs 1% (95% CI 0.1–
1%). When pets were also included (Figure 3), 
cases were attributed as follows: chicken 63% 
(95% CI 61–65%); pets 25% (95% CI 23–
26%); cattle 11% (95% CI 9–11%); pigs 0.5% 
(95% CI 0.1–0.8%); sheep 0.4% (95% CI 0.3–
0.5%); and environment 0.1% (95% CI 0.1–
0.2%).
 
 
Figure 3. Assignment source probability (%) estimated by the asymmetric island model with and without 
pets represented as a matrix plot. Each human case is a vertical column colored according to the 
probability it came from each considered source. To aid visualization, cases are ordered horizontally 
according to the probability attributed to chicken. 
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STs predominantly associated with 
pets included in the risk factor analysis 
(Prp0.60) were: ST-403 (Prp = 0.76), ST-508 
(0.74), ST-586 (0.74), ST-1326 (0.74), ST-878 
(0.73), ST-3130 (0.72), ST-1911 (0.70), ST-
2088 (0.67), ST-47 (0.67), ST-657 (0.63), ST-
2151 (0.62), ST-2130 (0.61), ST-122 (0.61), 
ST-22 (0.61), and ST-677 (0.60). 
The average Prp was significantly 
higher (p = 0.028) in dog owners (median Prp 
= 0.25, IQR = 0.3, n = 221) compared to non-
dog owners (median Prp = 0.18, IQR = 0.23, n 
= 516), and this difference became more 
evident when considering those owning a 
puppy (median Prp = 0.31, IQR = 0.43, n = 35, 
p = 0.001) or those owning both puppies and 
adult dogs (median Prp = 0.49, IQR = 0.34, n = 
12, p = 0.003). 
 
3.3. Risk factors for pet-associated human 
campylobacteriosis 
 
Several factors were significantly associated 
with C. jejuni and C. coli infection in the 
overall model (Table 2), including factors 
concerning contact with pets, such as 
ownership of several adult dogs and at least 
one puppy (OR 2.5, 95% CI 1.1–5.8); 
ownership of one or more cats (OR 1.4, 95% 
CI 1.2–1.8); and contact with dogs outside the 
household (OR 0.6, 95% CI 0.5–0.8). 
However, only three risk factors (two of which 
related to contact with pets) were significant in 
the model for campylobacteriosis of probable 
pet origin (Table 2). These were: 1) ownership 
of a puppy (OR 3.7, 95% CI 1.4–10.0); 2) 
ownership of several adult dogs and at least 
one puppy (OR 9.2, 95% CI 2.7–32.0); and 3) 
recent use of proton-pump inhibitors (OR 11.1, 
95% CI 5.4–22.9). The first risk factor was 
unidentified in the overall model. No 
significant interactions of these risk factors 
with age, gender, urbanization degree, season, 
or level of education were found. 
 
 
4. DISCUSSION 
 
This study shows that there is a high degree of 
overlap between human and pet C. jejuni and 
C. coli STs and that dog owners, especially 
puppy owners, are at higher risk for infection 
with STs associated with pets than controls and 
non-dog owners. Furthermore, there were two 
cases out of 68 where a patient and a pet living 
in the same household were infected with an 
identical ST. Although this may seem a minor 
proportion, it is considerable if we reflect on 
both the adopted sampling scheme 
(particularly the relatively long time lag 
between human and pet sampling) and the low 
occurrence of severe, symptomatic 
campylobacteriosis usually detectable by 
passive surveillance. Moreover, C. jejuni 
carriage in pets is infrequent and of short-term 
[26]. Accordingly, the expected occurrence of 
identical STs in a one-to-one relationship was 
significantly lower than that observed. 
Furthermore, although the 95% CIs of the PSI 
were largely overlapping, the point estimates 
showed a trend towards similarity of pet and 
human ST frequency distributions according to 
pet ownership. Taken together these results 
suggest that dog ownership increases 
significantly the risk of acquiring C. jejuni and 
C. coli infection caused by STs originating 
from pet and that co-isolation of identical 
strains in humans and their pets occurs 
significantly more often than expected by 
chance.  
There are four possible scenarios 
arising from our findings: 1) humans and pets 
become infected from the same source; 2) 
humans and pets become infected from 
different sources that incidentally carry the 
same strain; 3) humans become infected from 
dogs; 4) dogs become infected from humans. 
While the second scenario seems unlikely 
because of the large variety of existing STs, 
there may be many common sources of 
infection for pets and humans [27]. This is 
mainly because pet foods and treats contain 
ingredients of animal origin. Moreover, pets 
are increasingly regarded as real family 
members and tend to be fed with the same 
foods as their owners [28]. Feeding of a 
homemade diet or table and kitchen food 
scraps, especially raw meats, offal, and bones, 
is a risk factor for Campylobacter carriage in 
pets [29-31], and pets carrying Campylobacter 
may eventually act as reservoirs for 
transmission to humans either directly or by 
contaminating the household and immediate 
environments [27, 28]. As the sampling design 
was non-directional in the transmission of 
infection, our results support evidence for 
genetic association of C. jejuni and C. coli 
strains between humans and their pets but do 
not prove that transmission of such strains 
occurs from pets to humans or vice versa.  
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Table 2. Risk factors for human Campylobacter jejuni/coli infection in general (overall model) and for infection caused by C. 
jejuni/coli strains of pet origin (pet model) as assigned by the asymmetric island model for source attribution. 
Risk factor (% imputed missing values*) 
OR (95% CI) 
Overall model from  
Mughini Gras et al. [23]†‡ 
OR (95% CI) 
Pet model†§ 
Food consumption   
Chicken (1) 1.5 (1.2–1.9) ns 
Undercooked meat (5) 2.1 (1.6–2.7) ns 
Meat cooked at a barbecue, grill, or microwave oven (5)   
in urban areas 1.2 (0.7–2.2) ns 
in urbanized areas 1.7 (1.3–2.2) ns 
in rural areas 3.0 (1.8–4.9) ns 
Eating in a restaurant (0) 1.3 (1.1–1.6) ns 
Meat in paste (croquette, sausage roll, pastry) (5) 0.8 (0.6–1.0) ns 
Pasteurized milk (1) 0.8 (0.6–0.9) ns 
Pasteurized dairy products other than milk or cheese (2) 0.6 (0.5–0.7) ns 
Salad (2) 0.7 (0.6–0.9) ns 
Fruit with peel (2) 0.7 (0.6–0.8) ns 
Chocolate (2) 0.6 (0.5–0.7) ns 
Nuts (3) 0.6 (0.5–0.8) ns 
Seafood (4) 0.5 (0.4–0.7) ns 
Vegetarian diet (0) 0.4 (0.2–0.9) ns 
Contact with animals   
Contact with dogs owned by other people (3) 0.6 (0.5–0.8) ns 
Ownership of one dog aged <1 year (0) ns 3.7 (1.4–10.0) 
Ownership of more than one dog, at least one dog aged <1 year (0) 2.5 (1.1–5.8) 9.2 (2.7–32.0) 
Ownership of one or more cats (1) 1.4 (1.2–1.8) ns 
Recent use of medications    
Antibiotics (0) 0.4 (0.2–0.8) ns 
Proton–pump inhibitors (0) 3.7 (2.5–5.5) 11.1 (5.4–22.9) 
Kitchen hygiene and food processing   
Not cleaning a knife when using it for raw meat and other foods (1) 1.7 (1.1–2.6) ns 
Washing hands before food preparation (0) 0.6 (0.4–0.9) ns 
Contact with people with gastroenteritis outside the household (3) 1.5 (1.1–2.1 ns 
Having a gastrointestinal chronic disease (0) 2.4 (1.8–3.2) ns 
OR = odds ratio; 95% CI = 95% confidence intervals; ns = not significant (p>0.05). Boldface indicates the risk factors; protective 
factors are in normal font. 
*% of imputed missing values in the whole dataset. 
†Adjusted for age, sex, degree of urbanization, season, and level of education.  
‡n = 3856 (737 cases and 3119 controls). 
§n = 3195 (76 cases and 3119 controls). 
 
The contribution of pet ownership to 
human infections, as derived from case-control 
studies, appears to not exceed 10% [7]; thus, 
the pet attribution found in this study (25%) 
seems to be overestimated. Presumably, this is 
an artefact of the attribution process, as pets 
are not the main reservoir of STs found in pets 
and humans. The AI model could therefore 
have attributed many cases to the pets 
themselves instead of the common reservoirs. 
When including pets in the AI model, cases 
attributable to chicken decreased measurably 
(–14%), followed by cattle (–7%), sheep (–
2%), and the environment (–2%). The extent of 
this decrease is suggestive of the reservoirs 
from which pets may acquire infection in 
parallel with humans. Overall, figures provided 
by the AI model without pets concur with 
those of similar studies [13–7].  
We found that ownership of dogs, 
particularly puppies and several adult dogs, 
became a predominant risk factor when 
considering the cases with a high Prp. 
Campylobacter prevalence is higher in puppies 
and adult dogs housed in groups, possibly due 
to low levels of acquired immunity and dog to 
dog transmission, respectively [6,32]. 
Moreover, while puppies are usually housed 
indoors and have closer contacts with their 
owners, adult dogs living in groups are likely 
to have (unsupervised) outdoor access and act 
as vectors for environmental strains [23], 
especially if they have access to fields grazed 
by livestock or wildlife [27]. Eventually, 
owners walking their dogs may be particularly 
exposed to such environmental strains. While 
dog ownership increases the risk for pet-
associated infections, contacting dogs outside 
the household appears to be protective. A 
possible explanation is that contacting dogs 
other than their own encourages individuals to 
undertake protective actions such as hand 
washing [23]. 
In this study, cat ownership, unlike dog 
ownership, was not a significant risk factor for 
the most pet-associated STs. This is in 
accordance with canine behaviour that 
generally results in frequent soil and water 
contact, whereas cats usually hide and bury 
their faeces and lick their fur intensively, 
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making it easier to remove any possible 
Campylobacter-contaminated matter [4]. 
It has been shown that individuals 
acquiring C. jejuni and C. coli infection from 
different reservoirs have different associated 
risk factors [23, 24]. Modelling of MLST data 
is useful for determining where infection is 
likely to be acquired from. However, most 
cases cannot be attributed to a single reservoir; 
only those cases infected with rare STs, i.e. 
occurring 1-5 times on average [23], usually 
show a high Pr (i.e. ≥0.5) for a given reservoir 
and possess unique risk factors associated with 
that reservoir. Also in this study, ST’s 
reservoir specificity and rareness seem to 
correlate, as the Prp-based selection led to 76 
cases belonging to 15 different STs (5 cases 
per ST). Common STs are difficult to 
disentangle and assign to specific reservoirs 
because they could potentially originate from 
several reservoirs simultaneously. Moreover, 
the high Pr for a given reservoir cannot be 
excluded to vary over time: new STs may 
emerge at low frequencies in specific 
reservoirs (i.e. high Pr for a reservoir) and then 
either disappear or become increasingly 
widespread (i.e. almost equal Pr for different 
reservoirs). 
ST-45 and ST-658 were co-isolated in 
pets and their owners. Pets corresponded to the 
first and second most likely reservoir for ST-
658 (Prp = 0.59) and ST-45 (0.31), 
respectively. The globally widespread ST-45 
usually predominates in chicken [12,15,17,33–
35], as also indicated by our AI model with 
pets (Pr for chicken = 0.62). However, in our 
study and in another one from the UK [27], 
ST-45 was the most frequent ST in pets and 
was associated with contact with pets in 
Finland [33], suggesting that its circulation 
among pets is extensive. Furthermore, as ST-
45 was overrepresented in surface water [36], 
and open drains/pools have been associated 
with Campylobacter carriage in dogs [29], it 
has been hypothesized that ST-45 is an 
environmentally adapted ST that mainly 
infects humans through transmission pathways 
other than food, including contact with pets 
[30, 36]. 
In this study, the overall proportion of 
Campylobacter-positive samples in pets (19%) 
was relatively low compared to previous 
figures from the Netherlands (77%) based 
upon 22 healthy and 8 diarrheic household 
dogs aged 3 months-14 years [37]. In other 
studies [9,29–31], Campylobacter prevalence 
ranged between 15% and 76% for dogs, and 
11% and 43% for cats, but can be as high as 
87% and 75% in kennelled dogs and cats, 
respectively [32]. This variability is due to 
differences in age, sex, breed, diet, and 
housing of the examined animals, but also to 
the different management of faecal samples. 
The delivery of pet samples by mail could have 
affected the survival of the most fragile strains, 
possibly skewing our sample towards the most 
resistant ones.  
We also found a relatively large 
proportion of C. upsaliensis and C. helveticus 
(64%). In a Danish longitudinal study in which 
366 faecal samples from 26 household dogs 
were also sent by mail [26], 76% were 
Campylobacter-positive, 75% of which were 
C. upsaliensis and 19% C. jejuni. The Danish 
study included only puppies tested monthly 
until two years of age, a factor that may 
explain the higher overall isolation rate. 
However, the dog and cat Campylobacter 
species distribution we found is comparable 
with other reports [29–31,37], suggesting that 
taking delivery of pet samples by mail did not 
bias the Campylobacter species distribution. 
In conclusion, we compared C. jejuni 
and C. coli strains from pets and their owners 
using MLST and investigated risk factors for 
campylobacteriosis of probable pet origin by 
combining source attribution and case-control 
data. Although pets and humans share many 
sources of infection and directionality of 
transmission between humans and pets could 
not be inferred, the combined analysis and the 
co-isolation of identical STs in pets and their 
owners suggest that dog, and particularly 
puppy, ownership is a risk factor for C. jejuni 
and C. coli infection caused by STs of 
probable pet origin and that co-isolation of 
identical strains in humans and their pets 
occurs more frequently than expected. 
Probably, this evidence could have been even 
stronger if the time lag between the two 
samples had been shorter. 
Attributing human infections to pets 
may be deceptive when the goal is to identify 
the original reservoirs, as pets may artificially 
account for an abnormal amount of cases 
because they are, like humans, predominantly 
“final” hosts for C. jejuni and C. coli. 
Conversely, the contribution of the other 
reservoirs will be underestimated and probably 
biased towards those reservoirs from which 
pets acquire infection.  
It is unclear to what extent the 
increased risk of pet-associated 
campylobacteriosis in dog owners we found is 
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an indication of other unmeasured factors, such 
as owner’s personality traits, lifestyle, income, 
disability or other health problems, which can 
plausibly influence the chance of becoming 
infected and the decision and manner of 
owning a pet. The zoonotic risk posed by pets 
should therefore be put into context, depending 
on factors such as level of Campylobacter 
carriage and intensity and type of contact 
between pets and humans. 
Besides the previously identified risk 
factors for C. jejuni and C. coli infection [7], 
there are different risk factors depending upon 
the attributable reservoir [23]. In this study, we 
explored risk factors for infection with STs 
attributable to pets, a poorly characterized 
reservoir of human campylobacteriosis. This 
analysis provided insight into reservoir-
specific risk factors and transmission pathways 
for human campylobacteriosis, allowing for a 
better characterization of the zoonotic risk 
posed by pets. By enhancing our ability to 
characterize this zoonotic risk, public health 
initiatives can be better informed. 
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Campylobacteriosis in returning travelers and 
potential secondary transmission of  
exotic strains 
 
 
ABSTRACT 
 
Multilocus sequence types (STs) were determined for 232 and 737 Campylobacter jejuni/coli isolates 
from Dutch travelers and domestically-acquired cases, respectively. Risk factors for travel-related 
campylobacteriosis, and for domestically-acquired campylobacteriosis caused by exotically-introduced 
STs (carried by the returned travelers), were investigated. Traveling to Asia, Africa, Latin America 
and the Caribbean, and Southern Europe increased significantly the risk of acquiring 
campylobacteriosis compared to traveling within Western Europe. Besides eating chicken, using 
antacids, and having chronic enteropathies, we identified eating vegetable salad outside Europe, 
drinking bottled water in high-risk destinations, and contacting raw pork as specific risk factors for 
travel-related campylobacteriosis. Risk factors for domestically-acquired campylobacteriosis caused 
by exotic STs involved predominantly person-to-person contacts around popular holiday periods. We 
concluded that risk factors for travel-related campylobacteriosis differ from those for domestically-
acquired infections and that returning travelers may carry several exotic strains that might 
subsequently spread to domestic populations. 
 
 
1. INTRODUCTION 
 
Diarrheal infections remain a major 
concern for travelers, especially for those 
bound for destinations where relatively 
substandard hygienic conditions exist. A Dutch 
study showed that in a sample of 1202 
individuals traveling to developing countries, 
50% experienced ≥1 diarrheal episodes [1].  
Campylobacteriosis is a leading cause 
of traveler's diarrhea, particularly in travelers 
returning from Southern and South-Eastern 
Asia [2,3]. In The Netherlands (16.5 million 
population), an estimated 90,000 
campylobacteriosis cases occur annually, with 
~12% of them being estimated to be travel-
related [4]. Moreover, fluoroquinolone-
resistant Campylobacter infections occur 
significantly more often in travel-related cases 
[3,5].  
Travelers are particularly prone to 
experiencing (symptomatic) Campylobacter 
infections [2,6,7]. Among others, susceptibility 
to disease is associated with duration of 
foreign stay. For instance, duration of 
residence of expatriates in Nepal was linearly 
correlated with protection from diarrheal 
infection [8], and travelers experiencing 
multiple diarrheal episodes had a shorter 
duration of symptoms after the first episode 
[1]. Similarly, among US expatriates in 
Thailand, campylobacteriosis occurred 
significantly more often in those living there 
for <1 year [9]. A documented instance of 
acquired immunity in developed countries is 
with people professionally exposed. Newly 
employed poultry abattoir workers in Sweden 
have shown to suffer more often from 
campylobacteriosis than their longer employed 
colleagues [10]. If partial immunity to (severe) 
disease is acquired over time with repeated 
exposure, then such protection should correlate 
with age. Indeed, campylobacteriosis incidence 
peaks in infancy worldwide and older age 
groups are significantly less prone to infection 
with common Campylobacter strains compared 
to the young [11]. Moreover, Swedish travelers 
going to countries such as Germany, France, 
Belgium, The Netherlands, Austria, 
Luxemburg or Switzerland, all of which are 
developed countries with high hygienic 
standards, still have a 4.4–21 times higher risk 
of acquiring campylobacteriosis compared to 
those traveling to neighboring Norway [12]. A 
study comparing Campylobacter multilocus 
sequence typing (MLST) datasets from 
different countries has further highlighted the 
importance of geographical distance in strain 
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dissimilarity [13]. Moreover, serological 
studies of patients and volunteers infected with 
campylobacters (reviewed by [14]) have 
revealed an array of immunogenic components 
and elicited antibodies displayed little cross-
reactivity, indicating considerable antigenic 
variation. Although core-genome (as described 
by MLST) is not necessarily related to 
antigens, and cross-protection is expected to 
develop for strains sharing similar antigenic 
properties, the higher risk of 
campylobacteriosis in travelers does not seem 
to be limited to higher levels of exposure in 
developing countries, but also to the possible 
presence of "new" Campylobacter strains, 
endemic in the different regions, to which 
travelers have hardly been exposed before 
[14]. It follows that, probabilistically, these 
"new" strains are more likely to be associated 
with regionally untested antigens than 
widespread strains, and acquired protection 
may be ineffective when exposed to 
uncommon strains, as evidenced by a Canadian 
study [15]. 
It is conceivable that the infected, but 
not necessarily symptomatic [14], returning 
travelers, may introduce into the domestic 
population several "exotic" strains with a 
higher probability of possessing antigens that 
are underrepresented in the local reservoirs, i.e. 
food-producing animals, pets and wildlife. 
These exotic strains may therefore constitute a 
distinctive, primarily human-restricted 
Campylobacter population that may have at 
least the potential to spread domestically via 
the person-to-person pathway. Although 
Campylobacter person-to-person transmission 
is believed to be uncommon and up to 66% 
and 21% of laboratory-confirmed cases in The 
Netherlands are attributable to chicken and 
cattle, respectively [16], it has been shown that 
campylobacteriosis household outbreaks are 
more common than believed [17] and up to 
18% of putatively household outbreak-related 
cases are suggestive of secondary spread [18]. 
This raises the question to what extent 
exotically-introduced strains may spill-over 
into the domestic population and at first spread 
anthroponotically. 
Herewith we investigated the MLST 
profiles of Campylobacter strains isolated from 
travelers returned to The Netherlands in 
comparison with those from domestically-
acquired cases. We also investigated risk 
factors for travel-related campylobacteriosis by 
comparing the exposures of the returned 
travelers with those of travelers in the control 
population. Furthermore, we used a population 
genetics model for source attribution to 
estimate the probability that the domestically-
acquired infections were caused by exotic 
strains, putatively carried by the returned 
travelers. Finally, risk factors for exotically-
introduced domestic campylobacteriosis were 
investigated. 
 
 
2. METHODS 
 
2.1. Data 
 
An earlier case-control study on risk 
factors for campylobacteriosis conducted in 
The Netherlands between April 2002 and 
March 2003 [6] formed the basis of this study. 
Isolates of 3115 Campylobacter jejuni/coli 
cases identified by the Dutch Regional Public 
Health Laboratories (RPHL) through passive 
surveillance were sent to the Dutch Central 
Veterinary Institute (CVI) for molecular 
speciation [19,20]. Controls were selected 
from RPHL population registries by frequency 
matching (aiming at two per case) according to 
age, sex, urbanization degree and season 
[6,16,21]. Cases and controls were asked to fill 
in a questionnaire regarding foreign travel, 
food consumption, kitchen hygiene, contact 
with animals, contact with gastroenteritis 
cases, occupation, recreational activities, 
medication use and chronic disease history. 
Questions covered the seven days prior to 
symptoms onset (cases) or questionnaire 
completion (controls). Missing values were 
handled using multiple imputation [6,21]. 
Cases/controls not returning the 
questionnaire and/or living abroad were 
excluded, leaving 1428 cases and 3363 
controls enrolled in the study. Of these, 328 
cases and 244 controls had traveled abroad 
with ≥1 overnight stay in the destination 
country. A total of 66 countries were visited, 
with 36 cases and 27 controls visiting >1 
country during the same travel. For three cases 
and four controls the travel destination was 
unknown. Destination countries were grouped 
into travel regions by adapting the United 
Nations geoscheme (http://unstats.un.org/unsd/ 
methods/m49/m49regin.htm#europe, Table 1). 
Isolates from 737 non-travelers 
(domestically-acquired cases) and 232 
travelers were typed using MLST [22]. 
Association of the travelers' five most frequent 
sequence types (STs) and clonal complexes 
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(CCs) with travel regions was tested using χ2 
or Fisher exact tests. Proportional Similarity 
Index (PSI) [13] was used to measure the 
(dis)similarity between ST frequency 
distributions of travelers and non-travelers. PSI 
ranges between 0 (no common ST) and 1 
(identical distributions). Simpson's index of 
diversity was calculated to define the ST 
diversity of travelers and non-travelers as the 
probability that two randomly selected 
individuals were infected with different STs 
[23]. 
 
Table 1. Region of destination and length of stay for cases and controls that had traveled abroad. 
Destination region* 
Cases (n = 328) Controls (n = 244) 
Exposed (%) Days stayed† Exposed (%) Days stayed† 
Northern Europe‡ 3.3 4 (4–6) 8.6 13 (4–28) 
Western Europe§ 22.5 9 (4–16) 59.0 12 (4–19) 
Eastern Europe¶ 4.2 11 (6–21) 4.9 15 (4–22) 
Southern Europe# 22.5 14 (8–16) 24.1 11 (7–16) 
Northern Africa** 8.5 14 (8–26) 1.2 27 (16–31) 
Sub–Saharan Africa†† 4.2 21 (15–57) 0.4 3 (3–3) 
Western Asia‡‡ 13.7 14 (7–15) 2.0 14 (7–14) 
South–East Asia and China§§ 16.1 20 (15–27) 0.8 11 (9–13) 
Southern Asia¶¶ 3.6 38 (18–49) 0.4 22 (22–22) 
Oceania## 0.6 78 (34–122) 0.4 28 (22–22) 
North America*** None None 0.8 60 (11–109) 
Latin America and the Caribbean††† 4.8 22 (15–55) 0.4 7 (7–7) 
Unknown 0.9 11 (11–14) 1.6 11 (10–11) 
*Adapted from the United Nations scheme of the composition of macro geographical (continental) regions, 
geographical sub-regions, and selected economic and other groupings 
(http://unstats.un.org/unsd/methods/m49/m49regin.htm#europe). †Median (25th-75th percentile). ‡Includes 
travelers returning from the UK, Ireland, Denmark, Sweden, Norway, and Finland. §Includes travelers 
returning from Germany, France, Belgium, Austria, Luxemburg, and Switzerland. ¶Includes travelers 
returning from the Czech Republic, Hungary, Poland, Slovakia, and Romania. #Includes travelers returning 
from Spain, Italy, Portugal, Greece, Croatia, and Malta. **Includes travelers returning from Morocco, Egypt, 
and Tunisia. ††Includes travelers returning from Benin, Cameroon, Ethiopia, Ghana, Kenya, Mali, Nigeria, 
Rwanda, Tanzania, Botswana, Burkina Faso, South Africa and Namibia. ‡‡Includes travelers returning from 
Turkey, Jordan and Iraq. §§Includes travelers returning from China, Indonesia, Malaysia, Singapore, 
Philippines, Thailand, and Vietnam. ¶¶Includes travelers returning from India, Nepal, and Bangladesh. 
##Includes travelers returning from Australia and Fiji Islands. ***Includes travelers returning from the USA. 
†††Includes travelers returning from Bolivia, Ecuador, Peru, Venezuela, Chile, Costa Rica, Cuba, 
Dominican Republic, Haiti, Mexico, and Guatemala. 
 
2.2. Source Attribution 
 
The Asymmetric Island (AI) model, a 
Bayesian population genetics algorithm for 
modeling Campylobacter evolution and 
transmission [24], was used to estimate the 
probability (Pr) for the 737 non-travelers to be 
infected with exotically-introduced STs or with 
STs originating from four putative animal 
reservoirs (chicken, cattle, sheep, pig) or from 
the environment (water, sand, wild-birds), a 
proxy for other unidentified reservoirs 
putatively of wildlife origin [16]. This study 
was restricted to campylobacteriosis of 
probable exotic origin. Results regarding the 
other animal and environmental sources have 
been reported elsewhere [13,16]. 
To run the AI model, C. jejuni/coli 
MLST data from the aforementioned animal 
and environmental sources were supplied by 
the CVI and supplemented with other data 
[22,25,26] to provide a representative dataset 
for each source (Table 2). Supplementary data 
were selected among other published datasets 
(reported in [13]) using Smid's methodology, 
which allows for the selection of non-local and 
non-recent MLST datasets for Campylobacter 
source attribution while minimizing potential 
biases [13,16]. Differences in Pr for exotic 
origin (Pre) were tested for the variables age, 
sex, and season using the Kruskal-Wallis or 
Mann-Whitney tests. 
 
2.3. Risk Factors for Travel-related 
Campylobacteriosis 
 
Logistic regression was used to 
investigate risk factors for travel-related 
campylobacteriosis. The 325 diseased travelers 
and the 238 healthy travelers with known 
travel destination were included as cases and 
controls, respectively. Analysis was performed 
in the same way as in previous studies 
[6,16,21]. Factors showing a p0.10 for the 
association with the outcome in the single-
variable analysis were selected for inclusion in 
a multivariable model. A backward stepwise 
procedure was applied and variables with a 
p<0.05 were retained in the final model. 
Education level [16], travel region, and days 
stayed were always included as covariates to 
control for confounding in addition to the 
frequency-matched variables. As travel regions 
were almost mutually exclusive, Western 
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Europe, which The Netherlands belongs to, 
was made the base category against which the 
other regions were assessed. 
To explore if the risk factors of the 
reduced model differed according to age, sex, 
education level, season, and travel region, we 
also tested for their two-way interactions. The 
final multivariable model was then expanded 
to include significant interactions. Overall 
model significance and goodness-of-fit were 
verified by likelihood ratio χ2 and Hosmer-
Lemeshow tests, respectively. The best-fitting 
model was identified using the Akaike 
Information Criterion (AIC). Bias-corrected 
bootstrap confidence intervals were also 
calculated (1000 iterations) and compared with 
the standard ones. As these did not differ 
significantly, the standard ones were reported. 
Statistical analysis was performed using 
STATA 11.2. 
 
Table 2. Campylobacter jejuni/coli strains typed with MLST used to feed the asymmetric island model for source attribution. 
Country Humans (travelers) Chicken Cattle Sheep Pig Environment Reference 
The Netherlands 232* 236 0 9 0 106 (Water) Data† 
United Kingdom 0 73 46 46 72 50 (Sand) [22] 
Scotland 0 239 90 90 88 133 (Wild birds) [25] 
Switzerland 0 77 23 23 0 0 [26] 
Total 232 625 168 168 160 289  
*From the Campybobacter jejuni/coli-diseased travelers of the CaSa study [6]. 
†Provided by the Central Veterinary Institute (CVI) in Lelystad, The Netherland. 
 
2.4. Risk Factors for Exotically-introduced 
Domestic Campylobacteriosis 
 
To investigate risk factors for 
domestically-acquired campylobacteriosis 
caused by STs of probable exotic origin, 
MLST data of travelers were included as an 
additional source in the AI model. Similar to 
previous studies [16,27,28], the Pre distribution 
was assessed and a cut-off was determined to 
optimize the number of domestic cases 
assigned to be exotically-introduced and the 
confidence as to their correct assignment 
derived by the highest possible Pre. Logistic 
regression was then used to investigate risk 
factors for domestically-acquired 
campylobacteriosis caused by STs with at least 
77% probability (cut-off Pre0.77) of 
originating from abroad. This cut-off Pre 
resulted in the selection of 77 cases with a 
median Pre of 0.89 (mean = 0.88, range: 0.77-
0.99) belonging to 35 different STs. The 3119 
non-traveling controls were included in this 
analysis.  
The effect of the assignment cut-off 
Pre on the risk factors was checked by 
sensitivity analysis, repeating this for different 
cut-off Pre from 0.5 to 0.9. Low numbers of 
cases did not allow for the construction of 
models based on cut-off Pre>0.9. Finally, a 
case-case analysis comparing exposures of 
domestic infections with exotic vs. non-exotic 
STs was performed.  
 
 
3. RESULTS 
 
3.1. Genotypes 
 
The 737 typed strains from non-
travelers were assigned to 154 STs and 28 
CCs, whereas those from the 232 travelers 
were assigned to 127 STs and 23 CCs. 
Twenty-eight STs from non-travelers and 23 
STs from travelers were unassigned to 
previously identified CCs.  
In non-travelers, the top five STs (ST-
53, ST-50, ST-21, ST-48, ST-45) accounted 
for >25% of cases and the top five CCs (CC-
21, CC-45, CC-206, CC-257, CC-48) for 
>50% of cases (Figures 1 and 2). In travelers, 
the top five STs (ST-572, ST-21, ST-50, ST-
53, ST-353) accounted for ~20% of cases and 
the top five CCs (CC-21, CC-353, CC-828, 
CC-206, CC-52) for >50% of cases (Figures 1 
and 2). STs occurring once accounted for 46% 
and 70% of STs in non-travelers and travelers, 
respectively. PSI between travelers and non-
travelers was 0.47 (95% confidence interval 
[CI]: 0.34–0.59) while Simpson's index was 
0.972 (95% CI: 0.968–0.976) in non-travelers 
and 0.988 (0.984–0.992) in travelers.  
There were 68 STs (#74 cases) found 
only in travelers and absent in any of the 
considered sources and in non-travelers (Table 
3). Most cases (73%) infected with these 
traveler-only STs had traveled to Asia or 
Africa vs. 46% of all travel-related cases 
returning from these continents (z-test, 
p<0.001). Conversely, 23% of cases infected 
with traveler-only STs had traveled within 
Europe vs. 53% of all travel-related cases 
traveling within Europe (z-test, p<0.001). 
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ST-572 was significantly 
overrepresented (64%) in travelers from 
Western Europe (p = 0.001); ST-50 in those 
from Western Asia (40%; p = 0.014); ST-53 in 
those from Southern Europe (50%; p = 0.035); 
ST-353, CC-353 and CC-828 in those from 
Northern Africa (38%, 27%, and 46%; p = 
0.003, p<0.001, and p<0.001, respectively); 
CC-52 in those from Eastern Europe (23%; p = 
0.001). 
The 35 STs with Pre≥0.77 included in 
the risk factor analysis for exotically-
introduced domestic campylobacteriosis are 
reported in Figure 3. The five most exotic STs 
(Pre≥0.98) were ST-4284, ST-4278, ST-4311, 
ST-2123 and ST-3015. There was a significant 
seasonal effect (p = 0.036) on Pre, which 
peaked in October-December and decreased in 
April-June. No significant age and sex effects 
on Pre were found.  
 
 
Figure 1. Sequence types identified amongst Campylobacter jejuni/coli strains isolated from the 737 non-travelers (infections acquired in the Netherlands) 
and the 232 travelers returning to The Netherlands. Category „others‟ includes sequence types that occurred less than five (non-travelers) and two 
(travelers) times. 
 
3.2. Risk Factors for Travel-related 
Campylobacteriosis  
 
Compared to traveling within Western 
Europe, traveling to any region in Asia, Africa, 
Latin America and the Caribbean, and 
Southern Europe posed a higher risk to acquire 
campylobacteriosis (Table 4), whereas the risk 
posed by Northern and Eastern Europe and 
Oceania, as well as the length of stay, were not 
significant (p>0.05).  
Significant risk factors for travel-
related campylobacteriosis (Table 4) were: 
using proton-pump inhibitors, consuming 
vegetable salad when traveling outside Europe, 
contact with raw pork, having chronic 
enteropathies, drinking bottled water when 
traveling to Southern Europe or non-European 
countries, and consuming chicken. Consuming 
yoghurt and being employed in healthcare 
were protective. 
 
3.3. Risk Factors for Exotically-introduced 
Domestic Campylobacteriosis 
 
Risk factors for exotically-introduced 
domestic campylobacteriosis (Table 5) were: 
not washing hands after toilet visit in January-
April 2003, using proton-pump inhibitors, 
being a school-going child in April–June 2002 
and October–December 2002, attending public 
swimming pools in October–December 2002, 
and contact with gastroenteritis cases outside 
the household. Consuming yoghurt was 
protective. Sensitivity analysis of the cut-off 
Pre revealed that this had no effect on the main 
results. In case-case analysis, the same risk 
factors were identified apart from consuming 
yoghurt and antacids (no longer significant), 
and therefore no further results are presented. 
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Figure 2. Clonal complexes assigned to 154 and 127 Campylobacter jejuni/coli sequence types identified from the 737 non-travelers (infections acquired in 
The Netherlands) and the 232 travelers returning to The Netherlands, respectively. Category „others‟ includes clonal complexes that occurred less than 
twice (non-travelers) and once (travelers). 
 
 
Figure 3. Number of cases (bar chart, left y-axis) and estimated probability (line chart, right y-axis) of the sequence types included in the risk factor analysis 
for domestically-acquired campylobacteriosis of probable exotic origin. 
 
 
4. DISCUSSION 
 
The risk for Dutch travelers to acquire 
campylobacteriosis depended on the travel 
destination. Consistent with previous studies 
[2,3], Asia, Africa, Latin America and the 
Caribbean, and Southern Europe were regions 
associated with an increased risk for 
campylobacteriosis compared to Western 
Europe, which comprises the neighboring 
countries of The Netherlands. Regional risk 
variations may be due to differences in local 
epidemiology and hygiene standards. 
However, a cautious interpretation of these risk 
figures is warranted, as physicians may be 
more likely to decide on laboratory 
investigation when a gastroenteritis patient has 
traveled to a high-risk destination [2]. 
 
 
 
 
 
Mughini Gras, Smid, Wagenaar, et al. (submitted for publication) 
113 
 
Table 3. Sequence types found exclusively in travelers 
returning to The Netherlands but not in cases acquired in 
The Netherlands, nor in any of the sourced animal and 
environmental reservoirs. 
Sequence type Number of cases Travel destination 
4291 1 Austria 
474 1 Belgium 
4274 1 Bolivia, Peru 
3878 1 Czech Republic 
4252 1 Czech Republic 
830 1 Egypt 
931 1 Egypt 
2229 1 Egypt 
2968 1 Egypt 
3606 1 Ethiopia 
892 1 France 
1044 1 Germany 
446 1 India 
451 1 India 
1042 1 India 
4288 1 India 
530 2 Indonesia 
161 1 Indonesia 
2031 1 Indonesia 
2109 1 Indonesia 
2131 1 Indonesia 
2393 1 Indonesia 
2941 1 Indonesia 
4270 1 Indonesia 
4281 1 Indonesia 
4287 1 Indonesia 
4289 1 Indonesia 
4296 1 Indonesia 
4298 1 Italy 
4305 1 Jordan 
3630 1 Jordan, Iraq 
1380 1 Kenya 
466 1 Luxemburg, France 
4293 1 Malaysia 
1039 1 Mali 
4309 1 Mali 
2116 1 Morocco 
3575 1 Morocco 
4165 1 Morocco 
4299 1 Morocco 
986 1 Nepal, China 
1233 1 Peru 
4053 1 Peru 
2895 1 Philippines 
614 1 Poland 
4277 1 Portugal 
904 2 Portugal, Spain 
4275 1 Singapore 
148 1 Spain 
1710 1 Spain 
4294 1 Spain 
4313 1 Spain 
4408 1 Spain 
1919 3 Thailand 
768 2 Thailand 
407 1 Thailand 
1953 1 Thailand 
2083 1 Thailand 
2315 1 Thailand 
4303 1 Thailand 
3246 2 Turkey 
303 1 Turkey 
305 1 Turkey 
2066 1 Turkey 
2184 1 Turkey 
2275 1 Turkey 
3142 1 Turkey 
919 1 Vietnam, Malaysia 
 
STs of travelers and non-travelers were 
relatively similar and travelers showed more 
ST diversity than non-travelers, a possible 
reflection of the numerous countries where 
they acquired infection. Moreover, some STs 
were more likely than others to infect travelers 
visiting specific regions, and travelers infected 
with STs that were undetected domestically 
had traveled predominantly to distant 
destinations in Asia and Africa, suggesting that 
differences in STs are related, to some extent, 
to the geographical distance of the travel 
region compared to The Netherlands, with STs 
from nearby European countries being 
generally more similar than those from farther 
destinations [13]. 
The larger ST diversity in travelers 
combined with the association of some STs 
with specific destinations is also consistent 
with the presence of heterogeneously 
distributed clones that are endemic in the 
different regions but not so prevalent 
elsewhere in the world. Regionally endemic 
STs have been identified, for instance, in 
Australia [29], New Zealand [30] and Curaçao 
[31], and may emerge because of clonal 
expansion, niche adaptation, geographical 
isolation and host immune selection [32]. 
Although so far there has been no evidence of 
ST-specific immune responses, it is 
conceivable that the chance of being exposed 
to a ST with uncommon antigens is somewhat 
higher for STs that are rarely, rather than 
commonly, encountered. STs that are 
associated with strong regional clustering 
would therefore pose a higher risk to the 
travelers also because of limited, if absent, 
prior (repeated) exposure in addition to issues 
related to sanitation failure. The risk posed by 
uncommon STs is also suggested by their age 
distribution [16,33]. For instance, the three 
commonest STs among non-travelers were 
mainly found in the young relatively to the 
other STs, decreasing steadily with age (data 
not shown). Conversely, rare STs (<5 isolates) 
occurred independently of age. According to 
interpretation of similar findings [11], it is 
likely that antigenic properties associated with 
the common STs are frequently encountered 
throughout life; thus, the young would be more 
susceptible because they have encountered 
these less often. In contrast, rare STs, more 
probably related to uncommon antigens, would 
have seldom been encountered by all age 
groups. 
Seven risk factors for travel-related 
campylobacteriosis were identified. Consistent 
with evidence that poultry is the main reservoir 
for campylobacters, most studies concerning 
risk factors for campylobacteriosis have 
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identified an association with eating chicken 
[6,7,16,34,35], suggesting that this risk factor 
is not exclusive of acquiring infection abroad. 
This also applies to consuming antacids and 
having chronic enteropathies [6,7,16]. 
 
Table 4. Multivariable odds ratios (OR) and corresponding 95% confidence intervals (95% CI) of risk factors for Campylobacter jejuni/coli infection in 
travellers returning to The Netherlands. 
Risk factor (% of imputed missing values) OR (95% CI)** 
Days stayed (3) 1.0 (0.9-1.1)ns 
Region of destination*  
Western Europe Reference 
Northern Europe 0.8 (0.3-2.2)ns 
Eastern Europe 1.1 (0.3-2.2)ns 
Southern Europe 1.7 (1.0-3.3) 
Northern Africa 10.6 (2.3-49.0) 
Sub-Saharan Africa 25.4 (2.7-310.7) 
Western Asia 10.6 (2.8-39.9) 
South-Eastern Asia and China 27.8 (4.5-170.9) 
Southern Asia 28.9 (2.4-265.1) 
Oceania 0.8 (0.0-43040.2)ns 
Latin America and the Caribbean 20.8 (2.0-211.6) 
Eating chicken (2) 2.0 (1.1-3.5) 
Eating yoghurt (4) 0.4 (0.2-0.7) 
Eating vegetable salad (3)  
travelling within Europe 1.7 (0.9-3.1)ns 
travelling outside Europe  6.7 (2.1-40.2) 
Drinking bottled water (3)  
travelling within Europe, excluding Southern Europe 1.5 (0.6-3.6)ns 
travelling to Southern Europe and outside Europe  2.3 (1.6-5.0) 
Contact with raw pork (5) 6.2 (1.3-29.3) 
Recent use of proton-pump inhibitors 14.6 (3.0-82.0) 
Having a chronic gastrointestinal disease (5) 2.9 (1.7-4.8) 
Working in the medical/healthcare sector (1) 0.4 (0.1-0.9) 
ns = not significant ( p>0.05). *See Table 1 for details. **Adjusted for age, sex, degree of urbanization, season and level of education. Estimates are based 
on 328 cases and 244 controls. 
 
Table 5. Multivariable odds ratios (OR) and corresponding 95% confidence intervals (95% CI) of risk factors for Campylobacter jejuni/coli infection acquired 
in The Netherlands caused by strains of most likely exotic origin. 
Risk factor (% of imputed missing values) OR (95% CI)* 
Contact with people with gastroenteritis outside the household (3) 2.2 (1.9-4.6) 
Recent use of proton-pump inhibitors 9.5 (4.4-20.6) 
Eating yoghurt (2) 0.3 (0.2-0.6) 
Not washing hands after toilet visit  
in April-December 2002 6.8 (0.7-68.1)ns 
in January-April 2003 20.8 (1.9-233.4) 
Being a school going child  
in July-September 2002 and January-April 2003 1.4 (0.5-3.8)ns 
in April-June 2002 3.4 (1.0-11.4) 
in October-December 2002 4.0 (1.4-11.3) 
Swimming in a public swimming pool (1)  
in April-September 2002 and January-April 2003 1.0 (0.4-2.1)ns 
in October-December 2003 3.7 (1.3-11.0) 
ns = not significant (p>0.05). *Adjusted for age, sex, degree of urbanisation, season and level of education. Estimates are based on 77 cases 
and 3119 controls 
 
In The Netherlands, <1% of 
domestically-acquired Campylobacter 
infections have been attributed to pigs [16]. 
Moreover, eating pork has been associated 
with a reduced risk for C. coli [6] and chicken-
borne C. jejuni/coli [16] infections. 
Accordingly, Dutch retail pork has rarely been 
found contaminated with campylobacters [36]. 
The association with raw pork we found 
therefore suggests that pigs are an important 
reservoir (and pork an important exposure) of 
campylobacteriosis outside The Netherlands. 
In contrast to previous findings 
indicating that eating vegetable salad protects 
against domestically-acquired 
campylobacteriosis [6,16], we observed that 
this factor was associated with an increased 
risk for campylobacteriosis when traveling 
outside Europe. In Europe, extensive sampling 
of raw vegetables, including ready-to-eat 
salads, has generally found no, or very few, 
campylobacters [36], suggesting that 
contamination of such items during irrigation, 
harvesting and processing is unlikely and that 
salads may occasionally become cross-
contaminated during food preparation [34]. 
Conversely, exceptionally high Campylobacter 
isolation rates (~68%) in raw vegetables were 
reported from countries such as Malaysia [37], 
indicating that major problems can arise by 
consuming vegetables if hygiene practices are 
absent or break down.  
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Drinking bottled water was associated 
with an increased risk for campylobacteriosis 
when traveling to high-risk destinations. In the 
UK, drinking bottled water has been identified 
as a risk factor for campylobacteriosis [34], 
particularly C. coli infection [38], and 
ciprofloxacin-resistant Campylobacter 
infection acquired abroad [5], suggesting that 
bottled water could, given the right 
circumstances, provide a vehicle for 
campylobacters [34]. In fact, bottled water, 
unlike tap water, is not usually treated and 
testing for Campylobacter is rarely undertaken 
[34,38]. Moreover, in the event of dual 
contamination of bottled water 
(campylobacters and organic matter), C. jejuni 
may survive for prolonged periods [39]. 
However, our association with bottled water 
was only significant when traveling to high-
risk destinations, supporting the hypothesis 
that drinking bottled water acts as a proxy for 
local circumstances where there is a generally 
high risk for campylobacteriosis. Travelers are 
indeed usually advised to drink bottled water 
where there is any doubt about the local water 
quality. The use of bottled water may help in 
preventing infection but there may be 
circumstances where the risk is higher than 
that which can be prevented by drinking 
bottled water. Moreover, our questionnaire did 
not distinguish between sparkling and still 
bottled water and did not ask whether it was 
consumed with or without ice. Therefore, 
further investigation is needed to assess if the 
advice of drinking bottled water merits any 
refinement. 
Consuming yoghurt and working in 
healthcare were protective. It is believed that 
probiotic bacteria in yoghurt may alter the 
intestinal microflora in a way that prevents 
infection [35], while people working in 
healthcare might be particularly aware of the 
health risks (and ways to avoid them) when 
traveling. 
Risk factors for exotically-introduced 
domestic campylobacteriosis were suggestive 
of anthroponotic transmission, namely: contact 
with gastroenteritis cases outside the 
household (thus less likely to share the same 
exposure); not washing hands after toilet visit; 
being a school going child (usually having 
high frequencies of contacts); and attending 
public swimming pools (as recreational water 
has been proposed as a vehicle for 
Campylobacter transmission [16,35]). Except 
for the first risk factor, the others were 
unidentified in previous analyses where the 
same cases were not split according to their 
estimated exoticism [6,16]. Moreover, we 
found significant interactions with season, 
which is in accordance with the seasonal 
nature of traveling, as also shown by the 
finding that Pre varies seasonally. Periods most 
at-risk were mainly those around popular 
holiday periods in The Netherlands, notably 
the autumn break in October, Christmas/New 
Year in December–January, and Easter in 
April–May. Moreover, people most at-risk 
were school-going children for which 
additional peaks in domestic 
campylobacteriosis have already been noted 
shortly after the end of school breaks, 
suggesting that these additional peaks are due 
to exposure to less common strains from less 
common foods consumed during the festivities 
and to the mixing of people that have not been 
in contact for a long time following on from 
the previous holidays [40]. It was therefore 
hypothesized that travelers infected with 
strains possessing uncommon antigens might 
still be shedding them after returning home, 
most likely asymptomatically [14]. As there is 
unlikely to be a high prevalence of acquired 
protection to these exotic strains domestically, 
there is at least the potential for them to spread 
even through limited person-to-person 
transmission.  
In conclusion, we investigated MLST 
profiles of C. jejuni/coli strains isolated from 
travelers, the risk factors potentially 
responsible for acquiring such strains upon 
traveling, and those potentially responsible for 
their secondary spread to domestic 
populations. As travelers have dynamic 
interactions with people, places, and microbes 
during their journeys, they can be victims, 
carriers, and eventually transmitters of such 
agents to new regions and populations. Our 
understanding of campylobacteriosis may 
therefore depend on increased insight into 
Campylobacter transboundary epidemiology, 
including regional risk differences, high-risk 
exposures and Campylobacter behavior in 
response to newly available susceptible 
populations and changing environments.  
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General discussion and conclusions 
 
 
1. OUTLINE 
 
In this thesis, the sensitivity towards 
pathogens causing human gastroenteritis of 
two newly implemented regional surveillance 
systems in Italy was assessed, the occurrence 
and distribution of human Salmonella 
infections in Italy were explored, and sources, 
risk factors and transmission pathways of 
human salmonellosis (in Italy) and human 
campylobacteriosis (in The Netherlands) were 
investigated by developing source attribution 
models and tools for the combined analysis of 
source attribution and case-control data. This 
entailed considerable data mining and 
modelling work using different methodological 
approaches to target specific research 
questions. Evidence provided in this thesis can 
nicely integrate with, and further expand on, 
current knowledge in the field of epidemiology 
of salmonellas and campylobacters at the 
human-animal-environmental interfaces. As 
filling gaps in knowledge is the first step 
towards a comprehensive understanding of 
zoonotic enteric pathogens, this thesis is also 
expected to support evidence-based decision 
making on prevention and mitigation strategies 
for Salmonella and Campylobacter in the 
transmission chain. 
Each of the chapters of this thesis is 
"self-conclusive", that is, intended to stand 
alone as a detailed presentation of the topic 
(introduction), of the methods used and results 
obtained, as well as their discussion and 
conclusions drawn. The purpose of this general 
discussion is therefore to tie together the 
various studies presented in the body of this 
thesis and to make general comments and 
conclusions upon their meaning in relation to 
the four objectives of this thesis listed in the 
general introduction (Chapter 1). This also 
includes communicating the implications 
resulting from these papers and, when 
appropriate, making recommendations, 
forecasting future trends and the need for 
further research. 
 
 
 
2. OBJECTIVE 1 – EPIDEMIOLOGY 
AND SURVEILLANCE OF ENTERIC 
PATHOGENS IN ITALY, WITH A FOCUS 
ON HUMAN SALMONELLOSIS 
 
The first objective of this thesis was to 
provide an overview of the epidemiology of 
acute gastroenteritis in Italy, with a focus on 
human salmonellosis, particularly of S. 
enterica subsp. enterica serotypes, and to 
identify the most promising changes to be 
made to improve the sensitivity towards 
pathogens causing human gastroenteritis of 
Italy's current surveillance systems. 
The epidemiology of human 
salmonellosis in Italy was described through 
the occurrence and distribution of non-typhoid 
Salmonella infections in the Italian general 
population using two main sources of data: 1) 
the official notifications of cases reported by 
physicians to the Italian National Infectious 
Diseases Notification System (SIMI) and to the 
Italian National Institute of Statistics (ISTAT); 
and 2) the reports of Salmonella serotyped 
isolates from humans notified by a network of 
diagnosing laboratories to Enter-net Italia, the 
current Italian laboratory-based surveillance 
system for enteric pathogens. The analysis of 
these different data gave comparable results, 
but at different resolutions. Indeed, the 
SIMI/ISTAT data are not differentiated into 
Salmonella serotypes, while the Enter-net Italia 
data provide microbiological information (at 
least the serotype) on Salmonella isolates of 
approximately 50% of human cases of 
salmonellosis notified to the SIMI/ISTAT. The 
parallel analysis of these two sets of data was 
useful in defining the general epidemiological 
situation of human salmonellosis in Italy and 
provided an opportunity for us to generate 
hypotheses about the underlying factors 
driving the occurrence and distribution of 
human Salmonella infections in Italy. 
Most results were expected, 
particularly those regarding the age 
distribution (skewed towards the young) and 
the seasonal pattern (peaking in warmer 
months) of human Salmonella infections. It 
was, however, informative to discover that the 
Chapter 9 
122 
 
top six Salmonella serotypes isolated from 
humans (i.e., S. Enteritidis, S. Typhimurium, S. 
Infantis, S. Derby, S. Typhimurium 
monophasic variant 4,[5],12,:i:- and S. Napoli) 
accounted for 59% of all Salmonella isolates 
from humans. Also the observed decreasing 
temporal trend in human salmonellosis and the 
increasing one of non-Salmonella diarrhoeal 
infections are in line with the increasingly 
prominent role of pathogens other than 
Salmonella, such as campylobacters, which are 
the most frequent cause of human acute 
gastroenteritis in the EU [1]. Besides evidence 
that human salmonellosis as a whole has been 
decreasing significantly in Italy since the 
1990s, passing from 47 to 7 cases per 100,000 
population from 1992 to 2009, we also found 
that, since 2000, this decrease has mainly been 
driven by specific serotypes, such as S. 
Enteritidis and S. Infantis, whereas other 
serotypes have emerged (S. Typhimurium 
monophasic variant 4,[5],12:i:-, S. Derby and 
S. Napoli) or have remained fairly stable (S. 
Typhimurium) over time, suggesting that the 
applied control measures are not equally 
efficient against the different serotypes and 
that the sources of infection other than those of 
S. Enteritidis (laying hens and eggs) are 
probably becoming increasingly important. 
Indeed, the importance of the different sources 
of human salmonellosis may change over time 
[2], and failure to identify the most important 
reservoirs in space and time may result in 
relatively ineffective control measures and 
waste of resources. We also found that, since 
2000 in Italy, human S. Enteritidis infections 
fell consistently below those caused by S. 
Typhimurium, which is the most reported 
serotype in Italy in contrast to the international 
situation where S. Enteritidis still ranks at the 
top despite its significant decrease. This 
finding further provoked our strong interest in 
identifying the main reservoirs of human 
salmonellosis in Italy, as well as quantifying 
their importance in terms of human infections 
attributed to different animal and food sources, 
providing risk managers with evidence to focus 
Salmonella-reducing control efforts along the 
transmission chain. 
In sporadic cases of acute 
gastroenteritis, testing for Salmonella spp. and 
subsequent serotyping serve as the 
predominately used surveillance tool for 
reaching an aetiological diagnosis, monitoring 
trends over time, and attributing human 
infections to the different food and animal 
sources. Salmonella serotyping is therefore 
very useful for informing and addressing 
public health actions, providing also a basis for 
epidemiological research, especially regarding 
the emerging serotypes (which may reveal the 
presence of previously unrecognized sources 
of infection) and the efficacy of intervention 
strategies. However, it is generally recognized 
that underreporting to surveillance systems is 
massive and rather unbalanced over the various 
subgroups of the population. Because of this, 
there is still incomplete knowledge about the 
real incidence and distribution of human 
Salmonella infections in many countries, 
including Italy.  
Surveillance of zoonotic enteric 
pathogens is usually conducted to: 1) facilitate 
the control of the disease through prompt 
public health actions; 2) measure the 
magnitude and trends of the disease; 3) 
improve and update our knowledge of the 
determinants, sources, reservoirs, risk factors, 
transmission routes, morbidity and mortality of 
the disease; 4) guide intervention strategies and 
their evaluation; and 5) assist policy makers in 
setting priorities. To date, the SIMI (and Enter-
net Italia as well) is able to address only a few 
of these points. By evaluating the impact of the 
two newly implemented surveillance systems 
in Lombardy and Piedmont regions on their 
overall notification rate of acute gastroenteritis 
cases and food-borne disease outbreaks, we 
also aimed at identifying the most promising 
directions to improve reporting at the national 
level. We found that, compared with the 
national mean, data from Lombardy and, to a 
lesser extent, Piedmont showed a significant 
increase in notification rates of human cases of 
both non-typhoid salmonellosis and non-
Salmonella infectious diarrhoea, but for food-
borne disease outbreaks, the increase was not 
statistically significant in none of the two 
regions. However, a further study [3] on this 
subject using a more sophisticated statistical 
analysis has found a significant increase in 
food-borne disease outbreaks in Piedmont 
region. It was therefore concluded that these 
two regional systems have improved their 
sensitivity regarding notification of acute 
gastroenteritis cases and food-borne disease 
outbreaks, thereby providing a more complete 
picture of the epidemiology of these diseases 
in Italy.  
The "positive" impact of the 
implementation of the regional surveillance 
systems on acute gastroenteritis notification 
rates was, however, considerably more evident 
in Lombardy than in Piedmont. It follows that, 
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at least in principle, the system of Lombardy 
provides a more promising (regional) example 
to be emulated at the national level in order to 
improve reporting of acute gastroenteritis cases 
and consequently obtain a better estimate of 
their occurrence in the Italian population. 
Nevertheless, the system of Piedmont, which is 
dedicated to food-borne pathogens and 
specifically to early warning of food-borne 
disease outbreaks, allows for a broader 
collection of information that is not easy to 
obtain in other ways, and this is indeed 
particularly relevant for timely outbreak 
detection, investigation, prevention and 
response.  
In order to improve the surveillance of 
acute gastroenteritis at the national level by 
looking at the experience gained at the regional 
level, such as that of Lombardy and Piedmont, 
it is also necessary to consider the feasibility, 
cost-benefit and long-term sustainability (i.e. 
the resources needed to sustain the system in 
the long-term) of the changes to be made to the 
national system in addition to the 
desired/expected outcome in terms of 
underreporting reduction. Nonetheless, by 
merely looking at the desired/expected 
outcome, there is some suggestive evidence 
indicating that the sensitivity towards 
pathogens causing gastroenteritis of the Italian 
surveillance system might benefit from careful 
consideration of extending the Lombardy, and 
to a somewhat lesser extent, Piedmont systems 
to the other regions. Efforts should be focused 
on the integration and harmonization of 
different surveillance activities and sources of 
information, as well as evaluation of such 
activities, to obtain the best achievable impact 
on the burden of acute gastroenteritis in the 
population. There is also an urgent need for 
surveillance of enteric pathogens in Italy to 
work, at the same time, on isolating, 
identifying, and reporting of detailed typing 
findings for both diagnostic and public health 
purposes. 
 
 
3. OBJECTIVE 2 – ATTRIBUTION OF 
HUMAN SALMONELLOSIS TO ANIMAL 
AND FOOD SOURCES IN ITALY 
 
The second objective of this thesis was 
to develop source attribution models based on 
the microbial subtyping approach using Italian 
Salmonella data in order to estimate the 
relative contributions of different animal and 
food sources to human Salmonella infections 
in Italy. Moreover, we were interested in 
investigating the changes in attribution 
estimates over different models, time periods 
and attribution points along the farm-to-fork 
continuum. 
The modified Hald model [4] was 
adapted for source attribution of human 
salmonellosis in Italy. An original model that 
we called "modified Dutch model" was also 
developed and applied to the same data (and 
for the same purposes) as those of the modified 
Hald model. Both these models allowed for the 
estimation of the relative contributions of 
different animal and food sources, as well as 
outbreaks and foreign travel, to laboratory-
confirmed human Salmonella infections in 
Italy from 2002 to 2010. The methodological 
approach we used is, however, a flexible one, 
and could therefore be extended to other 
pathogens and countries in the near future. 
With some differences in consistency 
and precision of attribution estimates over time 
periods and sampling points, both our model 
adaptations identified pigs as the main source 
of human salmonellosis in Italy, accounting for 
approximately half of human cases, followed 
by Gallus gallus, whereas the contributions of 
turkeys and ruminants were only minor. This 
ranking provided significant insights about the 
sources that are being increasingly important in 
Italy, providing a basis for delineating future 
risk management strategies. Indeed, while the 
applied control measures seem to have worked 
well in poultry, it became apparent that there is 
an urgent need to focus attention on pigs. This 
is also substantiated by recent findings 
indicating that pigs are the most important 
source of human salmonellosis in other 
European countries, such as Belgium, Cyprus, 
Finland, France, Ireland, Poland and Sweden 
in addition to Italy, with also very similar 
proportions of cases attributed to poultry and 
to pigs in the Netherlands [5].  
The increasingly prominent role of 
pigs, and the decreasingly one of Gallus 
gallus, as sources of human salmonellosis in 
Italy nicely integrate with evidence provided in 
Chapters 3. Indeed, in Italy and in most other 
industrialized countries, there has been a 
drastic decrease in the number of human S. 
Enteritidis infections (for which Gallus gallus, 
and particularly layers, are the major reservoir 
[5,6]), whereas a sustained predominance of 
infections caused by S. Typhimurium and its 
monophasic variant 4,[5],12,:i:-, and an 
increase of those caused by S. Derby, have 
been observed. Accordingly, S. Typhimurium, 
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its monophasic variant 4,[5],12,:i:- and S. 
Derby entail pigs as the main reservoir [5,6]). 
Data used in our model adaptations 
were probably suboptimal for source 
attribution in some respects. This is a reflection 
of 1) deficiency in data availability, such as the 
lack of reliable Salmonella phage typing data 
for the commonest serotypes in humans and 
sources; 2) comprehensive travel and outbreak 
information, as well as detailed prevalence 
data in each of the sources; 3) the low number 
and resolution of sources surveyed, particularly 
Gallus gallus, which is not subdivided in at 
least broilers and layers; 4) no information on 
imported foods, nor on vegetables, which, to 
our knowledge, have never been considered in 
this kind of source attribution studies 
notwithstanding their increasing importance as 
a source of human salmonellosis [7–9]. Not to 
mention some special low-moisture foodstuffs, 
such as peanut butter, infant formula, 
chocolate, cereal products and dried milk, 
through which salmonellas can be delivered as 
well [10].  
The modified Dutch model represents 
a practical improvement of the original Dutch 
model [11], which, in spite of its simplicity and 
easiness of application, has the major 
disadvantage of not accounting for differences 
in the ability of the different subtypes and 
sources to cause disease in humans. This 
means that, within each microbial subtype, the 
original Dutch model assumes that the impact 
of every source is equal and proportional to the 
occurrence of that subtype in that source. 
Similar to the approach on which the 
(modified) Hald model relies, two major 
modifications were applied to our modified 
Dutch model. First, the prevalence was 
modelled using the methodology of Mullner et 
al. [4], which allowed us to take into account 
the overall probability of finding Salmonella in 
a given source in addition to the relative 
frequency of the different serotypes within 
each source. By doing so, the model can now 
make use of the best possible estimate of the 
prevalence. Second, as reliable food 
consumption data were available and 
environmental, anthroponotic or unknown 
sources were not included in the model, food 
consumption weights were incorporated to take 
into account the human exposure to the 
different sources. By incorporating food 
consumption data, the model is better informed 
and can more closely reflect the chance of a 
given source to act as a vehicle for Salmonella. 
It follows that, similar to the (modified) Hald 
model, our modified Dutch model no longer 
assumes an equal impact of the different 
subtypes and source on the human disease 
burden.  
In general, the conclusions reached by 
the two models applied at farm and food levels 
fundamentally agree with one another, and 
therefore provided little information to support 
risk managers in identifying the most 
promising targets along the farm-to-fork 
continuum on which control efforts should be 
focused. Discrepancies in the estimates 
between the two models may be explained by 
the different computational methods they use, 
as evidenced elsewhere [12–4]. Moreover, it is 
still rather unclear if the considerable increase 
in the contribution of Gallus gallus to human 
Salmonella infection from farm to food 
estimated by our modified Hald model is due 
to an important role played by leaks in hygiene 
practices along the food chain for chicken meat 
and eggs in modifying the within-source 
serotype distribution in such a way that the 
"risk" posed by Gallus gallus increases 
considerably at food level relative to that at 
farm, or is instead due to a particular 
sensitivity of this kind of model to biologically 
meaningless changes in within-source serotype 
distribution. As we could not determine here to 
what extent the changes (from farm to food) in 
the within-source serotype distribution we 
found were biologically meaningless, further 
investigations are needed. 
The serotype (qi) and source (aj) 
dependent factors of the (modified) Hald 
model merit special considerations. These 
factors should describe complex systems that 
are not still fully understood. It is assumed that 
qi accounts for differences in survivability 
(along the food chain) and pathogenicity (in 
humans) of the various Salmonella subtypes. 
Similarly, aj is assumed to account for 
variability in surveillance systems and for 
specific characteristics of the sources that 
allow them to act as vehicles for salmonellas. 
However, the method relies on a sort of "black 
box" model [2], and values taken by qi and aj 
are only assumed to be a summary reflection of 
unknown biological properties.   
In conclusion, attributing human 
Salmonella infections to animal and food 
sources in Italy is a valuable tool to quantify 
and rank their relative importance for human 
disease, and thus expected to support risk 
management decisions, assist prioritization of 
interventions, and help measuring the effect of 
control programmes in the near future. As 
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higher quality data from a fully integrated 
(human and animal) intensive surveillance 
system are needed to improve our attribution 
estimates, new developments in this field 
should work in parallel on empowering 
surveillance efforts and facilitating the 
application of source attribution analyses in the 
presence of imperfect surveillance data.  
 
 
4. OBJECTIVE 3 – COMBINING 
SOURCE ATTRIBUTION AND CASE-
CONTROL DATA ON HUMAN 
CAMPYLOBACTERIOSIS, WITH 
CONSIDERATIONS ON SAMPLING 
ISSUES 
 
The third objective of this thesis was to 
develop a combined analysis of source 
attribution and case-control data on human 
campylobacteriosis while accounting for 
sampling issues arising from source attribution 
in space and time. 
MLST is increasingly becoming the 
typing method of choice in source attribution 
studies of human campylobacteriosis, e.g. 
[4,14–16]. However, the implementation of 
intensive sampling schemes to obtain 
representative Campylobacter MLST datasets 
from multiple sources is rather expensive. 
Therefore, for the purposes of Campylobacter 
source attribution, investigators might be 
forced to use non-recent or non-local MLST 
data, which can potentially introduce bias in 
the attribution estimates [17]. Moreover, the 
use of small-sized datasets may result in 
uncertain estimates. Although there is evidence 
that Campylobacter multilocus genotypes are 
more strongly associated with specific hosts 
than with geographical location [18], there are 
still large geographical differences in the 
distribution of host-associated genotypes, and 
these can change over time as well [19]. This 
highlights the need to consider concurrent 
sampling of different reservoirs in time and 
space in parallel to that of humans. Other 
issues that may need further considerations are: 
1) which reservoirs to sample; 2) whether and 
how to sample the environment (e.g. water 
sources) as a proxy for unknown reservoirs; 
and 3) which genotyping tools to use in 
alternative to MLST. Within-country variation 
may also be considered when deciding whether 
to adopt a whole-country approach or to use 
sentinel sites [4]. At present, there are few 
indications about the impact of (spatial and 
temporal) genotype variation and sample size 
on source attribution estimates. This provoked 
our interest in investigating the consequences 
of using non-local or non-recent MLST data 
when attributing human Campylobacter 
infections to putative sources (i.e., chicken, 
cattle, sheep, pig and the environment). We 
have therefore performed a series of analyses 
aimed at determining how the Asymmetric 
Island (AI) model for source attribution 
performs in absence of local or recent data (by 
supplementing or substituting source data with 
data from other countries and/or time periods) 
and when only few data are available (power 
analysis). The importance of geographical 
distance in Campylobacter multilocus 
genotype dissimilarity was provided by 
comparing human MLST datasets from several 
countries to the Dutch ones. Indeed, data from 
nearby European countries were generally 
more similar than data from more distant 
countries with respect to The Netherlands. This 
is also in agreement with that we found in the 
study of travel-related Campylobacter 
infections presented in Chapter 8. Evidence 
was also found for a shift in ST frequencies 
over time.  
As MLST data become increasingly 
dissimilar as the geographical distance and the 
time period between different datasets are 
collected increases, the AI model can 
underestimate the importance of a source 
whose data are not collected 
contemporaneously with the human cases to be 
attributed. Indeed, although chicken was 
identified as the most important source of 
human campylobacteriosis in The Netherlands, 
accounting for 61-74% of cases, this high 
proportion of chicken-attributed cases (and the 
smaller ones attributed to non-chicken sources) 
depended on the origin of the source data 
included in the AI model. Generally speaking, 
the farther in space and time one takes the 
source data, the more their MLST profiles will 
differ, and the smaller will be the estimated 
proportions of human cases attributable to 
those sources. Nevertheless, there is also 
evidence that the extent of the bias introduced 
by temporal mismatching between human and 
source data is much smaller than that 
introduced by geographical mismatching. We 
therefore proposed a coarse rule stating that 
this bias increases with the geographical 
distance between the countries (and to a lesser 
extend with the temporal distance between the 
time periods) from which source data are used. 
However, our results also suggest that 
geographical distance may act together with 
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factors related to travel and trade between 
countries, as also evidenced in Chapter 8. 
These findings are expected to be practical in 
guiding sampling schemes for Campylobacter 
MLST data collection in future source 
attribution studies where the potential for 
geographical and/or temporal bias cannot be 
ignored. In general, however, the extent to 
which such bias is a matter of concern depends 
on how detailed in time and space is the 
research question to be addressed.  
We also proposed a very practical 
method, which is a sort of "poor man's 
solution", to select supplementary non-local or 
non-recent MLST source data with the aim of 
minimizing the potential geographical and 
temporal biases. This method is based on the 
assumption that if the human MLST data 
between different countries and time periods 
resemble one another (as revealed by PSI or 
principal component analysis - PCA), then also 
will their respective source MLST data, which 
may therefore be borrowed interchangeably 
from the other datasets in question. Finally, our 
results also suggest that it is recommendable to 
have over 100 isolates per source to perform 
source attribution using the AI model in order 
to have satisfactory statistical power. More 
detailed research questions might, however, 
ask for more precision, i.e. a larger strain set.  
Blending the properties of source 
attribution models and case-control studies was 
thought to be useful for risk management and 
prioritization of control strategies. This is 
because case-control studies alone are 
insufficient for attributing human infections to 
the different reservoirs, as they can only trace 
back the source of infection to the points of 
exposure (e.g. food items consumed), which 
may not point to the original (amplifying) 
reservoirs because of cross-contamination. 
Human Campylobacter infections can, 
however, be attributed to specific reservoirs 
using source attribution models based on 
MLST data, such as the AI model. Combining 
case-control data with the results of the 
attribution analysis would therefore allow us to 
explore risk factors at the point of exposure for 
human campylobacteriosis caused by strains 
originating from the different reservoirs, 
thereby tracing the transmission route from the 
exposure up to the reservoir, and vice versa. 
This may greatly improve our knowledge 
about the identification and characterization of 
potential reservoirs, risk factors and 
transmission pathways for human 
campylobacteriosis, as well to generate 
hypotheses and corroborate, to some extent, if 
MLST-based source attribution makes sense 
epidemiologically. 
Our combined analysis is based on the 
application of the AI model addressing the 
aforementioned sampling issues to estimate a 
probabilistic reservoir assignment (posterior 
probability) for each Campylobacter ST 
isolated from human cases, and using these 
attributed cases as outcome in the case-control 
study. This is an extension of earlier case-case 
comparisons of poultry- and ruminant-
associated cases of human campylobacteriosis 
[20,21] to include information on non-diseased 
controls, which is likely to identify more subtle 
associations and in turn improve source 
attribution modelling. We therefore 
investigated risk factors for human 
campylobacteriosis caused by STs with the 
highest possible probability to originate from 
chicken, ruminants (cattle and sheep) and the 
environment, considered as a proxy for other 
unidentified reservoirs. Once again, results 
revealed that most human cases were attributed 
to chicken (66%), followed by cattle (21%), 
which were therefore identified as the main 
reservoirs of human campylobacteriosis in The 
Netherlands. Moreover, our results provided 
suggestive evidence that chicken is the major 
reservoir for campylobacteriosis in young 
children living in urban areas compared with 
their rural counterparts, for which cattle seems 
to be more important.  
While the attribution analysis 
quantified the relative contributions of the 
considered reservoirs to human infections, the 
risk factor analysis identified the excess risk 
exposures for infections that were highly 
associated with these reservoirs, as well as 
their quantification in terms of population 
attributable risk (PAR). For instance, only up 
to 42% of the highly chicken-associated 
infections could be ascribed to consumption of 
chicken, suggesting that a considerable part of 
infections originating from chicken is acquired 
by pathways other than food, such as the 
environment or even by cross-contamination to 
commodities, utensils, and foods other than 
chicken. As expected, consuming chicken was 
identified as a risk factor for human 
campylobacteriosis caused by chicken-
associated STs, whereas consuming beef and 
pork were protective. Risk factors for human 
campylobacteriosis caused by ruminant-
associated STs were contact with animals, 
barbecuing in non-urban areas, consumption of 
tripe, and never/seldom consumption of 
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chicken, while consuming game and 
swimming in a domestic swimming pool 
during springtime were risk factors for human 
campylobacteriosis caused by environment-
associated STs. Infections with chicken- and 
ruminant-associated STs were, however, only 
partially explained by food-borne transmission; 
direct contact and environmental pathways 
were also important.  
Evidence provided by these results 
indicates that human campylobacteriosis in 
The Netherlands (but probably also in other 
countries) could greatly be reduced by 
focusing interventions on chicken and cattle, 
especially in urban and rural areas, 
respectively. However, pathways alternative to 
the food-borne one, such as direct contact and 
environmental contamination, do play a role as 
well, particularly in ruminant-associated 
infections. We also demonstrated that risk 
factors for Campylobacter infection depend 
upon the attributed reservoirs and that the 
exposure may plausibly direct to the original 
reservoirs when considering those STs that are 
indeed highly associated with the reservoirs in 
question. This provided a novel framework to 
support and generate hypotheses about 
Campylobacter epidemiology at the human-
animal-environmental interfaces and, in a 
broader perspective, to corroborate that the 
general concept of MLST-based source 
attribution modelling for campylobacteriosis is 
epidemiologically sensible.  
A number of case-control studies have 
explored risk factors for Campylobacter 
infection at the point of exposure while other 
studies have used MLST data to attribute 
Campylobacter infections to animal or 
environmental reservoirs. Our approach is 
innovative as it attempts to bridge this gap by 
exploring risk factors at the point of exposure 
for human campylobacteriosis of different 
origins, using a combined case-control and 
source attribution analysis. Obviously, this 
approach is not free of major caveats. For 
instance, some risk factors may be 
significantly associated with infections 
attributed to a given reservoir just because 
these infections have a residual contribution 
(i.e. attribution) from reservoirs other than 
those to which they were attributed. This 
residual contribution, although minimized 
through the selection of the most host-
associated STs, creates "noise" which could 
have masked or diluted some associations, or 
led to some additional associations, in the risk 
factor analysis. Nevertheless, all the risk 
factors we found were associated in an 
epidemiologically plausible way according to 
the reservoirs in question, which is an 
indication that the risk of spuriousness was 
handled fairly well.  
Two other interesting findings were: 1) 
dog ownership as a risk factor for 
environment-associated strains; and 2) risk for 
Campylobacter person-to-person transmission 
particularly pronounced for environment-
associated STs. It is clear that dogs are often 
carriers of campylobacters and that dog owners 
may be particularly exposed to Campylobacter 
strains of environmental origin while walking 
their dogs, and dogs may also act as a vehicle 
for Campylobacter strains of environmental 
origin. Moreover, considering that our 
environmental strains were sourced from water 
and sand among others, and that person-to-
person transmission seems particularly 
important in children [22], we speculated that 
sand (particularly the one in playground sand-
boxes) and recreational water can act as a 
vehicle for transmission among humans as 
well. These findings further provoked our 
interest in elucidating the role of pets in 
Campylobacter zoonotic transmission, as well 
as the role of potential anthroponotic sources, 
as presented in Chapters 7 and 8. 
Enhanced models and genotyping 
tools, as well as the integration of different 
approaches, e.g. epidemiological and 
genealogical modelling, in a single framework 
have the potential for improving the range of 
techniques available for source attribution in 
the near future. Molecular subtyping tools may 
also be improved with the addition of whole 
genome sequence data from high through-put 
sequencing platforms, particularly when 
combined with improved bioinformatics and 
Web-based database tools that input short read 
sequence data. These have already led to the 
development of extended and generic MLST 
schemes [23,24]. Exploring the genome 
evolution of epidemiologically relevant strains 
may also improve the discrimination of unclear 
reservoirs of human campylobacteriosis, such 
as cattle and sheep, and result in more precise 
attribution estimates. Moreover, the 
identification of genetic markers for resistance 
to bacterial stress could also help in 
determining the sources and transmission 
routes of Campylobacter strains isolated from 
humans, further refining attribution studies and 
possibly stimulating novel epidemiological 
insights towards reservoir-specific risk factors 
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and transmission pathways for human 
campylobacteriosis. 
 
 
5. OBJECTIVE 4 – EXTENDING THE 
APPLICATION OF COMBINED SOURCE 
ATTRIBUTION AND CASE-CONTROL 
MODELLING 
 
The fifth objective of this thesis was to 
extend the novel application of the combined 
source attribution and case-control analysis 
presented in Chapter 6 to include also factors 
that are not commonly considered when 
examining likely sources of human 
campylobacteriosis, such as zoonotic 
transmission through and/or from pets (dogs 
and cats) and potential (secondary) 
anthroponotic transmission involving returning 
travellers. Indeed, standard frameworks for 
(food- and environment-borne) Campylobacter 
source attribution studies rarely consider the 
potential impact of these atypical transmission 
routes with anything more elaborated than a 
quick note in the discussions of published 
journal articles in which such impact is 
assumed to be minimal based on empirical 
evidence. However, person-to-person spread 
could be included by considering humans as a 
spill-over host [25] infected from an animal 
reservoir. This is similar to the role played by 
imported food, which is still part of the food 
pathway, but with the reservoir located abroad. 
Moreover, some original reservoirs may be 
repeatedly infected by other reservoirs, 
effectively acting as an intermediate host 
instead of a real maintenance host. For 
example, pets may be repeatedly infected from 
food animals, but not be the primary 
amplifying hosts. This may also be the case of 
human infections associated with pet 
ownership, which may be the result of direct 
contact with pet food contaminated by food 
animals, rather than the pet itself. It is clear 
that such complex feedback loops representing 
transmission between reservoirs are often 
omitted in regular source attribution studies to 
keep this already intricate framework relatively 
simple. However, it should be recognized that 
these transmission loops may be important 
when considering possible interventions [6].  
To elucidate the role of pets, a poorly 
characterized reservoir of human 
campylobacteriosis, we first investigated 
MLST profiles of C. jejuni and C. coli strains 
isolated from pets and their owners in a one-to-
one relationship and then extended our 
combined source attribution and case-control 
analysis to explore risk factors at the point of 
exposure for human campylobacteriosis of 
probable pet origin. Results revealed a high 
degree of overlap between Campylobacter STs 
of human and pets, and dog owners, especially 
puppy owners, had an increased risk for 
infection with STs associated with pets 
compared to controls and non-dog owners. 
Furthermore, the expected occurrence of 
identical STs in humans and their pets in a 
one-to-one relationship was significantly lower 
than that observed. Taken together our results 
suggest that dog ownership increases 
significantly the risk of acquiring 
Campylobacter infection caused by STs 
originating from pet and that co-isolation of 
identical strains in humans and their pets 
occurs significantly more often than expected 
by chance. We therefore envisaged four 
possible scenarios: 1) humans and pets become 
infected from the same source; 2) humans and 
pets become infected from different sources 
that incidentally carry the same strain; 3) 
humans become infected from dogs; 4) dogs 
become infected from humans. As the 
sampling design was non-directional in the 
transmission of infection, our results support 
evidence for genetic association of 
Campylobacter strains between humans and 
their pets but do not prove that transmission of 
such strains occurs from pets to humans, or 
vice versa. Although directionality of 
transmission could not be inferred, the 
combined analysis and the co-isolation of 
identical STs in pets and their owners proved 
that dog (particularly puppy) ownership is a 
risk factor for human Campylobacter infection 
caused by STs of probable pet origin and that 
co-isolation of identical strains in humans and 
their pets occurs more frequently than 
expected. It is still unclear to what extent this 
increased risk in dog owners is an indication of 
other unmeasured factors, such as owner’s 
personality traits, lifestyle, income, disability 
or other health problems, which can plausibly 
influence the chance of becoming infected and 
the decision and manner of owning a pet. It is 
therefore recommendable to put the zoonotic 
risk posed by pets into context, depending on 
factors such as level of Campylobacter 
carriage and intensity and type of contact 
between pets and humans. 
We also noted that attributing human 
infections to pets using the AI model may be 
misleading when the goal is to identify the 
original reservoirs, as pets may artificially 
General discussion and conclusions 
129 
 
account for an abnormal amount of cases just 
because they are, like humans, predominantly 
endpoint hosts for campylobacters (as humans 
and pets share many sources of infection). 
Conversely, the contribution of the other 
reservoirs included in the model will be 
underestimated and probably biased towards 
those reservoirs from which pets acquire 
infection.  
To elucidate the role of travellers, a 
possible "anthroponotic source" of 
campylobacters, we investigated: 1) the MLST 
profiles of C. jejuni and C. coli strains isolated 
from travellers returning to The Netherlands in 
comparison with those isolated from 
domestically-acquired cases; 2) the risk factors 
for travel-related campylobacteriosis by 
comparing the exposures of the returned 
travellers with those of travellers in the 
enrolled control population; and 3) the risk 
factors for domestically acquired 
campylobacteriosis caused by strains of 
probable exotic origin (putatively carried by 
the returned travellers) by applying our 
combined source attribution and case-control 
analysis. 
Travellers are known to be particularly 
prone to experiencing symptomatic 
Campylobacter infections when travelling 
abroad as partial immunity to (severe) disease 
is acquired over time with repeated exposure to 
local Campylobacter strains. Indeed, there is 
some evidence suggesting that the 
disproportionately higher risk of 
campylobacteriosis in international travellers is 
not limited to higher levels of exposure in 
developing countries, but also to the possible 
presence of "new" (for the travellers) 
Campylobacter strains that are endemic in the 
different travel regions (strong regional 
clustering) and to which travellers have hardly 
been exposed before [27]. It follows that, 
probabilistically, these "new" strains are more 
likely to be associated with regionally untested 
antigens than widespread strains, and acquired 
protection may be ineffective when exposed to 
uncommon strains, as evidenced by a recent 
Canadian study [28]. We therefore 
hypothesized that when returning to the 
original countries, the infected, but not 
necessarily symptomatic [27], travellers, may 
introduce into the domestic population several 
"exotic" strains with a higher probability of 
possessing antigens that are underrepresented 
in the local reservoirs, i.e. food-producing 
animals, pets and wildlife. These exotically 
introduced strains would therefore have at least 
the potential to spill-over into the domestic 
population and at first spread 
anthroponotically. 
Results revealed, again and 
convincingly, that travelling to Asia, Africa, 
Latin America and the Caribbean, and 
Southern Europe is associated with an 
increased risk for campylobacteriosis 
compared to travelling to Western Europe, 
which comprises the neighbouring countries of 
The Netherlands. STs of travellers showed 
more ST diversity than non-travellers 
(domestically acquired infections), and some 
STs had a significant regional clustering. 
Moreover, travellers infected with STs that 
were undetected domestically had travelled 
predominantly to distant destinations, 
suggesting that differences in STs are related, 
to some extent, to the geographical distance of 
the travel region compared to The Netherlands, 
as also evidenced in the analysis presented in 
Chapter 5. The larger ST diversity in travellers 
combined with the association of some STs 
with specific destinations is consistent with the 
presence of heterogeneously distributed clones 
that are endemic in the different regions but 
not so prevalent elsewhere in the world. 
Although so far there has been no evidence of 
ST-specific immune responses, it is 
conceivable that the chance of being exposed 
to a ST with uncommon antigens is somewhat 
higher for STs that are rarely, rather than 
commonly, encountered. STs that are 
associated with strong regional clustering 
would therefore pose a higher risk to the 
travellers also because of limited, if absent, 
prior (repeated) exposure in addition to issues 
related to sanitation failure. This hypothesis 
nicely fits with existing knowledge about 
acquired immunity to campylobacters with 
repeated exposure over time, as also suggested 
by our age distribution of STs.  
From a preventive point of view, these 
results highlight the considerable potential 
value of Campylobacter vaccines for humans. 
This potential would relate to the prevention of 
acute infection and, most importantly, 
sequelae, which would lead to a greater 
reduction in the burden of disease. While 
vaccines are unlikely to be used in a 
prophylactic role for the general public, they 
would have a value for high-risk groups, such 
as travellers or military troops. However, 
considerable research is required before this 
potential can be realized. Indeed, in the past 
years, considerable research efforts have been 
made in both the public and private sectors to 
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develop new diarrhoeal disease interventions, 
including vaccines against rotavirus, cholera, 
typhoid, enterotoxigenic E. coli and Shigella. 
However, currently there are no approved 
vaccines or drugs that prevent Campylobacter-
associated traveller's diarrhoea. Obviously, 
antibiotics can treat illness, but cannot prevent 
it effectively, resulting in decreased 
productivity of travellers. Moreover, antibiotic 
treatment may have the unintended 
consequence of contributing to increased 
antimicrobial resistance. 
Besides universal risk factors for 
campylobacteriosis, such as eating chicken, 
using antacids, and having chronic 
gastrointestinal diseases, we also identified 
eating vegetable salad outside Europe, drinking 
bottled water in high-risk destinations (a proxy 
for local circumstances where there is a risk for 
campylobacteriosis higher than that which can 
be prevented by drinking bottled water), and 
contacting raw pork as specific risk factors for 
travel-related campylobacteriosis.  
Risk factors for domestically-acquired 
campylobacteriosis caused by exotic STs 
involved predominantly person-to-person 
contacts around popular holiday periods. It was 
therefore hypothesized that travellers infected 
with strains possessing uncommon antigens 
might still be shedding them after returning to 
The Netherlands, most likely 
asymptomatically. As there is unlikely to be a 
high prevalence of acquired protection to these 
strains domestically, there is at least the 
potential for these exotically introduced strains 
to spread even through limited person-to-
person transmission.  
Investigating MLST profiles of C. 
jejuni/coli strains isolated from travellers, the 
risk factors potentially responsible for the 
acquisition of such strains upon travelling, and 
those potentially responsible for their 
secondary spread to domestic populations, was 
useful in expanding our understanding of 
regional risk differences, high-risk exposures 
in varying epidemiological dimensions, and 
Campylobacter behaviour and survival 
strategies in response to newly available 
susceptible populations and changing 
environments. We concluded that risk factors 
for travel-related campylobacteriosis differ 
from those for domestically acquired 
infections. There is also suggestive evidence 
that returning travellers may play an important 
role in Campylobacter epidemiology by 
carrying several exotic strains that might 
subsequently spread to domestic populations.  
In extending the application of source 
attribution modelling to previously scarcely 
explored sources, we have discovered a mine 
of novel insights to expand our knowledge and 
generate hypotheses about Campylobacter 
(transboundary) epidemiology at the human-
animal-environmental interfaces. Ultimately, 
by enhancing our ability to characterize the 
risk for human campylobacteriosis, public 
health initiatives can be better informed. 
Future challenges of extended source 
attribution analyses will be the consideration of 
sources of particular subsets of human cases, 
such as those with infections resistant to 
antimicrobials and those associated with 
particular sequelae, such as Guillain-Barré 
syndrome. Moreover, methods based on 
microbial subtyping could be used to model 
the relative contribution of reservoirs 
contaminating particular pathways, such as 
surface water supplies to water treatment 
plants. Similarly, molecular epidemiological 
techniques using similar modelling approaches 
could be used to understand transmission 
cycles in primary production. This will require 
the conduction of newly tailored 
epidemiological studies and modelling 
approaches for the years to come. 
 
 
6. CONCLUSIVE CONSIDERATIONS 
 
Salmonella and Campylobacter are the 
most common zoonotic bacterial causes of 
human gastroenteritis in the world, causing 
considerable morbidity, mortality and 
economic impact. It is expected that these 
pathogens will continue to be of paramount 
importance in the future, as the global 
population moves toward animal products as a 
primary source of proteins. On a global scale, 
the distribution of such pathogens is also 
expected to be influenced by increased 
international trade and travel.  
The epidemiology of salmonellas and 
campylobacters is complex; thus, a multi-tiered 
approach to control is needed, taking into 
account the different reservoirs, pathways, 
exposures and risk factors involved. Most 
recent epidemiological research conducted on 
salmonellas and campylobacters has been 
focused on S. Enteritidis and S. Typhimurium, 
and on C. jejuni and C. coli, whereas relatively 
little is known about the epidemiology of the 
other Salmonella serotypes and Campylobacter 
species with zoonotic potential. In public 
health terms, there is already a sufficient 
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evidence base to deal with the burden of S. 
Enteritidis, S. Typhimurium, C. jejuni and C. 
coli infections, whereas the importance of 
other Salmonella serotypes and Campylobacter 
species, although unclear, is unlikely to eclipse 
that of these pathogens.  
Good surveillance is the starting point 
for studies of burden of disease and source 
attribution aimed at providing the evidence 
base that drives the need for control measures 
across all outcomes of human salmonellosis 
and campylobacteriosis. Recent developments 
in source attribution modelling and the ever-
increasing number of countries conducting 
integrated laboratory-based surveillance is 
expected to result in significant advances in 
epidemiological research on various food-
borne pathogens as well as in improved 
(evidence-based) control programmes.  
Food-borne disease control needs to be 
adapted to local possibilities, practicalities and 
preferences. Some basic principles, however, 
are generally applicable and recommendable 
(e.g. biosecurity). While, historically, the 
primary target for Salmonella- and 
Campylobacter-reducing control programmes 
has been the poultry sector and, to a lesser 
extent, pigs and ruminants, some (emerging) 
transmission vehicles, such as raw milk, fresh 
produce and drinking water are in urgent need 
of attention. Although poultry is the historical 
source of Salmonella and Campylobacter 
infection in many countries, there is evidence 
that controlling such pathogens in poultry will 
not completely eliminate the problem. Options 
are available to target control pathways other 
than poultry. 
It is difficult to trace sources of 
Campylobacter and, to a lesser extent, 
Salmonella infections because of their 
apparently sporadic nature and the important 
role of cross-contamination. Yet, many 
countries working to prevent food-borne 
salmonellosis and campylobacteriosis have 
made considerable progress on numerous 
fronts during the past years. Technological and 
scientific advances moving towards rapid, 
high-throughput, comprehensive analytical 
methods offer new approaches, such as whole 
genome sequencing. It is highly likely that 
most classical phenotyping techniques will be 
soon replaced by inexpensive and less labour-
demanding genome-based tools. Source 
attribution studies are therefore expected to 
adopt a more holistic attitude, integrating 
different approaches, considering multiple 
sources and pathways of exposure but also 
relying on (genotypic) data with enhanced 
discriminatory power. 
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1. GENERAL ABSTRACT 
 
Salmonella and Campylobacter are common causes of human gastroenteritis. Their 
epidemiology is complex and a multi-tiered approach to control is needed, taking into account the 
different reservoirs, pathways and risk factors. In this thesis, trends in human gastroenteritis and food-
borne outbreak notifications in Italy were explored. Moreover, the improved sensitivity of two 
recently-implemented regional surveillance systems in Lombardy and Piedmont was evidenced, 
providing a basis for improving notification at the national level. Trends in human Salmonella 
serovars were explored: serovars Enteritidis and Infantis decreased, Typhimurium remained stable and 
4,[5],12:i:-, Derby and Napoli increased, suggesting that sources of infection have changed over time. 
Attribution analysis identified pigs as the main source of human salmonellosis in Italy, accounting for 
43–60% of infections, followed by Gallus gallus (18–34%). Attributions to pigs and Gallus gallus 
showed increasing and decreasing trends, respectively. Potential bias and sampling issues related to 
the use of non-local or non-recent multilocus sequence typing (MLST) data in Campylobacter 
jejuni/coli source attribution using the Asymmetric Island (AI) model were explored. As MLST data 
become increasingly dissimilar with increasing geographical and temporal distance, attributions to 
sources not sampled close to human cases can be underestimated. A combined case-control and source 
attribution analysis was developed to investigate risk factors for human Campylobacter jejuni/coli 
infections of chicken, ruminant, environmental, pet and exotic origin. Most infections (~87%) were 
attributed to chicken and cattle. Individuals infected from different reservoirs had different associated 
risk factors: chicken consumption increased the risk for chicken-attributed infections; animal contact, 
barbecuing, tripe consumption, and never/seldom chicken consumption increased that for ruminant-
attributed infections; game consumption and attending swimming pools increased that for 
environment-attributed infections; and dog ownership increased that for environment- and pet-
attributed infections. Person-to-person contacts around holiday periods were risk factors for infections 
with exotic strains, putatively introduced by returning travellers.  
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